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Abstract 
Escherichia coli O157:H7 and over 380 non-O157 serotypes of Shiga toxin producing E. 
coli (STEC) are human food-borne pathogens that inhabit the hindgut of ruminants and are shed 
in the feces, which subsequently contaminate food products.  Recent epidemiological data have 
shown that six non-O157 STEC (O26, O103, O111, O121, O45 and O145) account for majority 
of human STEC infections.  Fecal shedding of STEC is influenced by a number of factors, 
including diets, supplements, and feed additives, because of their potential to alter hindgut 
ecosystem.  Not much is known about the fecal shedding of non-O157 STEC in cattle because of 
lack of standardized detection methods.  Fecal shedding of E. coli O157:H7 was studied to 
determine the effects of supplemental urea, monensin, an ionophore, and ractopamine, a beta-
agonist.  Cattle fed monensin at 44 mg/kg of feed had lower (P = 0.05) fecal O157:H7 
prevalence than cattle fed 33 mg/kg.  Supplemental urea (0.35 or 0.70% of the diet) and 
inclusion of ractopamine at 200 mg/animal/day had no effect on fecal shedding of E. coli 
O157:H7.  In an experimental inoculation study, inclusion of corn starch to a distiller’s grains 
(DG)-supplemented diet had no effect on fecal shedding of E. coli O157 suggesting that either 
the decreased starch content in the DG-supplemented diet is not a factor in the increased 
shedding of E. coli O157:H7 or inclusion of pure starch in the diet may not have achieved our 
intended goal to have starch flow into the hindgut similar to that of corn grain.  A multiplex PCR 
to detect O26, O45, O103, O111, O121, O145, and O157 was designed and applicability to 
detect the seven serogroups in cattle feces was evaluated.  A multiplex PCR, designed to detect 
E. coli O104, feces showed presence of O104 in cattle feces (20.6%), but the isolated strains did 
not carry genes characteristic of the virulent strain responsible for the 2011 food-borne outbreak 
in Germany.  Two preharvest interventions, a siderophore receptor and porin proteins-based 
vaccine and a Lactobacillus acidophilus-based direct-fed microbial, intended to control E. coli 
O157, had no effect on fecal shedding of O26 assessed by culture-based or PCR-based method. 
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Abstract 
Escherichia coli O157:H7 and over 380 non-O157 serotypes of Shiga toxin producing E. coli 
(STEC) are human food-borne pathogens that inhabit the hindgut of ruminants and are shed in 
the feces, which subsequently contaminate food products.  Recent epidemiological data have 
shown that six non-O157 STEC (O26, O103, O111, O121, O45 and O145) account for majority 
of human STEC infections.  Fecal shedding of STEC is influenced by a number of factors, 
including diets, supplements, and feed additives, because of their potential to alter hindgut 
ecosystem.  Not much is known about the fecal shedding of non-O157 STEC in cattle because of 
lack of standardized detection methods.  Fecal shedding of E. coli O157:H7 was studied to 
determine the effects of supplemental urea, monensin, an ionophore, and ractopamine, a beta-
agonist.  Cattle fed monensin at 44 mg/kg of feed had lower (P = 0.05) fecal O157:H7 
prevalence than cattle fed 33 mg/kg.  Supplemental urea (0.35 or 0.70% of the diet) and 
inclusion of ractopamine at 200 mg/animal/day had no effect on fecal shedding of E. coli 
O157:H7.  In an experimental inoculation study, inclusion of corn starch to a distiller’s grains 
(DG)-supplemented diet had no effect on fecal shedding of E. coli O157 suggesting that either 
the decreased starch content in the DG-supplemented diet is not a factor in the increased 
shedding of E. coli O157:H7 or inclusion of pure starch in the diet may not have achieved our 
intended goal to have starch flow into the hindgut similar to that of corn grain.  A multiplex PCR 
to detect O26, O45, O103, O111, O121, O145, and O157 was designed and applicability to 
detect the seven serogroups in cattle feces was evaluated.  A multiplex PCR, designed to detect 
E. coli O104, feces showed presence of O104 in cattle feces (20.6%), but the isolated strains did 
not carry genes characteristic of the virulent strain responsible for the 2011 food-borne outbreak 
in Germany.  Two preharvest interventions, a siderophore receptor and porin proteins-based 
vaccine and a Lactobacillus acidophilus-based direct-fed microbial, intended to control E. coli 
O157, had no effect on fecal shedding of O26 assessed by culture-based or PCR-based method.  
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Chapter 1 - Shiga toxin-producing Escherichia coli: A review of 
detection, isolation, pathogenicity and prevalence in ruminant feces. 
 
Introduction   
The bacterium, Escherichia coli, has been studied for over 125 years.  After a standardized 
serotyping scheme was introduced (Kauffmann, 1947), it was observed that certain serogroups E. 
coli (O26, O55 and O111) were more commonly associated with human disease (Ewing et al., 
1963); while other serogroups were seemingly avirulent (Koya et al., 1954).  As researchers 
began to identify the virulence factors and virulence mechanisms of pathogenic E. coli, a potent 
cytotoxin was identified in certain strains (O26, O111, O113 and O157; Karmali et al., 1983) 
which was differentiated from previously discovered toxins due to specific cytotoxic effects on 
Vero cells (Smith and Linggood, 1971; Konawalchuk et al. 1977).  Analysis of the toxin showed 
it to be an AB-type toxin similar that of Shigella spp leading some researchers to refer to it as 
“Shiga-like toxin” (O’Brien and La Veck, 1983).  Currently the toxin is referred to 
interchangeably as either Verotoxin (Vtx) or Shiga toxin (Stx); consequently E. coli producing 
the toxin is referred to as either Verotoxin-producing E. coli (VTEC) or Shiga toxin-producing E. 
coli (STEC; this review will use the Stx and STEC nomenclature).  Over 380 STEC serotypes 
have been identified (Karmali et al., 2010), however only a small subset of these produces the 
majority of human disease, which some researchers have further defined as enterohemorrhagic E. 
coli EHEC (Levine et al., 1987; Cleary, 2004).  However, in studies examining the ecology of 
STEC in ruminant reservoirs it is not possible to definitively differentiate STEC from EHEC, but 
putative EHEC from ruminants may be differentiated based on additional virulence factors 
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commonly observed in EHEC.  Additional STEC virulence classification systems (STEC groups 
A through E) have been devised based on a serotype’s past association with human disease 
(Karmali et al., 2003); however due to E. coli’s constantly evolving nature, recently 
demonstrated with the an outbreak of a hybrid strain of STEC O104:H4 in Europe (Bielaszewska 
et al., 2011), classifying STEC based on past strains may be problematic.   
Initially, only a few STEC serogroups were identified (O26, O111, O113 and O157; Karmali 
et al., 1983), but after large outbreaks of serotype O157:H7 (Riley et al., 1983; Bell et al., 1994) 
research was focused specifically on this serotype.  Recently epidemiological data have shown 
that non-O157 STEC account for over 60 percent of STEC infections in humans (Scallan et al., 
2011).  Some researchers have linked this increase to better and increased testing in state health 
laboratories (Stigi et al., 2012); however only 30% of laboratories have implemented some form 
of non-O157 STEC testing.  While the United States government declared O157:H7 an 
adulterant in raw ground beef and a reportable disease in 1994 and 1995 (USDA/FSIS, 2011), 
classification of non-O157 STEC as a reportable disease did not occur until 2005 and only the 
top 7 disease causing STEC serogroups have now been declared adulterants in non-intact beef 
cuts (USDA/FSIS, 2011).  As a result, only recently has interest and funding for research into the 
epidemiology and prevention of non-O157 STEC occurred.  The cost to the US economy 
through illness for O157:H7 is estimated to be 333.5 million dollars (Frenzen et al., 2005).  
However, this estimate only accounts for the O157 serogroup, since non-O157 STEC now 
account for a greater number of human illness and will now be subject to recalls, the cost to the 
US economy by STEC is likely to grow.  Therefore implementing intervention strategies that 
mitigate the risk of human disease and economic loss caused by STEC will become paramount.  
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However, to design and evaluate intervention strategies, the ecology of non-O157 STEC in beef 
cattle must be researched and understood.   
Ruminant animals are the primary reservoir for both non-O157 and O157 STEC where the 
organisms asymptomatically inhabit the gastrointestinal tract and are excreted in the feces, which 
subsequently contaminate meat, produce and water supplies, thereby contributing to human 
infections (Brooks et al., 2005; Karmali et al., 2010).  The prevalence and ecology of O157 
STEC in ruminants have been well studied and reviewed (Callaway et al., 2009).  While multiple 
researchers world-wide have examined the prevalence of non-O157 STEC in ruminants, a 
limited number of experiments have attempted to investigate the ecology of non-O157 STEC in 
ruminants.  However, due to the lack of a standardized and effective isolation and detection 
methods, coupled with the inherent variation in the shedding of E. coli, past research must be 
examined cautiously.   
In order to study the ecology of STEC in ruminants, the organism must first be isolated from 
fecal samples.  To isolate the O157:H7 STEC serotype, the procedure (Glyes, 2007; Vimont et 
al., 2006) has been standardized and optimized to the point in which it can be implanted in very 
large sample size studies.  This procedure involves enriching fecal matter in a selective broth, 
followed by concentration of the O157 STEC from the enriched broth with immunomagnetic 
beads, which are then plated on modified MacConkey agar developed to exploit conserved 
resistance to cefixime and potassium tellurite and inability to ferment sorbitol within the 
O157:H7 serotype (CT-SMAC; Chapman et al., 1991; Zadik et al., 1993).  However, CT-SMAC 
will not work to detect non-O157 STEC, primarily because majority of non-O157 STEC’s ability 
to ferment sorbitol (Caprioli et al., 1997; Posse et al., 2007).  Preliminary fecal sample screening 
methods, such as multiplex PCR (mPCR; Bai et al., 2012), have been developed to screen for 
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STEC serogroup and virulence genes, but mPCR screening cannot confirm that serogroup and 
virulence genes exist in the same E. coli.  Further processing of the sample to isolate the 
bacterium must be performed to determine if E. coli serogroups present harbor virulence genes.  
To isolate colonies, fecal samples must be enriched (Paddock et al., 2012), subjected to 
serogroup specific IMS procedures and plated on a selective and differential agar for STEC; 
however this agar has not been identified.  Currently, a medium described by (Posse et al., 
(2007) and commercial (Rainbow, CHROMagar STEC) agars have been developed for non-
O157 isolation and work relatively well to identify pure culture STEC serogroups (Hirvonen et 
al., 2012); however, when attempting to isolate STEC from a culture containing background 
flora, such as meat or fecal samples, the effectiveness has not been completely investigated and 
may be questionable.  This review will discuss the current detection and isolation techniques, 
virulence characteristics of non-O157 STEC and non-O157 STEC prevalence in cattle feces.   
 
Historical Overview 
 Escherichia coli was first described by Theodore Escherich (1885) as a commensal 
ubiquitous organism of healthy human feces.  The organism, originally termed Bacterium coli 
commune, was re-named to Escherichia coli and further biochemically characterized by 
Castellania and Chalmers (1919) due to the Bacterium taxonomic group growing too large and 
diverse, however the two names were used interchangeably until 1958 when the Judicial 
Commission of the International Committee on Bacterial Nomenclature officially adopted 
Escherichia coli for bacteria matching the physical (Gram negative, short rod) and biochemical 
properties (facultative anaerobic; glucose, lactose, dulcitol, and adonitol fermenting, and indole 
producing).  Early research into pathogenic E. coli involved investigations into infantile diarrhea, 
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also known as “summer diarrhea”, which was a leading cause of infant morbidity and mortality 
in industrialized nations during the late 19th and early 20th century (Robins-Browne, 1987) and is 
still a problem in developing countries (Trabulsi et al., 2002).  Seasonality and communal 
infection patterns observed with summer diarrhea lead early researchers to hypothesis it was 
caused by a bacterial agent (Robins-Browne, 1987).  Bray (1945) is regarded (Donnenberg and 
Kaper 1992; Jenkins et al., 2007; Robins-Browne 1987) as the definitive publication 
demonstrating a positive association between E. coli and summer diarrhea in infants.  However, 
evidence suggesting E. coli’s gastro-intestinal pathogenicity was demonstrated earlier by Lesage 
(1897) when serum from patients experiencing diarrhea agglutinated E. coli from different 
diarrheic patients, but not  E. coli of healthy individuals.  This research was also the first to 
postulate that there may be both pathogenic and non-pathogenic strains of E. coli.  Adam (1923; 
1927), Goldschmidt (1933), and Dulaney and Michelson (1935) all cultured sero-distinct E. coli 
strains from infants experiencing diarrhea, but it was not until Bray (1945), who identified an 
antigenically homogenous strain of E. coli from infants with diarrhea, which was subsequently 
confirmed by Giles et al., (1949) and Taler et al., (1949), did the scientific community accepted 
certain E. coli strains were pathogenic and the causative agent of summer diarrhea in infants.  At 
this time a standardized E. coli serotyping scheme, based the serotyping scheme for Salmonella 
enterica, was developed (Kauffmann, 1947) and researchers observed that the same serogroups 
were regularly isolated from infants experiencing diarrhea regardless of location (Neter et al., 
1955). 
Up to the early 1950, pathogenic E. coli were only considered to cause gastrointestinal 
disease in infants, the ability of certain E. coli strains to cause gastrointestinal disease in adults 
was not proven until Kirby et al., (1950); who performed experimental inoculations of E. coli 
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isolated from diarrhetic infants on adult volunteers resulting in diarrhea, but when E. coli from 
healthy babies was inoculated into adult volunteers no symptoms were observed (Koya et al., 
1954).  The term “Enteropathogenic E. coli” (EPEC) was subsequently coined by Neter et al., 
(1955) to describe E. coli strains causing gastrointestinal disease.  Research then began to focus 
on mechanisms of pathogenicity, primarily by identifying cytotoxic substances first in animal 
ligated-illeal loop models and later in vitro cell cultures.  Taylor and Bettelheim (1966) were the 
first to demonstrate a heat-liable enterotoxigenic (LT) substance from EPEC produced diarrheic 
effects when applied to a ligated-illeal loop assay, while E. coli from healthy individuals lacked 
these substances.  This was confirmed by Smith and Gyles (1970) who demonstrated that heat 
stable forms of the enterotoxin (HT) also existed.  Enteropathogenic E. coli strains producing HT 
and LT were re-termed enterotoxigenic E. coli (ETEC) and produce watery diarrhea commonly 
referred to as “Traveler’s Diarrhea”.  It was observed that some EPEC were negative for LT and 
HT therefore research continued and identified an additional toxin that was biochemically and 
antigenically different LT and HT (Smith and Linggood, 1971).  It was soon observed that this 
new toxin could be easily distinguished from HT and LT by observing its greater cytotoxic 
effects on Vero cells (kidney cells from African green monkey; Smith and Linggood, 1971) and 
was therefore termed Verotoxin (Vtx; Konowalchuck et al., 1977).  The structure of Vtx was 
observed to be closely related to the Shigella spp toxin (O’Brien and La Veck, 1983) and 
therefore some began referring to Vtx as Shiga toxin (Stx).  The Vtx and Stx nomenclature are 
used interchangeably; strains of E. coli the toxin gene or producing toxin are commonly referred 
to as either Verotoxin-producing E. coli (VTEC) or Shiga toxin-producing E. coli (STEC), 
during this review the Stx and STEC nomenclature will be used. 
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Since these early discoveries over 380 serotypes of STEC have been identified (Karmali et 
al., 2010) belonging to 162 O groups (Bettelheim, 2007); however only a small subset of these 
cause the majority of human illness.  While the infamous O157:H7 serotype has received much 
of the public and research attention due to early well publicized outbreaks (Riley et al., 1983; 
Bell et al., 1994), other major STEC serogroups (O26, O103, O111, O128 and O145) were 
simultaneously causing less publicized outbreaks (Bettelheim, 2007).  Recently epidemiological 
data have shown that non-O157 STEC account for over 60 percent of STEC infections in 
humans (Scallan et al., 2011); however only 30% of laboratories test for non-O157 STEC (Stigi 
et al., 2012).  The top human disease causing STEC serogroups in the US are O157, O26, O103, 
O111, O121, O45, O145 O124 O118, O69 and O128 (Scallan et al., 2011).  Epidemiological 
investigations into outbreaks of these serogroups have commonly identified ruminants as the 
source of contamination (Brooks et al., 2005).  Research studying the prevalence of non-O157 
STEC in ruminants have also commonly isolated these serogroups (Bettelheim, 2007); however 
due to variations in detection and isolation methods, it is difficult to compare results across 
studies and to access the effectiveness of each studies ability to detect and isolate non-O157 
STEC.  
 
Fecal Detection and Isolation Methodologies 
While the fecal detection and isolation methods for the STEC O157 are well defined and 
accepted, similar procedures have not been fully developed for non-O157 STEC.  Due to the lack 
of standardized isolation and detection methods for non-O157 STEC, clinical laboratories have 
made limited attempts to detect STEC, most often only screening fecal matter for the Stx (Stigi 
et al., 2012).  Not only are non-O157 STEC fecal isolation methods required for defining human 
8 
 
clinical cases, these methods are also required to study the ecology of the organism in its primary 
reservoir and source of human infection, cattle.  For studies examining the prevalence of non-
O157 STEC in cattle feces, few have used the same methodologies and even fewer have used all 
of the most current technologies (enrichment, screening, IMS and selective/differential agar). 
This section will focus on detection and isolation methodologies developed specifically to study 
non-O157 STEC in cattle feces.   
 
 Fecal Sampling methods 
Variation in methodologies begins with the collection of a fecal sample; researchers have 
generally collected samples in one of four ways: pen floor fecal pat, rectal fecal grab, rectal fecal 
swab or recto-anal mucosal swab.  It has not been examined if any one method is potentially 
more sensitive than the other for the detection of non-O157 STEC; however differences among 
fecal sampling methods have been examined for isolation of STEC O157.  Cultures from recto-
anal mucosal swabs were observed to have a greater sensitivity than fecal samples for the 
detection of STEC O157 (Rice et al., 2003; Greenquist et al., 2005); probably due to the 
colonization of the recto-anal mucosal by STEC O157 (Naylor et al., 2003; Walker et al., 2010).  
In contrast, others (Khaitsa et al., 2005; Niu et al., 2008) have found fecal grab samples to be 
more sensitive in the detection of STEC O157 compared to recto-anal mucosal swabs.  It is 
possible that non-O157 STEC colonizes the same location and therefore sample collection 
techniques would be expected to similarly affect non-O157 STEC prevalence; however this has 
not been examined.  Sample collection technique is more likely to be dictated by the 
experimental design and facilities available.  Rectal fecal grab, rectal swabs and recto-anal 
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mucosal swabs must be collected when the animal is restrained in a squeeze chute.  While this is 
an advantage in longitudinal studies since the prevalence in individual animals may be followed, 
it may not be practical for large or commercial feedlot studies.  Also by moving the animals 
through the same chute system it is conceivable that any treatment effects being investigated may 
be confounded due to the spread of fecal matter throughout the chute system and cross-
contamination of animals of different treatment groups.  Pen floor fecal samples are logistically 
easier, avoid removing the animals from their pens, and minimize cross-contamination.  
However, records of which fecal pat came from which animal are not easily documented, 
therefore individual animal prevalence throughout a longitudinal study cannot be easily 
ascertained.  Furthermore, care must be taken when collecting pen floor fecal pats in order to 
avoid ground contamination and repeated sampling of the same animal on the same sampling 
day. 
 
 Enrichment method 
The collected fecal samples are commonly suspended in a broth either to allow for easier 
direct streaking onto isolation agar or for an enrichment step prior to IMS and streaking onto 
isolation agar.  While the enrichment step is optional, if it is not utilized, only fecal samples with 
high concentrations (> 105 CFU/g) of the organism can be detected (Paddock et al., 2012).  If an 
enrichment step is included the detection limit can be enhanced to approximately 102 CFU/g of 
pre-enrichment STEC (Paddock et al,. 2012); however those detection limits are based on a 
screening of the enrichment broth with a multiplex PCR, isolation techniques are less sensitive.  
A variety of enrichment procedures have been used with different broths, inoculation ratios and 
incubation conditions.  The inoculation ratio of fecal sample placed in broth has ranged from 1.0 
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g of feces in 10.0 ml of broth up to 25.0 g of feces in 225 ml of broth.  Across most studies, a 
dilution factor of 1 part feces to10 parts broth was utilized; however extremes were observed 
such as 0.05 g in 10.0 ml of broth (Pearce et al., 2004).  Evans et al. (2011) evaluated the 
effectiveness of different ratios finding that 1.0 g of feces in 10.0 ml of broth compared to 10.0 g 
of feces in 225 ml of broth resulted in a greater numbers of fecal samples positive for targeted 
isolates.  Evans et al. (2011) also observed that higher prevalence of target isolates were 
observed when samples were run in duplicate.  Furthermore, collection of larger fecal samples 
(10.0 g) may be difficult.  When swabs are used the weight of the sample cannot be determined 
but the swab is generally placed in 10.0 ml of broth (Cobbold and Desmarchelier, 2000; Cobbold 
et al., 2004; Fukushima and Seki, 2006).   
 For the enrichment media, a variety of broths have been utilized both non-selective and 
selective.  Buffered peptone water (BPW) and trypticase soy broth (TSB) has been used as a 
non-selective recovery broth (Pearce et al., 2004; Shaw et al., 2004; Cookson et al., 2006; 
Fukuchima and Seki 2006; Pearce et al., 2006; Evans et al., 201; Khandaghi et al., 2011); while 
these broths may increase the viability of any STEC present they would may also increase the 
viability of background microflora.  Kobayashi et al., (2001) used a modified version of E. coli 
broth in which the bile salts were removed due to reports that bile salts inhibit recovery of 
injured STEC cells (Kobyayshi et al., 2001); however bile salts are the selective component of E. 
coli broth and by removing them they were using a broth similar to TSB with the similar non-
selective issues.  A selective enrichment step using MacConkey broth has been utilized by Pradel 
et al., (2000) and Renter et al., (2005), which would prevent growth of enteric Gram positive 
bacteria but not select against non-STEC Gram negative bacteria.  Others (Cobbold and 
Desmarchelier, 2000; Cobbold et al., 2004; Jeon et al., 2006; Sasaki et al., 2011) have utilized 
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selective media such as E. coli broth and enhanced it’s selectivity with the addition of antibiotics 
(novobiocin at 20 mg/l), however this addition is controversial due to the documented inhibition 
of some STEC strains by this antibiotics (Kanki et al., 2011; Vimont et al., 2007).  Joris et al., 
2011 utilized a procedure developed and validated by Posse et al., (2008) in which TSB was 
modified by the addition of novobiocin (8 mg / l), vancomycin (16 mg / l), rifampicine (2 mg / l), 
bile salts (1.5 g / l) and potassium tellurite (1.0 mg / l).  A limitation this broth (Posse et al., 
2008) would be it was validated with a limited number STEC strains; therefore it is not known 
how many strains would be excluded when it was used in a larger population.  Paddock et al., 
(2012) compared modified TSB described in Posse et al., (2008) and EC broth and observed that 
EC broth had a one log greater detection limit when the enrichment broth was tested with a 
multiplex PCR.   
Incubation conditions have also varied, even when using the same broth.  Temperatures, 
ranging from 37°C to 42°C or higher, have been used with the most common temperature being 
37°C.  It has been suggested (Gonthier et al., 2001; Vimont et al., 2006) the common use of 37°C 
originates from a publication utilizing the original outbreak strain of STEC O157 (Doyle and 
Schoeni et al., 1984).  In other studies, utilizing many strains, the optimal growth temperature for 
STEC O157 was reported to be 40°C (Gonthier et al., 2001; Nauta et al., 1999).  Few studies 
have examined optimal growth temperatures in non-O157 STEC; Gontheir et al., (2001), 
utilizing small sample sizes, have observed optimal temperatures of 41°C.  Paddock et al., (2012) 
and Vimont et al., (2007a) also compared different enrichment temperature for smaller sample 
sizes of STEC strains and observed higher temperatures (42°C) resulted in better detection 
limits.  No studies have examined optimal growth or enrichment temperatures for a larger 
collection of STEC strains.  The length of incubation has also varied but can generally be 
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classified into either shorter (6 h) or longer (18-24 h) incubations lengths.  Paddock et al., (2012) 
and Tutenel et al., (2003) documented shorter, 6 h, compared to longer, 24 h, incubation lengths 
resulted in the better detection limits when fresh bovine feces was experimentally inoculated 
with serial dilutions of STEC.  Enrichment tubes maybe held static or gently agitated during the 
incubation.  In general, the logistically simpler, static incubations are used; however some 
studies have applied agitation (Renter et al., 2005) during the incubation.  No studied has directly 
compared the recovery rates between static or agitation incubations.   
At this point enriched fecal samples may or not be screened for STEC serogroup specific 
genes and virulence genes by PCR.  Generally, a sub-sample of the enriched fecal sample is 
removed, boiled and centrifuged to lyse the bacterial cells releasing the DNA into the supernate.  
The DNA must then be extracted and purified from the supernate via any number of commercial 
kits.  A single or multiplex PCR (Bai et al., 2012) may then be run on the purified DNA to 
determine if any genes of interest are present.  The advantage to screening fecal sample is the 
number of samples that need to be further process may be reduced.  While decreasing the 
number of samples that need to be further processed can greatly decrease cost and logistical 
concerns, there are disadvantages and concerns with screening samples by PCR.  First while it is 
generally accepted that PCR is more sensitive than culture based methods, however this may not 
necessarily always hold true.  The PCR screening must be completed quickly as to know which 
samples will need to be further processed.  Also if more than one gene are examined (i.e. a STEC 
serogroup and stx) this method cannot determine if those genes were in the same isolate.  Also 
this method relies on gene specific primers, if base pair mutations occur in the primer region of 
the target genes the PCR may no longer detect that gene.   
 
13 
 
Immunomagnetic separation is commonly performed on enriched fecal broths.  The 
procedure consists of mixing a small aliquot of enriched fecal broth with metallic beads coated 
with antigens specific to a serogroup.  The fecal broth bead mixture is gently mixed and 
incubated during which time bacteria with the appropriate surface serogroup will associate bead 
surface antigens.  The bacterial/bead complexes are removed with magnets, washed and plated 
on agar plates (described below) for colony growth.  While the advantages to the method are 
obvious in that a target bacterium are concentrated while at the same time background or non-
target bacteria are removed thereby increasing selectivity and sensitivity (Olsvik et al., 1994), 
there are just as important disadvantage.  First each bead is specific to a target serogroup; 
therefore this procedure and subsequent plating must be repeated by the number of serogroups 
that are targeted.  Currently these beads are only produced by a couple of commercial companies 
around the world and shortages are common at this point in time.  Also these beads are only 
commercially available for 5 serogroups (O26, O103, O111, O145 and O157), although blank 
beads are available and the procedure to coat beads in a serogroup of the researchers choosing 
has been published.   
 
 Isolation Media 
Whether it is the bacteria/bead complex or enriched fecal broth, to obtain isolates these 
materials must be plated on agar for colony growth and selection.  Even after selective 
enrichment and an IMS step there are still non-target organisms present.  Some researchers have 
plated enriched fecal broth or IMS beads on simple non-selective agars, such as blood agar 
(Beutin et al. 1989) or semi-selective medium such as MacConkey agar (Paddock et al., 2012).  
When random colonies are then chosen from these agar plates and tested for STEC, their success 
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is dependent on simply the ratio of STEC to non-target bacteria.  Although, some researchers 
have added a DNA hybridization step (Jenkins et al., 2002) at this point to help them identify 
STEC from the mixed colony population (discussed below).  Ideally, we should have a selective 
and differential agar for STEC similar to CT-SMAC for the O157 STEC serogroup. Most of the 
selective agars, some available commercially, were developed to target major STEC serogroups; 
however even within a STEC serogroup resistance and fermentation characteristics may widely 
vary (Posse et al., 2007).  When it is taken into account that each major serogroup will undergo 
IMS with serogroup specific beads, it may be more advantageous to develop serogroup specific 
agars.  For the STEC agars that have been developed, their efficacy when testing pure cultures or 
mixed populations of known STEC serogroups is often questionable; further exacerbating any 
discrepancies observed in pure culture tests happens when fecal samples are analyzed because 
the fermentation characteristics of the ever present background flora cannot be predicted and 
may phenotypically resemble a target serogroup.  While the serogroup specific agar approach has 
been utilized in the case of O157 for many years, only recently has the approach been applied to 
the O26 serogroup.  A Japanese research group (Hiramatsu et al., 2002) developed an agar based 
on the O26 serogroups Rhamnose fermentation deficiency and resistance to cefixime and 
potassium tellurite.  However when researchers examined 102 disease causing strains of O26, 
only 89 were able to grow on the agar and 7 of the 89 were able to ferment the rhamnose sugar 
(Bielaszewska et al., 2005).  Posse et al., (2007) developed a general STEC agar and procedure 
targeting the top 6 non-O157 serogroups.  This procedure relies on antibiotic resistance 
(novobiocin and potassium tellurite) and fermentation characteristics of the STEC serogroups.  
However this procedure was only validated with 10 to 15 strains per serogroup.  Furthermore 
after the initial plating, secondary plating on agars specific to each serogroup must be performed.  
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Commercial agars such as CHROMagar STEC (CHROMagar, Paris, France) and Rainbow 
STEC (Biolog Inc., Hayward, CA), likely work off principles similar to Posse et al., (2007), but 
do not disclose their composition.  To date, no publication has compared these media for their 
ability to recover STEC from fecal samples.  Regardless of the selectiveness or differentiating 
ability of an agar, colonies must be subsequently tested for stx and serogrouped.   
 
 Detection Methods 
Once colonies are grown on an agar plate, even if suspect colonies are differentiated by a 
type of agar plate utilized, further testing is required to confirm both virulence and serogroup.  
Multiple methods exist for the confirmation testing, each with its own advantages and 
disadvantages.  The most comprehensive method in which all colonies grown on a plate can be 
tested is known as colon hybridization (Paton and Paton, 1998).  During this process colonies are 
replicated on a nylon membrane and DNA oglio-nucleotides specific to either stx or a specific 
serogroup.  Once positive colonies are identified they can be taken from the original plate and 
preserved.  While the advantage to this method is that all colonies present on a plate are screened 
during a single procedure, however the procedure is time consuming and would be difficult for 
large numbers of plates.  All other confirmation methods involve sub-culturing a certain number 
of colonies then testing those colonies.  However the number of colonies that are sub-cultured 
varies widely (ranging from 1 to 50 to not stated) and publications rarely describe how they 
arrived at the number of colonies they are sub-culturing.  Subcultured colonies are commonly 
screened via PCR for stx or serogroup specific DNA.  These PCR reactions have been combined 
into a one-step multiplex PCR (Bai et al., 2012) to detect top virulence (including stx) and 
serogroup genes (O26, O45, O103, O111, O121, O145 and O157).  While this method is quicker 
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and easier than a hybridization method, it is limited in that a separate reaction must be performed 
for every colony.  Another method to detect Stx is to grow suspect colonies in a broth, centrifuge 
and filter sterilize the resulting supernate, then add this supernatant to Vero cells to observe 
cytotoxicity.  The gold standard for serogroup determination is agglutination with a standardized 
set of antisera; however this is only practical for serogroup reference labs that specialize in this 
method as a service.  Individual serogroup antisera can be obtained, but this method is more 
subjective than the PCR method for serogroup determination.  A less subjective antisera-based 
method (latex agglutination) that is faster than PCR is available commercially for the O157 
serogroup, however it has yet to become commercially available for any other serogroup. 
 
Virulence Genes and Pathogenicity 
Shiga toxin-producing E. coli by definition carry single or multiple prophages harboring a stx 
gene.  Over 380 serotypes of STEC have been identified (Karmali et al., 2010); however only a 
subset of these are capable of causing human disease and are typically referred to as EHEC. 
Shiga toxins are A-B type toxins (O’Brien et al., 1992), with a B-pentamer subunit that binds to 
the Gb3 host cell receptor (Lingwood, 1987; Lingwood, 1996) and an A-monomer subunit that 
internalizes into the host cell, which then alters ribosomes, blocking protein synthesis (Donohue-
Rolfe et al., 1989).  There are two isomers of Stx, referred to as Stx1 and Stx2.  Both Stx1 and 
Stx2 are associated with prophages (O'Brien et al., 1989; Strockbine, 1986) and share 56% 
amino acid homology (Jackson et al., 1987).  Shiga toxin 1 has been shown to preferentially bind 
to the host Gb3 receptors in lung tissues and is cleared relatively quickly from the host serum 
(Rutjes et al., 2002).  Shiga toxin 2 preferentially binds to host Gb3 receptors in the kidneys and 
has a longer half-life in the serum (Rutjes et al., 2002); consequently Stx2 has been shown to be 
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400 times more lethal in mouse model (Tesh et al., 1993).  Furthermore, Stx2 is more frequently 
associated with severe human disease compared to Stx1 (Boerlin et al., 1999; Ostroff et al., 
1989).  The DNA sequence of stx1 is highly conserved (Paton et al., 1995) with only a few 
variants (Stx1a, Stx1c and Stx1d; Burk et al., 2003; Paton et al., 1995).  Alternatively over 23 stx2 
variants have been identified in the literature (Stx2, Stx2v, Stx2va, Stx2vh-a, Stx2vh-b, Stx2vh-c, 
Stx2v-ox392, Stx2v-ox393, Stx2c, Stx2d-ox3a, Stx2ox3b, Stx2d-ount, Stx2O118, Stx2O111, Stx2O113, Stx2O48, 
Stx2e, Stx2ev, Stx2NV206, Stx2f, Stx2g, Stx2h, and Stx2i) which may occur alone or in combination 
(Bertin et al., 2001; Gannon et al., 1990; Ito et al., 1990; Johnson et al., 1991; Leung et al., 2003; 
Meyer, 1992; Paton et al., 1995; Paton and Paton, 1998; Paton, 1993; Pierard et al., 1998; 
Schmidt et al., 2000; Schmitt et al., 1991; Strockbine, 1986; Weinstein et al., 1989).  Due to a 
variety of stx2 variant’s nomenclatures that have been employed throughout history some of 
these names are likely referring to the same or very similar variants.  Scheutz et al., (2012) has 
set forth a Stx nomenclature system to help resolve these issues in which variants are named in a 
sequential alphabetical order (Stx2a, Stx2b, Stx2c, etc.).  As seen in figure 1, serogroups can vary 
widely between stx variants; therefore under the historical system in which some variants were 
named after the serogroup in which they were detected may greatly confound research efforts.   
 
Virulence can vary widely between variants with some Stx2 variants (Stx2a, Stx2d and 
elastase-cleaved Stx2d) being up to 25 times more virulent compared to other Stx2 variants 
(Stx2c and Stx2b; Fuller et al., 2011).  Sequence analysis comparing variants that are commonly 
associated with severe human disease to variants which are not has revealed small amino acid 
differences within in either the α-subunit or β-subunit (Ito et al., 1990; Schmitt et al., 1991) 
contributing to these variations. For example, Stx2c has α-subunit is identical to Stx2, however 
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the β-subunit is closer to the Stx2vh-a β-subunit (Schmitt et al., 1991).  The changes in the Stx2c 
β-subunit have been shown to decrease its affinity for the Gb3 receptor (Lindgren et al., 1994).  
While past researchers (Beutin et al., 2001; Brett et al., 2003) have examined the stx subtype 
within different serogroups from cattle, these studies were performed prior to the standardized 
stx nomenclature scheme and therefore it difficult to determine associations to current stx 
variants.  However it was observed that a wide range of stx variants exists and can multiple 
variants can be found with in a serogroup (Figure).   
 
Multiple copies of stx harboring prophage can be present in a single bacterium although these 
are not maintained efficiently (Fogg et al., 2011).  Loss of the prophage from STEC has also 
been document in human infections (Bielaszewska et al., 2007) and upon sub-culturing of 
ruminant isolates (Joris et al., 2011).  While stx is responsible for the severe disease caused by 
STEC, some STEC do not cause disease signifying other virulence and colonization factors may 
be required for disease.   
STEC form a close attachment to the host intestine through effector proteins that target the 
microvilla epithelial cells, inducing actin re-arrangement and pedestal formation (Knutton et al., 
1989) resulting in effacement of the microvilli (Moon et al., 1979) creating areas known as 
attachment and effacement lesions (A/E; Moon et al., 1983).  The first of these proteins to be 
discovered was intimin (Jerse et al., 1991) which is a bacterial cell surface protein that assists in 
the attachment of bacterial cells and the host cells.  The intimin protein is encoded by a gene 
termed E. coli attaching and effacing (eae; Jerse et al., 1990) located on a chromosomally 
encoded pathogenic island termed the locus of enterocyte effacement (LEE).  Presently 33 
variants of the eae have been described (Horcajo et al., 2011).  The LEE pathogenicity island and 
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specially eae is commonly used as a marker for EHEC.  While much of the research into eae and 
LEE was carried out with O157:H7 strains, it has been documented that non-O157 STEC strains 
have the same eae variants and similar LEE pathogenicity islands.  Posse et al., (2007) examined 
84 STEC strains and that 97.6 % were positive for eae.  When the eae variants were determined, 
an association between variant and serotype was documented (Table 1).   
The LEE also encodes a variety of effector proteins as well as a type III secretion system 
(T3SS) that injects the effector proteins directly into host cells.  One effector protein is a 
translocated intimin receptor (tir) host cells that acts as a receptor for eae.  A-typical EPEC are 
hypothesized to be closely related to STEC as they harbor eae and LEE with the same 
association between serotype and eae variant (Sekse et al., 2011).  It is further hypothesized that 
aEPEC are STEC that have lost the stx prophage (Bielaszewska, et al., 2007; Joris et al., 2011) or 
alternatively STEC are aEPEC that have gained a stx prophage (Sekse et al., 2011).   
STEC may possess accessory putative virulence factors such as the enterohemolysin, also 
known as enterohemorrhagic E. coli hemolysin (EHEC-Hly; Beutin et al., 1989), which is 
encoded by ehx gene on a plasma termed pO157 (Schmidt et al., 1995).  This hemolysin 
produces a small turbid zone of hemolysis on blood agar after 18-24 h.  It is commonly 
associated with O157 and non-O157 STEC (Djordjevic et al., 2004) and is thought to enhance 
the virulence of STEC through synergistic cell disruption effects with Stx.  Posse et al., (2007) 
examined 84 STEC strains and observed that 91.7% were positive for ehx. 
The fliC gene is responsible for the H-type of E. coli and has also been associated with 
disease causing strains (Beutin et al., 2004).  While some H-types have a clear and well known 
association to disease causing serotypes, such as the H7 in the O157:H7 serotype, associations 
with disease and non-O157 serotypes is less clear.  Some associations have been documented 
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(Table 2); however H-negative clinical STEC strains have also been historically associated with 
these O-groups.  The discrepancy may arise from the method of H-typing that was performed.  
When classic antigen-based typing is performed, the flagella must be present on the surface of 
the bacteria; however when molecular methods targeting polymorphisms in the fliC gene are 
utilized, only the gene must be present (Prager et al., 2003).  When researchers have re-examined 
culture collections of STEC which were previously evaluated with H-type antigen-based testing 
with molecular H-type testing, an H-type was observed which matched the expected H-type of 
flagella producing strains.   (Mellmann et al., 2008). 
Genetic transfer has been shown to be a major factor of bacterial evolution (Ochman et al., 
(2000) responsible for the Stx prophages that convert E. coli to STEC.  Ogura et al., 2009 
performed genomic analysis on published sequences of 4 STEC and 21 other non-STEC E. coli 
finding that an independent, parallel evolution lead to the many serogroups of EHEC; probably 
due to each EHEC serogroup having similar propensities for taking up bacterial phages, 
plasmids, and other integrative elements ubiquitous in the environment.  With a past record of 
acquiring genetic virulence elements, such events are likely to occur in the future creating new 
STEC strains or hybrid STEC will emerge in the future.   
 
Prevalence and Ecology of STEC in Ruminants 
Ruminant animals are asymptomatic carriers of STEC and are considered to be the primary 
reservoir (Karmali et al., 2010).  Human STEC infections typically occur via consumption of 
contaminated meat or produce; contamination is thought to originate with ruminant fecal matter 
(Karmali et al., 2010).  Ecological and epidemiological studies of STEC in ruminants are 
important tools for determining the interventions strategies to reduce or prevent STEC 
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contamination and subsequent outbreaks.  These studies rely on our ability to determine STEC 
prevalence in ruminants which commonly involves isolating STEC from bovine feces which is 
complicated by the greater than 1012 CFU/g background microflora.  Multiple isolation and 
detections procedures for non-O157 STEC have been utilized but a standardized, efficacious 
procedure has not been agreed upon.  Many studies have examined the prevalence of STEC in 
cattle feces; however this review will focus on studies which utilized all of the most up-to-date 
techniques including: fecal enrichment, screening of fecal enrichment by PCR, concentration of 
target organisms with IMS beads and plating the beads on a selective agar before screening of 
individual isolates. 
Barlow and Mellor, (2010) collected 300 fecal samples from both grain-fed and grass-fed 
cattle from 25 different abattoirs in Australia over an 8 month period.  Twenty-five grams of 
fecal sample were diluted into 250 ml of trypticase soy broth (TSB) and incubated at 37°C for 18 
h.  A sub-sample of the enriched fecal broth was tested with PCR for stx and eae; samples 
positive for both genes were subsequently tested by PCR for the top 8 disease causing STEC 
serogroups.  For serogroups with commercially available IMS beads (O26, O103, O111, O145 
and O157), IMS was performed and beads were plated onto chromocult-TBX agar (O103, O111 
and O145), rhamnose MacConkey agar (O26) and sorbitol MacConkey agar (O157) with 
cefixime and potassium tellurite.  For O121, O91 and O45 enriched fecal broth was plated on 
Chormocult-TBX agar (Merck KGaA, Darmstadt, Germany). and colony hybridization was 
performed with probes targeting those serogroup (O121, O91 and O45).  Following each 
procedure, up to 50 isolates were streaked individually and tested again by PCR.  Forty-two 
percent (128 out of 300) of enriched fecal broths were positive for stx and 61 % (78 out of 128) 
of those were also positive for eae and 38 % (30 out of 78) of those were positive for at least one 
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of the 8 serogroups.  Of the 30 samples that screened positive for stx, eae and a serogroup, 25 
isolates of the target serogroups (at least one from every serogroup tested for except O145) were 
recovered, however only 4 of those isolates (1 O91 and 3 O157) harbored stx classifying them as 
STEC.   
 Fukushima and Seki, (2004) collected 605 fecal samples from cattle presented at an abattoir 
in Japan.  One-tenth of a gram of feces was inoculated into 0.9 ml of 0.85% NaCl solution and 
ten-fold serial diluted; then 0.7 ml of the ten-fold dilution was inoculated into 10 ml of TSB and 
incubated for 6 h at 42°C.  Immunomagnetic separation was performed with 1ml sub-sample of 
the fecal enrichment using commercial IMS beads (O26, O111 and O157).  Both the fecal 
enrichment and recovered IMS beads were streaked onto sorbitol-MacConkey agar (O157 IMS 
beads) and Chromocult agar (fecal enrichment, O26 and O111 IMS beads) then incubated at 
37°C for 18h.  A colony sweep was screened with a PCR to detect stx genes.  Fifty colonies from 
stx positive samples were individually sub-cultured and five isolates were then pooled together 
and screened a second time for stx before individual isolates were tested for stx and serotyped.  
The stx gene was detected in 37.5% of the colony sweeps and STEC isolates were recovered 
from 50% of the stx positive colony sweeps.  While the most prevalent STEC was the O26 
serogroup, 68 different STEC serogroups were isolated.   
 Hofer et al., (2012) collected fecal samples (n = 573) over an eleven month period from 7 
abattoirs in Switzerland.  Fecal samples were collected using swabs after evisceration.  The 
swabs were placed in a bag with 20 ml of modified tryptic soy broth (16mg/l of novobiocin), 
stomached and incubated 16 h at 37°C.  Fifty micro-liters of this enrichment was screened for stx 
with PCR and stx positive samples were further screened for serogroup specific genes for O26, 
O103, O111, O145 and O157.  Strain isolation was attempted on samples that were positive for 
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stx and O26, O145 or O157.  For the strain isolation a secondary enrichment was performed by 
adding 1 ml of the original fecal enrichment to10 ml of brain heart infusion broth which was 
incubated overnight at 37°C.  Then IMS was performed with O26, O145 and O157 beads.  Beads 
were plated on sheep blood agar and incubated overnight at 42°C.  Colony hybridization for the 
serogroup specific genes was performed.  One to four positive colonies were picked from the 
sheep blood agar and serogroups were confirmed along with stx status by PCR.  Of the 573 
enriched fecal samples, 72.7% (417) tested positive for the stx genes and 23.9, 25.9, 0.8, 41.9 
and 7.8% of the 417 samples were positive for O26, O103, O111, O145 and O157 serogroups, 
respectively.  For O26, O145 and O157 positive samples, isolates were obtained from less than 
18% of O26 and O145 and 40% for O157.  However, most isolates were not STEC; only 9 out of 
17 O26 isolates, 4 out of 28 O145 isolates, 5 out of 12 O157 isolates were stx positive.   
 Lynch et al., (2012) collected five rectal fecal swabs six dairy farms in Ireland over a 
seventeen month period.  The rectal fecal swabs were submerged in the 225 ml of modified TSB 
(cefixime and vancomycin), vortexed and incubated overnight at 37°C.  A DNA extraction was 
performed using 1.0 ml of enrichment broth and a commercial DNA extraction kit.  The 
extracted DNA was screened for stx genes by real-time PCR.  Samples positive for stx genes 
were subjected to a serogroup-specific real-time PCR (O157, O111, O26, O103, and O145).  All 
samples that tested positive for stx and a targeted serogroup were further processed by IMS 
(O157, O26, O103, and O145).  Samples positive for O157 were than plated on MacConkey agar 
with cefixime (0.05 mg/l) and potassium tellurite (0.25 mg/l).  Non-O157 serogroups were plated 
on Chromocult supplemented with cefixime (0.05 mg/l), cefsulodin sodium salt (5 mg/l) and 
vancomycin hydrochloride hydrate (8 mg/l).  All plates were incubated at 37°C for 18h and 
isolates were tested by PCR for stx and serogroups.  Three hundred eight six of the 600 (63.3%) 
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rectal fecal swabs screened positive for stx genes of these positive samples 39% (O145), 19% 
(O103), 7% (O26), 3% (O157), and 0.001% (O111) were positive for the indicated serogroups.  
Isolates were recovered from 56% of the O157, 31% of the O26, 21% of the O103 and 8% of the 
O145 positive samples.  However of the isolated E. coli, only 8.3% of the O26, 40.0% of O157, 
3.8% of O103 and 0% of the 0145 were considered STEC.   
 Shinagawa et al., (2000) collected fecal samples from 510 cattle near Tohoku, Japan.  One 
gram of feces was added to 20 ml of modified TSB (novobiocin at 25µg/ml) and incubated for 
18 h at 37.  A second enrichment was then performed by removing 1 ml of the primary 
enrichment and adding it to 10 ml TSB and incubating at 37°C for 18h.  One milliliter of this 
secondary enrichment was used a PCR reaction to detected stx.  For those enrichments that were 
stx positive the original fecal sample was inoculated into modified EC broth with novobiocin, 
however no incubation was performed.  Immunomagnetic separation was performed on these un-
incubated fecal broths with beads for O157, O26, and O111.  The IMS beads were plated onto 
CT-SMAC agar and CHROMagar then incubated at 37°C overnight.  Five to 6 colonies from 
each plate were test by agglutination for serogroup (O157, O26 and O111) and then tested by 
PCR for stx.  Fifty percent (258 out of 510) of enriched fecal samples were positive for stx; 
however only 4 O26, 1 O111 and 5 O157 STEC isolates were recovered. 
 Thomas et al., (2011) collected 1.0 g rectal fecal samples over a 14 month period from 402 
different animals.  The 1.0 g fecal samples were added to 19 ml of mTSB (vancomycin at 6 mg/l 
and cefixime at 50 µg/l) and incubated at 37°C for 6h.  DNA was then extracted from a sub-
sample of the enriched fecal broth using a commercial kit and screened by PCR stx genes.  
Samples positive for stx were than screened for serogroup specific genes (O157, O26, O111, 
O103 and O145).  Automated IMS was performed on samples positive for stx and a serogroup 
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with beads specific for O26, O111, O103, O145 and O157.  The beads were plated onto CT-
SMAC agar (O157) and modified CHROMagar (supplemented with cefixime at 50 µg/l, 
cefsulodin at 50 mg/l and vancomycin at 8 mg/l; O26, O103, O111 and O145) and incubated at 
37°C for 24h.  Up to 5 colonies from these plates were sub-cultured and tested by PCR for 
serogroup then presences of stx genes.  The majority of samples (301 out of 402) were found to 
be positive for stx and O157 or O111; interestingly all samples screened positive for stx and O26, 
O103 or O145.  However only 8 (1.99%) O26, 34 (8.46%) O103, 0 O111, 3 (0.75%) O145 and 8 
(2.66%) O157 isolates were recovered of which 6 of the O26, 4 of the O103, all 3 of the O145 
and 7 of the O157 isolates possessing stx and therefore being considered STEC.   
From these studies it can be concluded that a large majority cattle feces contains STEC; 
however due to deficiency’s in isolation techniques, determining if these STEC are among 
serogroups commonly observed in human illness cannot be reliably determined.  Furthermore 
when serogroups common to human illness were isolated, they did not necessarily harbor stx and 
therefore may not produce human illness.  Better isolation techniques will be need to isolate 
STEC from bovine fecal samples in order to determine if the high rates of STEC observed in 
cattle feces are a threat to human health. 
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Figure 1.1. Neighbor joining cluster analysis of stx sequences, high-lighting there serogroup 
and proposed classification.  Adapted from Scheutz et al., (2012). 
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Table 1.1. Association between eae variant and serogroup in STEC from human clinical cases.1 
E. coli serotype N= eae variant 
O26:H11 6 β 
O26:H-unknown 9 β 
O26:H-unknown 1 Negative 
O103:H2 9 θ 
O103:H2 2 ε 
O103:H-unknown 2 θ 
O103:H-unknown 1 Negative 
O111: H-unknown 12 γ 
O111:H-unknown 3 ε 
O145:H-unknown 13 γ 
O157:H7 25 Γ 
O157:H-unknown 1 Negative 
1Adapted from Posse et al., (2007) 
48 
 
Table 1.2. STEC O-group and commonly associated H-group1 
STEC O-group Common H-group 
O26 H11 
O103 H2 
O111 H8 
O121 H19 
O145 H28 
O157 H7 
1Adapted from Beutin et al., 2004 
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Chapter 2 - Dietary monensin level, supplemental urea, and 
ractopamine on fecal shedding of Escherichia coli O157:H7 in 
feedlot cattle 
 
(Published in Journal of Animal Science, 2011, 89 (9); 2829-2835) 
Abstract 
Inclusion of distiller’s grains (DG) in cattle diets has been shown to increase fecal shedding 
of E. coli O157:H7.  It is hypothesized that altered gut fermentation by DG may be responsible 
for the positive association.  Therefore, feed additives affecting ruminal or hindgut fermentation 
of DG also may impact fecal shedding of E. coli O157:H7.  The objectives of the study were to 
evaluate effects of monensin level (33 or 44 mg/kg DM), supplemental urea (0, 0.35, or 0.70% of 
DM), and ractopamine (0 or 200 mg/steer daily administered during the last 42 d of finishing) in 
a steam-flaked corn grain-based diet containing 30% wet sorghum DG on fecal shedding of E. 
coli O157:H7.  Seven-hundred and twenty crossbred beef steers, housed in 48 pens (15 
steers/pen), were assigned to dietary treatments in a randomized complete block design with a 2 
x 3 x 2 factorial treatment arrangement.  Fresh pen floor fecal samples (10 per/pen) were 
collected every 2 wk for 14 wk (July through November) and cultured for E. coli O157:H7.  
Isolation of E. coli O157:H7 was by selective enrichment of fecal samples in an enrichment 
broth, immunomagnetic separation, followed by plating onto a selective medium.  Samples that 
yielded sorbitol-negative colonies, which were positive for indole production, O157 antigen 
agglutination, and contained rfbE, fliC, and stx2 were considered positive for E. coli O157:H7.  
Fecal prevalence data were analyzed as repeated measures using negative binomial regression to 
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examine effects and interactions of sampling day, urea, monensin, and ractopamine.  Mean fecal 
prevalence of E. coli O157:H7 was 7.6%, and ranged from 1.6 to 23.6%.  Cattle fed monensin at 
44 mg/kg of feed had lower (P = 0.05) fecal E. coli O157:H7 prevalence than cattle fed 33 mg/kg 
(4.3 vs 6.8%).  Although the reason for the reduction is not known, it is likely because of 
changes in the microbial ecosystem induced by the higher dose of monensin in the hindgut.  
Supplemental urea at 0.35 or 0.70% had no effect (P = 0.87) on fecal shedding of E. coli 
O157:H7.  Fecal prevalence of E. coli O157:H7 were 5.3, 5.7, and 5.9 % for groups fed 0, 0.35 
and 0.7% urea, respectively.  The inclusion of ractopamine at 0 or 200 mg/head/d had no effect 
(P = 0.89) on fecal prevalence of E. coli O157:H7 (4.4 vs 4.0 %).  Additional research is needed 
to confirm the reduction in fecal shedding of E. coli O157:H7 in cattle fed monensin at 44 mg/kg 
of feed compared cattle fed 33 mg/kg of feed. 
 
Introduction 
Escherichia coli O157:H7 is a food borne pathogen that inhabits the hindgut (Naylor et al., 
2003; Walker et al., 2010) and is shed in the feces, which can subsequently contaminate food 
products (Rangel et al., 2005).  Fecal shedding of E. coli O157 is influenced by a number of 
factors, including diets (Callaway et al., 2009).  It is hypothesized that dietary ingredients that 
flow into the hindgut are likely to affect fecal shedding of E. coli O157 (Jacob et al., 2009).  
Distillers grains (DG), which contain little starch and approximately three times higher lipid, 
protein, and fiber than corn (Spiehs et al., 2002), increase fecal E. coli O157 prevalence in cattle 
(Jacob et al., 2008).  Increased flow of lipid, protein and fiber to the hindgut are likely to alter 
ecology of the hindgut and have an impact on E. coli O157.  Provision of ammonia as urea may 
enhance ruminal fermentation and decrease flow of fiber to the hindgut.  Monensin at 33 mg/kg 
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DM has been shown to have no effect on E. coli O157 in cattle (Jacob et al., 2008; McAllister et 
al., 2006).  In 2006, 44 mg of monensin/kg of feed was approved as the upper limit in feedlot 
cattle diets (NADA 095-735, 2006).  The impact of feeding 44 mg/kg of monensin on fecal 
shedding of E. coli O157 has not been determined.  Ractopamine, a beta-agonist, (Schroeder et 
al., 2003; Laudert et al., 2004) has been shown to reduce (Edrington et al., 2006b) or have no 
effect (Edrington et al., 2009) on fecal E. coli O157.  These conflicting data suggest that further 
studies are needed.  Therefore, our objectives were to evaluate the effects of monensin level (33 
or 44 mg/kg DM), supplemental urea (0, 0.35, or 0.70% of DM), and ractopamine (0 or 200 
mg/steer) on fecal shedding of E. coli O157:H7 in cattle fed diets supplemented with wet 
sorghum DG.   
 
Materials and Methods 
All procedures in the care and management of cattle were approved by the Kansas State 
University Institutional Care and Use Committee.   
 
 Study Design 
Seven hundred and twenty crossbred beef steers (initial BW = 433 ± 23.1 kg) were used in a 
randomized complete block design with a 2 x 3 x 2 factorial treatment arrangement.  Factors 
were monensin level (33 or 44 mg/kg DM), level of supplemental urea (0, 0.35, or 0.70% of 
DM), and ractopamine (0 or 200 mg/steer daily, fed during the last 42 d before harvest; Figure 
1).  The basal diet consisted of steam-flaked corn with 30% wet sorghum DG (Table 1).  Steers 
were allowed ad libitum access to alfalfa hay and water from arrival until processing at the start 
of the adaptation phase.  On day 0 of the adaptation period, steers were weighed, vaccinated, 
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stratified by weight into two blocks and then randomly assigned to pens.  Forty-eight dirt-floor 
pens (10.4 x 26.8 m) containing 15 steers each were randomly assigned to 1 of 12 treatment 
combinations.  Two transition diets and a final diet were fed over a 21 day step-up period.  The 
amount of feed offered to the pen was determined at approximately 7:00 a.m., and the daily 
rations for each pen was delivered at approximately 8:00 a.m. and 2:00 p.m. each day.  Cattle 
were fed amounts sufficient to result in traces of residual feed at the next feeding and fresh water 
was available at all times.   
The three treatments were not started at the same time point of the study, and therefore, not 
all sample events occurred in steers fed diets with all treatments (Figure 1).  Monensin was 
included in the transition and final diets while urea supplementation was initiated at the end of 
the adaptation phase and after the first sampling event.  Ractopamine administration began after 
five sampling events, and therefore, the last four samples were from steers fed diets that included 
all three treatments.   
Fecal samples (10/pen) were collected, July through November, from the surface of each pen 
approximately every 2 wk for 14 wk (n = 9).  Samples (approximately 100 g) were collected 
from freshly defecated fecal pats using a plastic spoon, and care was taken to avoid ground 
contamination or repeat sampling from the same steer on the same sampling.  The spoon with 
feces was placed into a Whirl-pack bag (Nasco, Ft. Atkinson, WI), and once samples were 
collected, they were placed in a cooler with ice packs and delivered to the Kansas State 
University College of Veterinary Medicine Pre-harvest Food Safety Laboratory for processing.   
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 Isolation of E. coli O157:H7 
Fecal samples were cultured for E. coli O157:H7 as previously described (Greenquist et al., 
2005).  Briefly, samples were kneaded for 30 sec and approximately 1 g of feces was placed in 
tubes containing 9 mL Gram-negative (GN) broth (Becton Dickinson, Franklin Lakes, NJ) with 
cefixime (0.05 mg/L), cefsoludin (10 mg/L), and vancomycin (8 mg/L; GNccv).  The GNccv 
broth was then incubated for 6 h at 37°C.  After enrichment, immunomagnetic bead separation 
(IMS) was performed, followed by plating onto sorbitol-MacConkey agar with cefixime (0.5 
mg/L) and potassium tellurite (2.5 mg/L; CT-SMAC).  Plates were incubated overnight at 37°C, 
and up to six sorbitol negative colonies were streaked onto blood agar plates.  Colonies were 
tested for indole production and latex agglutination for the O157 antigen, and further 
characterized by multiplex PCR to identify eae (intimin), stx1 (Shiga toxin 1), stx2 (Shiga toxin 
2), hly (hemolysin), rfbE (O157 antigen) and fliC (flagella) genes (Bai et al., 2010).  Personnel 
conducting sampling and laboratory analyses were blinded to the treatment assignments.   
 
 Statistical Analysis 
Descriptive statistics on prevalence outcomes were assessed prior to multivariable analysis.   
A repeated measures negative binomial generalized linear model (PROC GENMOD, SAS v. 9.2, 
Cary, NC) with a log links was used to analyze data.  The negative binomial function was 
chosen, as it best represented data having a high number of zero prevalence samples and few 
samples with very high prevalence.  It was verified to be the correct function by examining the 
dispersion parameter point estimate (α).  Because the 95% confidence interval did not include 0, 
the negative binomial model was deemed appropriate (Heeringa et al., 2010).  Pen was 
considered the experimental unit with the count of positive samples as the outcome.  This was 
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offset by the natural log of the number of samples processed for each pen.  Pen over time was 
included as a repeated (random) effect to account for the lack of independence among samples 
from the same pen over sampling days.  Score statistics for the generalized estimating equations 
were used to assess significance of sampling day, monensin, urea, ractopamine, and their 
interactions.  Because urea and ractopamine were not fed throughout the trial, the data were 
analyzed in three phases.  Results were considered significant at P < 0.05 and manual backward 
selection was used to remove variables that were not significant.  
 
Results and Discussion 
 Overall fecal prevalence of E. coli O157:H7 was 7.6% (327 of 4,300 fecal samples), and 
ranged from 23.6% on the first collection (July) to 1.6 % on the eighth collection day (October; 
Figure 2).  The multiplex PCR analyses revealed that all isolates (N=327) were positive for eae, 
stx2, hly, rfbE and fliC, and only 14% of the isolates (47/327) were positive for stx1.  There were 
no two- or three-way interactions observed between monensin, urea and ractopamine treatment; 
however, there was a tendency for interaction between monensin and sampling week (P = 0.06), 
indicating that E. coli O157:H7 prevalence between monensin treatments tended to vary by 
sampling week.  Fecal shedding of E. coli O157:H7 in cattle is influenced by a number of 
factors, including diets and dietary additives fed to the animal (Callaway et al., 2009; Jacob et 
al., 2009).  It is believed that dietary ingredients that flow into the hindgut and alter the microbial 
population and fermentation products are likely to have an impact persistence and fecal shedding 
of E. coli O157:H7 (Jacob et al., 2009).   
Cattle fed monensin at 44 mg/kg of feed had lower (P = 0.05) E. coli O157:H7 prevalence 
than cattle fed 33 mg/kg (4.3 vs 6.8%, Figure 3).  Previous studies generally examined monensin 
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at 33 mg/kg and compared it to a control group that lacked monensin in the diet.  Van Baale et 
al., (2004) in a challenge study (n= 12) fed at a slightly higher dose of 39.6 mg/kg, found no 
difference in fecal E. coli O157 over a 63-d study period, but observed an initial decrease (first 5 
d) in fecal concentration of E. coli O157 in monensin-fed cattle on a grain diet, but not in forage-
fed animals.  McAllister et al. (2006) observed no difference in fecal shedding of E. coli O157 
(66 vs. 71%) when cattle (n = 32) were fed monensin at 0 or 33 mg/kg in the diet.  Jacob et al., 
(2008) in a natural prevalence study found no differences (P = 0.8) in fecal E. coli O157:H7 
between cattle fed diets with 0 and 33 mg/kg monensin.  Although monensin is not generally 
inhibitory to gram negative bacteria, some are susceptible to high concentrations (Nagaraja and 
Taylor, 1987).  In vitro studies have shown that monensin at concentrations equal to (Bach et al., 
2002) or higher (Van Baale et al., 2004) than concentrations expected in the rumen when 33 
mg/kg of monensin is fed did not affect the growth of E. coli O157:H7.  Because a substantial 
proportion of monensin passes through the intestinal tract intact, it is likely that the reduction in 
fecal shedding of E. coli O157:H7 observed with the higher dose of monensin is because of 
changes in the microbial populations and fermentation products in the hindgut.  The effects of 
monensin on hindgut fermentation, such as increased propionic acid, are similar to that described 
in the rumen (Yokoyama et al., 1985; Marounek et al., 1990).  
Supplemental urea at 0.35 or 0.7 % had no effect (P = 0.87) on fecal shedding of E. coli 
O157:H7.  Fecal prevalence of E. coli O157:H7 were 5.3, 5.7, and 5.9 % for groups fed 0, 0.35 
and 0.7% urea, respectively (Figure 4).  Distillers grains, which contain little starch (< 5% in DG 
vs. >70% in corn, Belyea et al., 2004) and approximately three times higher lipid, protein, and 
fiber contents than corn grain (Spiehs et al., 2002), have been shown to increase E. coli O157:H7 
prevalence in cattle (Jacob et al., 2008; Wells et al., 2009).  Increased flow of lipid, protein and 
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fiber to the hindgut are likely to alter ecology of the hindgut, which may have an impact on 
persistence of E. coli O157:H7.  Increased flow of lipid into the hindgut may have a negative 
effect on E. coli O157:H7 because of the antibacterial effects of the released free fatty acids 
(Annamalai et al., 2004).  It is possible that lipid may get digested and absorbed from the small 
intestine and not flow in sufficient amounts into the hindgut to have a negative effect.  Dietary 
fiber is known to alter the physiology and stimulate bacterial growth in the human colon 
(Cummings and Stephan, 1980).  Possibly, increased flow of fiber into the hindgut stimulates 
mucus production, which may be stimulatory to E. coli O157:H7 growth (Fox et al., 2009).  
Because DG contain less degradable protein (Klopfenstein et al., 2008), ruminal availability of 
nitrogen may be limiting, which may hinder fiber (Firkins et al., 1986) or starch (Fron et al., 
1996) digestion in the rumen.  Provision of supplemental ruminal ammonia as urea may enhance 
ruminal fermentation and decrease flow of fiber to the hindgut.  Firkins et al. (1986) 
demonstrated that diets containing DG had less ruminal NDF digestion compared to a diet 
containing dry corn gluten feed, but the total tract NDF digestion was greater for DG diet 
suggesting greater hindgut fermentation.  Based on in vitro and in vivo studies, Fron et al. (1996) 
demonstrated that inclusion of condensed distiller’s byproducts altered microbial activities 
(increased ruminal populations of starch and lactate utilizing bacteria) and increased the rate of 
fermentation of lactic acid, however, ruminal pH was unaffected.  Varying levels of urea, which 
could potentially improve ruminal fiber digestion, did not affect fecal prevalence of E. coli 
O157:H7 in this study.  It is possible that ammonia was not a limiting factor, hence urea 
supplementation did not have an effect fecal shedding of E. coli O157:H7.  Increased availability 
and degradation of protein in the hindgut and therefore, increased ammonia production and 
elevated pH may favor persistence of E. coli O157:H7. 
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The inclusion of ractopamine at 0 or 200 mg/head/d had no effect (P = 0.89) on fecal 
prevalence of E. coli O157:H7 (4.4 vs 4.0 %; Figure 5).  However, the power to detect an effect 
was low due to low E. coli O157:H7 prevalence in the final phase of the study.  The mean fecal 
prevalence in the last four samples (collected in the month of October) was 4.2% compared to a 
mean of 10.3% in the first five samples (collected in July, August, and September).  The 
reduction in prevalence in October is likely because of seasonal influence on fecal shedding of E. 
coli O157:H7 (Edrington et al., 2006a; Fernández et al., 2009).  Ractopamine, a beta-agonist, is 
used to accelerate gain and improve efficiency in cattle during the final 4 to 6 wk of the finishing 
phase (Schroeder et al., 2003; Laudert et al., 2004).  Ractopamine may potentially interact with 
the bacterial quorum-sensing systems (Sperandio et al., 2003) to affect E. coli O157:H7 
prevalence.  Studies have shown that the neuroendocrine environment of the gastrointestinal 
tract, particularly norepinephrine released by the enteric nervous system, has influence on 
bacterial growth, and in certain pathogens, including E. coli O157:H7, expression of virulence 
factors (Lyte etal., 1997).  Edrington et al. (2006b) conducted a study with a small number of 
cattle (n=20) that were administered 0 or 20 mg of ractopamine daily for 28 d and observed a 
reduction in fecal shedding (P = 0.006) with ractopamine (51.2 vs 41.8%, for 0 and 20 mg 
ractopamine, respectively).  In another study (Edrington et al., 2006b) with 1,800 feedlot heifers, 
in three replicates, ractopamine fed at 200 mg/animal daily for 28 d lowered (P = 0.05) E. coli 
O157:H7 prevalence (8.5 vs 13.8% ) in feces compared to control heifers fed no ractopamine.  
However, there were no significant differences in two of the three replicates.  Recently, 
Edrington et al., (2009) used 504 feedlot heifers in a 2 x 3 factorial design, with ractopamine 
included at 0 or 200 mg/heifer daily for 14, 28, or 42 d.  Fecal samples were obtained at day 0 
58 
 
and then at days 14, 28, or 42 corresponding to each treatment period.  There were no significant 
differences in prevalence among treatments.   
In conclusion, our results suggest inclusion of supplemental urea in the diet had no effect on 
fecal shedding of E. coli O157:H7 in cattle.  Our premise in testing the effect of supplemental 
urea was the potential effects of altered ruminal and possibly hindgut fermentation on E. coli 
O157:H7.  Because we did not monitor ruminal or hindgut fermentation changes, we have no 
evidence that fermentation was altered by feeding supplemental urea.  Similarly, the low 
prevalence of E. coli O157:H7 during ractopamine feeding precluded us from assessing the 
impact of ractopamine.  The reduction in fecal shedding of E. coli O157:H7 associated with 
feeding the high dose of monensin is interesting and somewhat surprising considering that prior 
studies (although with lower doses) had shown no effect.  Therefore, additional research is 
needed to confirm the reduction in fecal shedding of E. coli O157:H7 in cattle fed 44 mg/kg 
monensin.
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Figure 2.1. Timeline for administration of dietary treatments and fecal sampling events 
(indicated by arrows). 
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Figure 2.2. Overall fecal prevalence of Escherichia coli O157:H7 in cattle fed steam-flaked 
corn grain based diet supplemented with 30% wet distiller’s grains (n = 48 pens; SEM = 0.7). 
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Figure 2.3. Fecal prevalence of Escherichia coli O157:H7 in steers fed steam-flaked corn grain-
based diet with 30% wet sorghum distiller’s grains and supplemented with monensin at 33 or 44 
mg/kg of feed (n = 24 pens/treatment; SEM  = 1.2).   
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Figure 2.4. Fecal prevalence of Escherichia coli O157:H7 in steers fed steam-flaked corn grain-
based diet with 30% wet sorghum distiller’s grains and supplemented with urea at 0, 0.35, or 
0.70 % of the diet (n = 16 pens/treatment SEM = 1.2). 
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Figure 2.5. Fecal prevalence of Escherichia coli O157:H7 in steers fed steam-flaked corn grain-
based diet with 30% wet sorghum distiller’s grains and supplemented daily with ractopamine at 
0 or 200 mg/steer (n = 24 pens/treatment; SEM = 1.2). 
 
 
70 
 
 
Table 2.1. Ingredient and chemical composition of the diet 
Item Percentage, DM basis 
Ingredient 
 
Steam-flaked corn 58.1, 57.7, or 57.3 
Wet sorghum distiller’s grain 30.0 
Wheat straw 7.0 
Premix1 2.38 
Limestone 1.80 
Urea 0, 0.35, or 0.70 
Supplement2 0.71 
 
 
Nutrient Composition 
 
Dry matter, % 57.5 
CP, % DM 14.2, 15.4, or 16.5 
NDF, % DM 19.2 
1Feed additive premix provided 33 or 44 mg of monensin sodium (Elanco Animal Health, 
Greenfield, IN) and 11 mg tylosin (Elanco Animal Health, Greenfield, IN) per kg of feed. 
2Supplement contained 2,650 IU vitamin A; 10 mg Cu; 0.5 mg I; 0.15 mg Co; 0.25 mg Se; 50 
mg Zn; and 50 mg Mn per kg of diet DM; Ractopamine hydrocholoride (Elanco Animal Health, 
Greenfield, IN) included in the diet at 0 or 200 mg per animal daily the last 42 d before harvest. 
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Chapter 3 - Effects of feeding dried distillers grains with 
supplemental starch on fecal shedding of Escherichia coli O157:H7 
in experimentally inoculated steers  
 
(Published in Journal of Animal Science, 2013, 91 (3); 1362-1370) 
Abstract 
Distillers grains (DG), a co-product of ethanol production used as protein and energy 
supplements in cattle diets, have been shown to increase fecal shedding of Escherichia coli 
O157:H7, a major foodborne pathogen.  The reason for the positive association is not known.  
Because DG often replaces grain in the diet, decreased starch content and flow to the hindgut 
may create a favorable environment for E. coli O157:H7.  Our objective was to determine 
whether the addition of starch to a DG-supplemented diet negates the effects of DG on fecal 
shedding of E. coli O157:H7.  We conducted a study with 21 steers fed one of three diets: a corn 
grain-based basal diet (CON), basal diet supplemented with 25% dried DG (DDG), and basal 
diet supplemented with 25% DDG with corn starch (DDG+S) added at a level intended to raise 
starch concentration to that of the CON diet.  Steers, housed individually in a biosafety level 2 
animal facility, were randomly allocated to treatment diets and orally inoculated with a 5-strain 
mixture (109 cfu per steer) of nalidixic acid-resistant (NalR) E. coli O157:H7.  Fecal samples 
were collected for 5 wk, and on d 35, steers were euthanized and necropsied to collect gut 
content samples.  Fecal or gut samples were cultured to determine prevalence and concentrations 
of NalR E. coli O157:H7.  Dietary starch concentrations, based on feed analysis, were 46.3% in 
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the CON compared with 43.3% and 41.3% in the DDG and DDG+S diets, respectively.  Steers 
fed DDG or DDG+S diets shed NalR E. coli O157:H7 more often (P < 0.01) and at higher 
concentrations (1.9 or 2.0 cfu/g; P < 0.01) than those fed CON diet (1.4 cfu/g), but no difference 
was observed between DDG and DDG+S diets.  Cumulative prevalence and concentrations of 
NalR E. coli O157:H7 were higher in gut samples collected at necropsy in steers fed DDG and 
DDG+S diets compared with those fed CON diet, but no difference was observed between DDG 
and DDG+S diets.  The study confirms our previous finding of the positive association between 
feeding DG and fecal shedding of E. coli O157:H7.  The lack of effect of starch addition to the 
DDG diet on fecal shedding of E. coli O157:H7 may be because either the decreased starch 
content in the DG-supplemented diet is not a factor in the increased shedding of E. coli O157:H7 
or added starch was completely digested in the rumen and small intestine with no starch reaching 
the hindgut to have an impact.  
 
Introduction 
Escherichia coli O157:H7, a major food borne pathogen, inhabits the hindgut of cattle and is 
shed in the feces (Naylor et al., 2003; Walker et al., 2010).  Cattle feces can be a source of 
human infection through direct or indirect contamination of food and water (Rangel et al., 2005).  
Fecal shedding of E. coli O157:H7 is influenced by a number of factors, including diet 
(Callaway et al., 2009).  Dietary ingredients that flow into the hindgut and potentially alter the 
ecosystem are likely to affect fecal shedding of E. coli O157:H7 (Jacob et al., 2009).  Distillers 
grains (DG), a co-product of ethanol production, are widely used as an energy or protein 
supplement in cattle diets.  Feeding DG, which contain no or very little (< 5%) starch (Spiehs et 
al., 2002; Belyea et al., 2004), has been shown to increase fecal shedding of E. coli O157:H7 in 
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cattle by more than 30% (Jacob et al., 2008b; Jacob et al., 2010; Wells et al., 2009).  The reason 
for the increase is not known.  Distillers grains could contain components that directly or 
indirectly stimulate growth of E. coli O157:H7 (Jacob et al., 2008a); indirect stimulation is likely 
mediated by the impact of DG component(s) on hindgut microbial ecology.  Replacing corn 
grain with DG supplementation in the diet reduces starch content and results in decreased starch 
flow to the hindgut, which likely alters ecology of the hindgut and creates an environment 
favorable to the growth and persistence of E. coli O157:H7 (Jacob et al., 2009).  Therefore, we 
hypothesized that decreased starch content of the DG-supplemented diet may account for the 
increased fecal shedding of E. coli O157:H7.  Our objective was to determine whether addition 
of starch to the DG-supplemented diet would negate the increased fecal shedding of E. coli 
O157:H7.  We formulated a DG-supplemented diet to equal the starch content of corn grain-
based diet and used an experimental inoculation model to test our hypothesis. 
 
Materials and Methods 
 All procedures in the care and management of cattle in the study were approved by the 
Kansas State University Institutional Care and Use Committee. 
 Animals and Treatment Groups 
Twenty-one Holstein steers (mean BW = 166.4 ± 4.3 kg) were randomly assigned using a 
spreadsheet algorithm to one of three dietary treatments (Table 1).  Initially, animals within each 
treatment group were housed together in outdoor concrete-surfaced pens.  A high-grain diet 
consisting of 70.1% dry-rolled corn grain constituted the control diet (CON).  The second dietary 
treatment had 25% dried DG (DDG) added, on a DM basis, to replace a portion of the dry-rolled 
corn.  The third dietary treatment (DDG+S) consisted of 25% DDG with 23.5% of the remaining 
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dry-rolled corn grain replaced with corn starch in order to have starch and nonfiber carbohydrate 
(NFC) concentrations similar to that of the CON diet.  The diets were formulated to meet NRC 
requirements and adjusted to contain as similar concentrations of all other nutrients as possible 
(Table 1).  Steers were stepped-up with 3 increments of their respective diets (50, 65, and 85% 
concentrate) approximately every 4 d over a 2 wk period.  Steers were then moved to individual 
pens (1.52 × 3.05 m) within a biosafety level 2 facility and allowed to acclimate for 1 wk prior to 
oral inoculation with E. coli O157:H7.  Steers were randomly (spreadsheet algorithm) assigned 
to the individual pens that have walls high enough (1.8 m) to prevent physical contact between 
adjacently penned animals.  Each pen was equipped with a built-in head catch to facilitate 
stomach tubing, so the steers were not moved from their pens.  Diets were fed twice daily at 
levels targeting 5% refusals, which were mixed into the next feeding; all steers had ad-libitum 
access to fresh water.  Pens were surface washed with minimal splashing and cleaned once daily; 
pen floors and drains were designed to prevent wash water from contaminating adjacent pens.  
Body weights were recorded on the day steers were moved to the individual pens and on the 
necropsy day to determine ADG over the duration of the experiment.  
 
 Escherichia coli O157:H7 Inoculation 
Steers were orally inoculated with a 5-strain mixture (KSU 01-2-8970, 01-2-10004, 01-2-
10530, 01-2-7443, and 01-2-12329) of E. coli O157:H7, previously isolated from feedlot cattle 
feces (Sargeant et al., 2003) and made resistant to 50 µg/mL nalidixic acid (NalR E. coli 
O157:H7).  All 5 strains were PCR positive for the eae (intimin), stx2 (Shiga toxin 2), ehxA 
(enterohemorrhagic hemolysin), and fliC (flagellar antigen) genes, and 1 strain (01-2-8970) was 
also positive for the stx1 (Shiga toxin 1) gene.  Individual isolates from frozen storage beads 
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were streaked on blood agar plates (BAP; Remel, Lenexa, KS) and grown overnight at 37˚C.  A 
single colony was selected, inoculated into 10 mL of tryptic soy broth (TSB; Difco, BD, Sparks, 
MD) and incubated overnight at 37˚C.  One milliliter of TSB culture was then inoculated into 
100 mL of TSB and incubated for 7 h at 37˚C to reach an absorbance of 0.6 at 600 nm.  Aliquots 
of 5 strains cultures were mixed together and 1 mL of the pooled culture was serially diluted 10-
fold in buffered peptone water (Remel) and spread plated (4 plates per dilution) onto sorbitol-
MacConkey agar (Difco) plates with cefixime (0.5 mg/L), potassium tellurite (2.5 mg/L), and 
nalidixic acid (50 µg/mL; CTN-SMAC) to determine the concentration of NalR E. coli O157:H7.  
Each steer was dosed orally, via stomach tube, with 5 mL of pooled culture mixed with 100 mL 
of 1% sterile skim milk (Oxoid, Basingstoke Hampshire, UK).  The final inoculum (5 mL) 
contained 5.6 × 109 cfu of NalR E. coli O157:H7.  Steers were monitored twice daily following 
inoculation for clinical signs of infection including general depression, respiratory distress, 
depressed feed intake, and loose stool. 
 
 Fecal Sampling and Detection of E. coli O157:H7 
Fecal samples were collected from each animal before inoculation (d -7 and 0) and tested to 
for E. coli O157:H7 as described previously (Greenquist et al., 2005).  Briefly, 1 g of fecal 
sample was enriched in 9 mL of Gram Negative broth (Difco) with cefixime (0.5 mg/L), 
cefsoludin (10 mg/L), and vancomycin (8 mg/L; GNccv).  Immunomagnetic bead separation 
(Dynal Inc., New Hyde Park, NY) was performed and samples were plated onto sorbitol-
MacConkey agar (Difco) with cefixime (0.5 mg/L) and potassium tellurite (2.5 mg/L; CT-
SMAC).  Six sorbitol-negative colonies were picked and tested for indole production and O157 
antigen latex agglutination (Oxoid).   
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After oral inoculation with NalR E. coli O157:H7 (d 0), fecal samples were collected from 
each steer 3 times a wk (Monday, Wednesday, and Friday).  Foot baths with 1% Virkon 
S/Trifectant (21.4% potassium peroxymonosulfate; 1.5% sodium chloride solution; Vètoquinol, 
Fort Worth, TX) were used and gloves were changed between each steer.  Fecal samples were 
collected via rectal palpation or from pen floors if defecation was observed, placed in Whirl-pack 
bags (Nasco, Ft. Atkinson, WI), and transported to the laboratory.  Approximately 10 g of feces 
was also placed in a 50 mL conical tube containing 25 mL of double-deionized water and 
vortexed for 1 min.  The pH of the fecal suspension was immediately measured using an 
Accumet AB15 Basic pH meter (Fisher Scientific, Waltham, MA).  Aliquots of fecal samples 
collected on d 5, 12, 21, 28, and 35 were frozen at -20° C for nutrient (ADF, NDF, CP and 
starch) analysis. 
 
 Detection and Enumeration of NalR E. coli O157:H7 
Approximately 1 g of feces was added to a pre-weighed tube containing 9 mL of GNccv 
broth and the tube was weighed again to record the sample weight.  One milliliter of the GNccv 
fecal suspension was serially diluted 10-fold in buffered peptone water.  One hundred microliters 
of different dilutions were spread-plated, in triplicate, on CTN-SMAC.  Plates were incubated 
overnight at 37˚C and the sorbitol-negative colonies were counted to determine the 
concentrations of NalR E. coli O157:H7.  The remaining GNccv broth was enriched for 6 h at 37º 
C, after which 1 mL was removed and inoculated into another 9 mL tube of GNccv broth 
(secondary enrichment) and incubated for 16 to 18 h at 37ºC.  If colonies were not recovered by 
direct plating, 100 µL of the secondary enrichment was plated onto CTN-SMAC.  A colony from 
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each direct or secondary enrichment plate was picked, plated on BAP and tested for indole 
production and O157 antigen latex agglutination.  
 
 Necropsy and collection of gut contents 
Thirty-five days after inoculation, steers were euthanized and necropsied.  Steers were 
divided into 2 groups and euthanized on 2 consecutive days with treatment groups balanced 
across euthanasia days.  The order of animals euthanized was random and steers were not fed on 
the day of euthanasia, which was performed in the morning.  Steers were then immediately 
necropsied and contents from the rumen, cecum, colon, and rectum were collected, transported to 
the laboratory and concentrations of NalR E. coli O157:H7 were determined as above.  The pH of 
rectal contents were measured after preparing a suspension in double-deionized water and that of 
rumen, cecum, and colon samples were measured without the addition of double-deionized 
water.  The rectum was removed and cut open, the mucosa was rinsed with water to remove 
visible fecal material and the 3- to 5- cm area proximal to the rectoanal junction, was swabbed 
with a foam-tipped applicator (RAMS; VWR International, Buffalo Grove, IL; Fox et al., 2008).  
Swabs were placed in 3 mL of GNccv broth, transported to the laboratory, vortexed and 
processed for detection of NalR E. coli O157:H7 as described above.   
 
 Feed and Fecal Nutrient Analyses 
Approximately, 0.5 kg of each diet was collected (n = 15 per treatment) on each day of fecal 
sampling, and composited within treatment.  The composite samples were sent to Cumberland 
Valley Analytical Services (Hagerstown, MD) for DM, NFC, starch (according to Hall, 2009), 
CP and NDF analyses.  Frozen fecal samples from d 5, 12, 21, 28, and 35 were submitted to the 
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Animal Science Analytical Lab (Kansas State University, Manhattan, KS) for DM, ADF, NDF, 
CP, and starch analyses. 
 
 Statistical Analysis 
Dietary treatment effects were assessed in linear or generalized linear mixed models (LMM 
and GLMM, respectively; Proc Glimmix; SAS Version 9.2, SAS Institute inc., Cary, NC) 
depending on whether the outcome variable was continuous or categorical, respectively.  When 
the outcome variable was continuous, as was the case for concentrations of fecal NalR E. coli 
O157:H7 and nutrient components (DM, starch, CP, NDF and ADF) and fecal pH, a LMM was 
used to access the effects of dietary treatment.  When a categorical outcome variable, such as 
whether an animal’s sample from feces or necropsy was positive or negative for NalR E. coli 
O157:H7, was being analyzed, a GLMM was used assuming a binomial distribution and utilizing 
a logit link function.  Concentrations of NalR E. coli O157:H7 were log10 transformed before data 
analyses.  If NalR E. coli O157:H7 was not detected by direct plating, but the enriched sample 
was positive, the lowest enumerable concentration was assigned to account for sample weight 
(100 cfu/g).  The concentration in RAMS samples was not determined because the size of the 
inoculum was unknown; therefore, RAMS were considered positive (direct plating or 
enrichment) or negative and included only in analysis of prevalence data.   
Initially in both LMM and GLMM for data from individual fecal samples collected 
throughout the trial, the linear predictors were dietary treatment, sampling day and dietary 
treatment × sampling day interaction.  For data from samples taken at necropsy, dietary 
treatment, sample site (rumen, cecum, colon, rectum or RAMS) and dietary treatment × sampling 
site interaction were initially included in the model as linear predictors, for both LMM and 
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GLMM.  In addition, animal was included as a repeated effect in all models of data from 
repeated sampling in order to account for the lack of independence between samples.  When 
GLMM with repeated measures failed to converge properly, additional GLMM specified in an 
events/trials format were used to model cumulative prevalence (total sampling days positive or 
total gut sampling sites positive for each animal (events) over total number of samples collected 
(trials) for each animal) with dietary treatment as the linear predictor.  For animal performance 
outcomes (ADG and DMI) that were averaged over the trial, a LMM with dietary treatment 
included as a single linear predictor was used.  Model-adjust means (LSmeans; back transformed 
to the original scale when appropriate) and corresponding standard error of the means are 
reported.  For all models, P values < 0.05 were considered statistically significant and P values 
ranging from 0.05 to 0.10 were considered statistical trends.   
 
Results 
All steers tested negative for fecal prevalence of E. coli O157:H7 on the day of and the 7 d 
prior to oral inoculation.  None of the steers exhibited any adverse clinical signs following oral 
inoculation of E. coli O157:H7.  We detected no differences between dietary treatment groups in 
ADG and DMI of steers during the 35 d of the experiment.  The 3 treatment diets were 
formulated to be as similar as possible in all nutrient composition except starch and NFC.  The 
starch concentrations, based on feed analysis, were 46.3% in the CON diet compared with 43.3% 
and 41.3% in the DDG and DDG+S diets, respectively.  The NFC concentrations were 61.7 % in 
the CON, 58.3% in the DDG, and 61.9% in the DDG+S diets, respectively.   
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 Fecal Shedding of NalR E. coli O157:H7 
Two days after oral inoculation with NalR E. coli O157:H7, all steers were shedding NalR E. 
coli O157:H7, which was detected only after samples were enriched and plated on CTN-SMAC.  
The level of shedding could not be quantified because the dilutions chosen (10-3 to 10-6) to 
inoculate the plates showed no growth, indicating that fecal concentration was below 104 cfu/g of 
feces.  However, in the samples collected on d 5, concentrations of NalR E. coli O157:H7 in feces 
from all three groups of steers ranged from 104 to 105 cfu/g.  Data analyses of the fecal 
concentrations of NalR E. coli O157:H7 showed that the sampling day × dietary treatment 
interaction was not significant (P = 0.21).  Sampling day had a significant effect (P < 0.001) on 
the fecal concentration of NalR E. coli O157:H7.  After d 5 in the CON group, fecal 
concentrations of NalR E. coli O157:H7 declined gradually, and positive samples were only 
detectable by direct plating of enriched samples by d 19 (≤ 100 cfu/g; Figure 1).  The fecal 
concentrations of NalR E. coli O157:H7 were different (P < 0.001) between dietary treatments.  
Feces from steers in the DDG (1.94±0.10 log10 cfu/g) and DDG+S (2.03±0.10 log10 cfu/g) 
groups had higher (P < 0.01 and P < 0.001, respectively) NalR E. coli O157:H7 concentrations 
than the CON group (1.44±0.10 log10 cfu/g), but no difference (P = 0.52) was observed between 
the DDG and DDG+S groups (Figure 1). 
Analysis of cumulative fecal prevalence of NalR E. coli O157:H7 (total number of sampling 
days a steer was positive from d 2 to 35) demonstrated a significant dietary treatment effect 
where more steers were positive for fecal shedding of NalR E. coli O157:H7 in DDG (P < 0.01) 
and DDG+S (P < 0.001) compared with the CON group, and again there was no difference (P = 
0.26) between the DDG and DDG+S groups (Figure 2). 
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 Concentrations and Prevalence of NalR E. coli O157:H7 in Necropsy Samples 
At the time of necropsy, the concentrations of NalR E. coli O157:H7 in gut contents was not 
associated with the gut sample site (rumen, cecum, colon, or rectum) × dietary treatment 
interaction (P = 0.85), but was significantly affected by gut sample site (P = 0.03) and tended to 
be affected by dietary treatment (P = 0.06).  The rectal contents contained significantly higher (P 
< 0.01) concentrations of NalR E. coli O157:H7 compared with the contents of the rumen, cecum 
or colon, which did not differ.  Overall across all sites, the DDG+S group contained higher 
concentrations of NalR E. coli O157:H7 than the CON (P = 0.02), and tended to have higher 
concentrations compared to DDG (P = 0.09) group (Table 2); CON and DDG groups did not 
differ (P = 0.48).  Recto-anal mucosal swabs were not included in the gut sampling site 
concentration analysis because the RAMS method does not use a measured amount of sample. 
The cumulative prevalence of NalR E. coli O157:H7 (total sampling sites positive per animal) 
at necropsy was significantly affected by dietary treatments (P = 0.05).  Across all gut sample 
sites, dietary effects showed that steers in the DDG+S group had higher prevalence of NalR E. 
coli O157:H7 compared to CON (P = 0.05) or DDG (P = 0.03) group (Table 2).  No difference 
(P = 0.80) in prevalence was detected between steers in the DDG and CON groups. 
 
 Fecal pH 
Overall, fecal pH was significantly different over sampling days (P < 0.01) and between 
dietary treatment groups (P < 0.001; Figure 3), but sampling day × dietary treatment interaction 
was not significant (P = 0.18).  The average fecal pH of steers in the DDG group (pH = 6.18) 
was lower (P < 0.01) than that of the CON and DDG +S groups (pH = 6.34 and 6.26, 
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respectively).  The average fecal pH of steers of the DDG+S group tended to be lower (P = 0.07) 
than the CON group. 
 
 Gut contents pH at necropsy 
A tendency (P = 0.07) was observed for gut pH to be associated with sample sites (rumen, 
cecum, colon, and rectum) × dietary treatment interaction; whereas pH was significantly 
different across gut sample sites (P = 0.05) and between dietary treatment groups (P < 0.001; 
Table 3).  Ruminal pH was lower than the cecum, colon, and rectum, which were not different 
from each other.  The pH of cecal and colonic contents were higher in the control group 
compared to DDG or DDG+S groups.  The pH of gut contents did not differ (P = 0.35) between 
DDG and DDG+S treatment groups. 
 
 Fecal Composition 
Overall, fecal protein and starch concentrations were significantly different (P < 0.001 and P 
= 0.04, respectively) between dietary treatment groups (Table 4), but did not change significantly 
over time, and no dietary treatment x sampling day interactions occurred.  The fecal starch 
concentration of steers in the DDG+S group (11.5%) was lower than those of the CON group 
(16.0%; P = 0.01) and tended to be lower than DDG group (13.1%; P = 0.09); the CON and 
DDG groups were not different from each other.  The fecal protein concentration of steers in the 
DDG+S group was lower (13.5%) than that of the CON (16.2%; P < 0.001) and DDG groups 
(15.8%; P < 0.01), which were not different (P = 0.50) from each other.   
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Discussion 
Cattle fed high grain diets supplemented with DDG had increased fecal shedding of NalR E. 
coli O157:H7, and more animals were fecal positive for NalR E. coli O157:H7 for a longer 
duration compared with the control that had no DDG supplement.  These findings are in 
agreement with previous research on DG effects on fecal shedding of E. coli O157:H7 (Jacob et 
al., 2008a,b, 2010; Wells et al., 2009, 2011).  The reason(s) behind the positive association are 
unknown.  Escherichia coli O157:H7 colonizes within the hindgut of cattle (Naylor et al., 2003; 
Walker et al., 2010), therefore, changes in hindgut microflora, pH and VFA concentrations 
associated with altered nutrient flow and availability may directly or indirectly affect the ability 
of E. coli O157:H7 to proliferate, colonize and persist in the hindgut.  Our hypothesis was that 
lower starch concentrations in DG-supplemented diets, due to corn grain replacement, may 
contribute to higher fecal prevalence of E. coli O157:H7.  We added corn starch to the DDG diet 
to achieve estimated NFC and starch concentrations similar to that of the control diet (60.0% 
estimated NFC; 49.0% estimated starch).  We expected that some of the starch would flow into 
the hindgut and alter the conditions to have an effect on E. coli O157:H7; however, the fecal 
concentration and number of steers shedding E. coli O157:H7 in DDG+S were similar to that of 
DDG group, suggesting that inclusion of additional starch to the DDG diet had no effect on fecal 
shedding of NalR E. coli O157:H7.  Because the starch added to the diet was pure, the starch 
could have been digested completely in the rumen and small intestine, with no starch reaching 
the hindgut to have an impact on hindgut fermentation.  This possibility is supported by fecal 
starch concentrations, which were lowest in steers fed the DDG+S diet.  The amount of corn 
grain that was replaced with corn starch (23.5% of DM) in the DDG+S diet was estimated from 
NRC (2000) values for corn grain (75.5% NFC; 68.0% starch) and Hall, (2009) for corn starch 
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(≥ 95% NFC; 95% starch).  The added corn starch in the DDG+S diet did not achieve a similar 
concentration of starch compared with the CON diet (46.3% in CON vs. 41.3% in DDG+S).  
Furthermore, the DDG diet had a slightly greater concentration of starch compared to the 
DDG+S diet (43.3% and 41.3%, respectively); however, the amount of corn starch added to the 
DDG diet achieved a concentration of NFC similar to the CON diet (61.7 % in CON vs. 61.9 % 
in DDG+S), whereas the DDG diet had slightly lower than expected NFC concentration (58.3%).  
The discrepancy between NFC and starch concentrations in the DDG+S diet could not be 
explained and individual ingredient samples were not collected, so determining the exact cause 
of the discrepancy was not possible.  Even with these differences in NFC and starch 
concentrations among dietary treatments, we observed a significant increase in the fecal 
shedding of E. coli O157:H7 by steers on DDG-supplemented diets.  This result suggests that 
other nutrients or substances in DDG supplemented diets may be responsible for fecal shedding 
increase of E. coli O157:H7.  We were not able to balance the diets for NDF due to the high 
concentration of NDF in DDG-supplemented diets, which resulted in DDG and DDG+S diets 
having 30.2% and 16.3% increase in NDF, respectively, over the CON diet, suggesting that NDF 
may influence the fecal shedding of E. coli O157:H7. 
We had previously hypothesized (Jacob et al., 2009) that higher hindgut starch 
concentrations provide more substrate for the microbes and lead to low pH and high VFA 
concentration, thereby decreasing E. coli O157:H7.  We observed a significantly lower fecal pH 
in the DDG and DDG+S groups compared with the CON diet, suggesting higher hind gut 
microbial activity, although we did not measure VFA concentrations.  The higher concentration 
of fecal protein in the CON and DDG diets compared to the DDG+S diet suggests greater 
microbial growth in the hindgut (Ørskov et al., 1970).  Kudva et al. (1997) showed that sheep, 
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experimentally inoculated with E. coli O157:H7 and fed a grass hay diet, shed the organism for a 
longer duration and at higher concentrations than sheep fed a corn and alfalfa pellet diet.  These 
researchers also observed fewer positive animals when the grass hay diet was abruptly changed 
to a corn and alfalfa pellet diet, suggesting feeding of a starch-based diet hinders E. coli 
O157:H7’s ability to persist in the hindgut.  Fox et al. (2007) and Jacob et al. (2008a) showed 
that increased ruminal degradability of grain, associated with processed grains (steam-flaked vs. 
dry-rolled), increased the prevalence of E. coli O157:H7, probably due to less starch reaching the 
hindgut.   
Distillers grains have increased concentrations of protein, fiber, and lipids (Spiehs et al., 
2002), which alter the flow and availability of nutrients in the hindgut.  Increased protein and 
fiber contents may allow for greater protein and fiber fermentation within the hindgut, thereby 
altering pH and concentrations of fermentation products.  Increased flow of fiber may stimulate 
mucus production, and constituents of mucus, particularly gluconic acid, have been shown to 
stimulate growth of E. coli O157:H7 (Fox et al., 2009).  In our study, dietary protein was held 
constant across all diets by altering the amount of soybean meal in the diet (10.8% in the CON 
diet and 1.5% in the DDG+S diet).  Dietary NDF was highest in the DDG diet (16.1%), lowest in 
the CON diet (11.8%) and the amount in the DDG+S diet (14.1%) was between DDG and CON 
diets.  However, fecal concentration and prevalence of NalR E. coli O157:H7 did not differ 
between DDG and DDG+S groups, and DDG+S tended to have a higher concentration and 
significantly higher prevalence of NalR E. coli O157:H7 in necropsy samples.  Increased dietary 
lipid concentrations will increase the flow of free fatty acids, which could exert antimicrobial 
effects (Annamalai et al., 2004), but free fatty acids are likely to be absorbed and not reach the 
hindgut; also, the lipid concentrations across all 3 diets were held constant by adding fat (white 
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grease) to the CON diet.  Another possibility (Jacob et al., 2008a, 2009) is that DG may contain 
unknown substances that have a stimulatory effect on E. coli O157:H7, and this idea is supported 
by an apparent stimulatory effect of DG when added to in vitro rumen fluid cultures inoculated 
with E. coli O157:H7; however, the same effect was not seen in fermentations with fecal 
bacterial cultures (Jacob et al., 2008a). 
Regardless of the nutritional mechanism, feeding DG to cattle results in higher levels of E. 
coli O157:H7 in the feces which leads to higher levels of environmental E. coli O157:H7.  Varel 
et al. (2008) demonstrated that E. coli O157:H7 inoculated into manure slurries from cattle fed 
DG (20 or 40% of DM) persisted longer and at higher concentrations over a 14 d- room 
temperature incubation compared with control manure slurries from cattle fed 0% DG.  Higher 
concentrations of E. coli O157:H7 in a feedlot pen would create an environment more likely to 
reinoculate the bacteria into the gastrointestinal tract of cattle, furthering its persistence within a 
cohort of animals.   
In conclusion, our experimental inoculation study confirms the positive association between 
feeding DG and fecal shedding of E. coli O157:H7.  Furthermore, addition of starch to the DDG 
diet to achieve concentration of estimated starch similar to that of the corn grain-based diet 
without DG supplement diet had no effect on fecal shedding of E. coli O157:H7.  However, 
inclusion of pure starch in the diet may not have achieved our intended goal to have starch flow 
into the hindgut similar to that of corn grain.  Perhaps use of ruminally- protected starch or 
infusion of starch post ruminally would have been a better approach to test our hypothesis.  Also, 
research is needed to understand whether other components of DG, protein or fiber, may be 
responsible for the positive association with E. coli O157:H7 fecal shedding.
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Figure 3.1. Fecal concentration of nalidixic acid-resistant (NalR) Escherichia coli O157:H7 
following oral inoculation with a 5-strain mixture of NalR E. coli O157:H7 in steers fed a corn 
grain-based, high grain diet supplemented with no dried distillers grains (CON; n = 7; 
mean=1.44 ± 0.10 log10 cfu/g), 25% dried distillers grains (DDG; n = 7; mean=1.94 ± 0.10 
log10 cfu/g) or 25% DDG plus corn starch (DDG+S; n = 7; mean=2.03 ± 0.10 log10 cfu/g).  
Steers in the CON group had significantly lower (P < 0.001) fecal concentrations of NalR E. coli 
O157:H7 compared with DDG or DDG+S; all other treatment comparisons, the day x treatment 
interaction, and the main effect of day were not statistically significant. 
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Figure 3.2. The number of cattle that tested fecal positive for nalidixic acid-resistant (NalR) 
Escherichia coli O157:H7 by sampling day following oral inoculation with a 5-strain mixture of 
NalR E. coli O157:H7.  Cattle were fed corn grain based high-grain diets supplemented with no 
dried distillers grains (CON; n = 7), 25% dried distillers grains (DDG; n = 7) or 25% DDG plus 
corn starch (DDG+S; n = 7).  The cumulative prevalence of NalR E. coli O157:H7 between days 
2 and 35 was higher in steers fed DDG (P < 0.01; mean=80.6 ± 4 %) and DDG+S (P < 0.001; 
mean 86.7 ± 3.4%) compared with CON (mean=57.1 ± 5.0 %) steers. 
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Figure 3.3. Fecal pH of steers fed corn grain-based high-grain diets supplemented with no dried 
distillers grains (CON; n = 7; mean=6.34 ± 0.03), 25% dried distillers grains (DDG; n = 7; 
mean=6.18 ± 0.03) or 25% DDG plus corn starch (DDG+S; n = 7; mean=6.26 ± 0.03) by 
sampling day following oral inoculation with nalidixic acid-resistant Escherichia coli O157:H7.  
Fecal pH was significantly different between dietary groups (P < 0.001), and between sampling 
days (P < 0.01), but the dietary group x sampling day interaction was not significant (P = 0.18). 
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Table 3.1. Ingredient and chemical composition of the treatment diets 
Item 
Corn grain-based high grain diet supplemented with (% 
DM): 
0% dried distillers 
grain (DDG; 
Control) 
25% DDG 
25% DDG plus 
corn starch 
Ingredients 
   
Dry rolled corn 70.1 60.6 36.1 
Corn DDG 
- 25.0 25.0 
Chopped alfalfa hay 10.0 7.0 7.0 
Soybean meal 10.8 - 1.5 
Choice white grease1 2.3 - - 
Molasses 2.5 3.0 2.5 
Corn starch 
- - 23.5 
Supplement2 2.0 2.0 2.0 
Medicated premix3 2.4 2.3 2.4 
 
 
Nutrient composition 
 
DM, % 91.1 90.9 90.5 
Nonfiber carbohydrates, % DM 61.7 58.3 61.9 
CP, % DM 14.6 14.1 13.8 
Starch, % DM 46.3 43.3 41.3 
NDF, % DM 11.8 16.9 14.1 
1Choice white grease was from Key Feeds, Clay Center, KS. 
2Supplement contained 15.5 g of limestone, 3.2 g of CaCl, 1,749 IU vitamin A, 0.1 mg Co, 6.6 
mg Cu, 0.33 mg I, 0.17 mg Se, 33 mg Mn, and 33 mg Zn per kg of diet DM. 
3Medicated premix provided 33 mg of monensin sodium (Elanco Animal Health, Greenfield, 
IN) and 11 mg tylosin (Elanco Animal Health) per kg of feed in a ground corn carrier.
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Table 3.2. The prevalence and concentration of nalidixic acid-resistant (NalR) Escherichia coli O157:H7 in gut 
contents at necropsy from cattle fed corn grain-based, high-grain diets supplemented with no dried distillers 
grains (0% DDG [Control]; n = 7), 25% DDG (n = 7), or 25% DDG and corn starch (DDG+S; n = 7)1. 
Gut site  
 Corn grain-based, high grain diet supplemented with: 
0% DDG 
(Control) 
25% 
DDG 
25%  
DDG+S 
 0% DDG  
(Control) 
25% 
DDG 
25% 
DDG+S 
SEM 
Prevalence (Positive/Total)  Concentration (log10 cfu/g) 
Rumen 0/7 0/7 2/7  0.00 0.00 0.43 0.09 
Cecum 2/7 1/7 4/7  0.44 0.19 0.94 0.16 
Colon 1/7 2/7 4/7  0.30 0.43 1.10 0.19 
Rectum 3/7 3/7 5/7  0.74 1.70 1.95 0.39 
Rectoanal mucosal swab 6/7 5/7 6/7  - - - - 
Rumen+Cecum+Colon+Rect
um 
6/28
b 
6/28
b 
15/28
a 
 
0.37
b
 0.58
ab
 1.10
a
 0.21 
1
 The concentrations of NalR E. coli O157:H7 in gut contents was not associated with the gut sample site (rumen, 
cecum, colon, or rectum) × dietary treatment interaction (P = 0.85), but was significantly affected by gut 
sample site (P = 0.03) and tended to be affected by dietary treatment (P = 0.06).  The cumulative prevalence of 
NalR E. coli O157:H7 (total sampling sites positive per animal) at necropsy was significantly affected by 
dietary treatments (P = 0.05).    
a, b Within cumulative prevalence values, treatments without a common superscript letter differ at P < 0.05; within 
concentration values, treatments without a common superscript letter differ at P < 0.05 
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Table 3.3. Gut content pH at necropsy of cattle fed corn grain-based, high-grain diets 
supplemented with no dried distillers grains (0% DDG [Control]; n = 7), 25% DDG (n 
= 7), or 25% DDG and corn starch (DDG+S; n = 7) following oral inoculation with 
nalidixic acid-resistant Escherichia coli O157:H7.1 
Source  
Corn grain-based, high grain diet supplemented with: 
SEM 0% DDG 
(Control) 
25% DDG 25% DDG+S 
Rumen 5.62 5.78 5.77 0.097 
Cecum 6.51
a
 6.13
b
 6.09
b
 0.057 
Colon 6.57
a
 6.17
b
 6.08
b
 0.055 
Rectum 6.42 6.47 6.28 0.055 
1
 Fecal pH was significantly different between gut sampling site (P < 0.05), and between 
dietary treatment group (P < 0.001), but the gut sampling site x dietary group interaction 
was not significant (P = 0.07)  
a, b Within a row, means without a common superscript letter differ at P < 0.05. 
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Table 3.4. Dry matter content and nutrient composition of feces from of cattle fed corn grain-
based high-grain diets supplemented with no dried distillers grains (0 % DDG [Control]; n = 7), 
25% DDG (n = 7), or 25% DDG and corn starch (DDG+S: n = 7) following oral inoculation with 
nalidixic acid-resistant Escherichia coli O157:H7 
Nutrient 
Corn grain-based high grain diet supplemented with: 
SEM P-value 0% DDG 
(Control) 
25% DDG 25% DDG+S 
DM, % 23.0
b
 23.3
b
 25.0
a
 0.54 0.04 
Starch, % of DM 16.0
a
 13.1
ab
 11.5
b
 1.30 0.04 
CP, % of DM 16.2
a
 15.8
a
 13.5
b
 0.46 < 0.001 
NDF, % of DM 30.2
c
 39.3
a
 32.8
b
 0.90 < 0.001 
ADF, % of DM 14.8
a
 15.0
a
 12.9
b
 0.49 < 0.001 
a,b,c Within a row, means without a common superscript letter differ at P < 0.05. 
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Chapter 4 - Detection of Escherichia coli O104 in the Feces of 
O104 in the Feces of Feedlot Cattle by a Multiplex PCR Assay 
Designed to Target Major Genetic Traits of the Virulent 
Hybrid Strain Responsible for the 2011 German Outbreak 
 
 
(Published in Veterinary Microbiology, 2012, 156 (3-4) 381-388) 
 
Abstract 
We have developed an 11-gene multiplex PCR (mPCR), based on genes that code for 
serogroup-specific O-antigens and four major virulence factors (intimin, hemolysin and Shiga 
toxins [Stx] 1 and 2), to detect O157 and the ‘top six’ non-O157 (O26, O45, O103, O111, O121, 
and O145) Shiga toxin-producing Escherichia coli (STEC).  The assay specificity was validated 
with pure cultures of the seven STEC (185 strains), 26 other STEC (65 strains), non-STEC (5 
strains) and 33 strains of other species.  Sensitivity of the assay with fecal sample spiked with 
pooled cultures of seven STEC was 105 CFU/g before enrichment and 102 CFU/g after 
enrichment.  The applicability of the assay to detect STEC in fecal samples (n=50), before and 
after enrichment, was evaluated by comparing with culture-based methods for O26, O111, and 
O157.  The mPCR assay of 50 fecal samples showed seven (14%) positive for a total of nine O-
groups compared to 23 (46%) positive for 34 O-groups after an enrichment step.  Overall, 17 and 
27 of 50 fecal samples were positive, by culture-based methods, for O157 and non-O157 (4 for 
99 
 
99 
 
 
O26, 3 for O45 and 20 for O103) serogroups, respectively.  None of the 27 non-O157 isolates 
possessed the stx genes, suggesting that cattle harbor Shiga toxin negative E. coli belonging to 
the ‘top six’ non-O157 serogroups.  Our data, although based on a limited number of samples, 
suggest that the sensitivities of the mPCR and culture-based methods in detecting the seven 
serogroups of STEC in feces differed between O-groups.  An obvious limitation of our mPCR is 
that the concurrent detection of virulence genes and the serogroups in a sample does not 
necessarily associate the virulence genes with the prevalent serogroups in the same sample.  The 
major application of our11-gene mPCR assay may be in identifying putative colonies of STEC 
obtained by culture-based methods. 
 
Introduction 
Cattle harbor Shiga toxin-producing E. coli (STEC) in the gastrointestinal tract, particularly 
in the hindgut (Hussein and Bollinger, 2005), and serve as a primary reservoir.  The STEC is 
shed in the feces, which serves as a major source of food and water contaminations for food 
borne infections (Ferens and Hovde, 2011; Rangel et al., 2005).  Among STEC, the O157 
serogroup has long been recognized as a major foodborne pathogen (Paton and Paton, 2003; 
Pennington, 2010).  Recently, non-O157 serotypes, belonging to six O groups, O26, O111, 
O103, O121, O45, and O145, have been recognized as a growing public health concern (Brooks 
et al., 2005).  According to the Centers for Disease Control and Prevention, STEC account for 
approximately 175,000 illnesses annually, and O157 and non-O157 are responsible for 36 and 
64% of the total STEC infections, respectively (Scallan et al., 2011).  The traditional method to 
detect and isolate E. coli O157 from cattle feces involves an enrichment step, followed by 
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immunomagnetic bead separation (IMS) and plating on a selective medium that can 
phenotypically and presumptively distinguish O157 from other E. coli.  The confirmation is 
made with O157-specific agglutination, followed by PCR for genes that code for O-group 
antigen (rfbO157), H7 (fliC), Shiga toxins and other virulence factors (Bai et al., 2010).  Cultural 
procedures for detection and isolation of non-O157 E. coli, however, are not yet established.  
Commercial IMS beads are available for four of the ‘top six’ non-O157 serogroups and selective 
media that can phenotypically distinguish non-O157 STEC serogroups have not been developed.   
Multiplex PCR (mPCR)-based detections have been developed to identify non-O157 STEC 
in food and carcass samples.  Genes in the O-antigen cluster, especially wzx, which encodes a 
flippase required for O-polysaccharide export, has been used in various PCR-based detections 
(DebRoy et al., 2005; DebRoy et al., 2011; Fratamico et al., 2009; Monday et al., 2007; Perelle 
et al., 2004; Perelle et al., 2007; Valadez et al., 2011).  However, none of them has evaluated 
applicability of the mPCR to detect O157 and the ‘top six’ non-O157 serogroups in fecal 
samples of cattle.  A PCR assay that detects the major virulence genes concurrently with the 
identification of the major serogroups will have an obvious advantage.  Therefore, we designed 
an 11-gene multiplex PCR assay to detect the seven major STEC serogroups (O26, O45, O103, 
O111, O121, O145, and O157) concurrently with the four major virulence genes (stx1, stx2, 
hlyA, and eae).  The assay was validated with pure cultures of STEC and applicability of the 
assay to detect the seven STEC in fecal samples was evaluated. 
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Materials and Methods 
 Primer design  
The wzx gene, which encodes for a flippase required for O-polysaccharide export, was used 
to design primers for serogroups O26, O45, O103, O111, and O145.  The wbqE gene, which 
encodes for a putative glycosyl transferase, and wbqF, which encodes for a putative acetyl 
transferase (Fratamico et al., 2003), were used to design primers for O121.  Primers used for 
stx1, stx2, hlyA, eae, and rfbO157 genes were validated in our previous study (Bai et al., 2010).  
Primers were designed to amplify the targets with distinct amplicon sizes, and were designed to 
match all available sequences for the respective O-serogroups at the time of designing.  The wzx 
gene in each serogroup was found specific, except for O121 in which the wzx gene was nearly 
identical to that from a Shigella strain (AY380835.1), thus wbqE-F were used to specifically 
amplify E. coli O121.  All primer sequences are given in Table 1.   
 
 PCR reactions and visualization 
All primer stocks were prepared in 1X TE buffer (Integrated DNA Technologies, Inc., 
Coralville, Iowa) at concentrations of 100 pM/µl.  Equal volumes of the 11-primer pairs (22 
primers) except for O111, which was doubled, were mixed together.  One microliter of the 
primer mix was used in a 20 µl PCR reaction resulting in final primer concentrations of 0.42 µM 
for O111 and 0.21 µM for all other primers in the reaction.  Each reaction also contained 10 µl of 
BioRad iQ Multiplex Powermix (without additional supplement), 1 µl of boiled bacterial cells, or 
DNA extracted from fecal, spiked fecal or enriched fecal samples, and 8 µl nuclease-free water.  
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The PCR amplification program included a 5 min denaturation at 94o C, followed by 25 (for pure 
culture) or 35 cycles (for all others) of 94oC for 30 sec, and 67oC for 80 sec.  The PCR products 
were run on 1.2% agarose gel and visualized with a GelDoc 2000 Fluorescent Imaging System 
(BioRad, Hercules, CA). 
 
 Template DNA preparation 
 Bacterial cultures, stored in protect beads at −80°C, were streaked on blood agar plates 
(Remel, Lenexa, KS) and incubated overnight at 37°C.  One or two colonies of each strain were 
suspended in 1 ml of distilled water and boiled for 10 min.  After a quick centrifugation, 1 µl of 
the supernatant was used as DNA template.  GeneClean DNA extraction kit (MP Biomedicals, 
Solon, OH) was used for all Escherichia coli (EC)-broth (Oxoid Ltd., Hampshire, England; 
(Vimont et al., 2007) enriched fecal samples, and QIAamp DNA stool mini kit (Qiagen, 
Valencia, CA) was used for all fecal and fecal samples spiked with pure cultures.   
 STEC strains used in the initial assay development  
Strains representing the seven O-serogroups were used for the initial assay development and 
to determine detection sensitivity.  Strains TW 1597 (O26), 2566:58 (O45) were kindly provided 
by The Thomas S. Whittam Microbial Evolution Laboratory, Michigan State University; Strains 
15612-1 (O103), 4190 (O121), 7726-1 (O111), 1234-1 (O145) were from our collection (Renter 
et al., 2005); and strain 43894 (O157) was from the American Type Culture Collection 
(Manassas, VA).  For assay development, single colonies of the seven strains from BAP were 
cultured overnight in Luria Bertani (LB) broth individually, and 100 µl was inoculated into 10 
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ml LB broth and incubated for 4-5 h until they reached an absorbance of 0.5 at 600 nm (~108 
CFU/ml).  The seven strain-cultures were mixed in equal amounts, and 1 ml of the pooled 
mixture was boiled for 10 min, and 1 µl of the supernatant after a quick spin was used in the 
mPCR reactions.  For the pure culture sensitivity test, six 10-fold dilutions were made from the 
seven strain-culture mixture, and 1 ml of each dilution was boiled and centrifuged as before for 
use as template in mPCR.  Aliquots of the same dilutions were spread-plated on MacConkey 
agar to determine bacterial cell concentrations.   
 
 E. coli and non-E. coli strains used for assay specificity validation  
A collection of 185 strains belonging to the seven major STEC (Table 2), 65 strains 
belonging to 26 other STEC serogroups (O6 [2], O8 [3], O15 [2], O22 [1], O38 [3], O39 [3], O49 
[1], O74 [3], O84 [3], O88 [3], O91 [2], O96 [3], O109 [3], O113 [3], O116 [3], O117 [3], O118 
[2], O130 [4], O136 [3], O141 [3], O146 [1], O153 [2], O159 [1], O163 [3], O171 [3], O172 [2]), 
five strains of non-STEC (ATCC 43886, 12014, 35401, 43896, and 25922), and 33 strains of 
other Gram negative and Gram positive bacteria (Enterobacter aerogenes [1], Enterococcus 
casseliflavus [1], Enterococcus faecalis [3], Enterococcus faecium [2], Enterococcus gallinarum 
[1], Klebsiella pneumoniae [1], Listeria monocytogenes [1], Morganella morganii [1], Proteus 
mirabilis [1], Salmonella enterica serotypes [19 strains from 16 serotypes: S. Agona, S. Anatum. 
S. Bareilly, S. Braenderup, S. Derby, S. Enteritidis, S. Infantis, S. Kentucky, S. Mbandaka, S. 
Montevideo, S. Muenchen, S. Oranienberg, S. Orion, S. Reading, S. Senftenberg, and S. 
Typhimurium], Serratia marcescens [1], and Streptococcus pyogenes [1].  The bacterial cultures 
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stored at -80oC were grown on BAP to obtain single colonies.  One or two colonies were 
suspended in 1 ml of water, boiled and centrifuged as before for use in mPCR reactions.   
 
 PCR Assay sensitivity with pure cultures and cattle fecal sample spiked with pure cultures 
The seven STEC strains were grown individually to an absorbance of 0.5 at 600 nm (~108 
CFU/ml), and equal volumes of the cultures were pooled together.  A serial of 10-fold dilutions 
were made, and 1 ml of each dilution was boiled and used for the mPCR assay.  For fecal 
samples spiked with the seven STEC strains, the pooled cultures were prepared as before, and 
10-fold serially diluted mixtures were inoculated into aliquots of a fecal sample collected from a 
feedlot steer.  DNA extractions were performed with QIAamp DNA stool mini kit on fecal 
samples spiked with different culture dilutions.  One gram of each fecal sample inoculated with 
different dilutions of the culture mixture was also enriched in 9 ml EC broth for 6 h at 40oC, and 
DNA was extracted by GeneClean kit.  The dilutions of the seven strain mixture were also 
spread-plated on MacConkey agar to determine bacterial cell concentrations.  The experiment to 
determine assay sensitivity was repeated with a different fecal sample.   
 
 PCR assay vs. culture detection of STEC in cattle fecal samples 
A total of 50 fecal samples were collected from feedlot cattle and ~1 g of each sample was 
mixed in 9 ml EC broth, and incubated at 40oC for 6 h.  DNA was extracted from fecal 
suspensions in EC broth, before and after enrichment, with the GeneClean kit and used in mPCR 
assay.  The enriched samples were also subjected to immunomagnetic separation (IMS) with 
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Dynabeads (Invitrogen, Carlsbad, CA) for O26, O111, and O157.  The O157 beads were plated 
on sorbitol MacConkey agar (SMAC) with cefixime (0.5 mg/L) and potassium tellurite (2.5 
mg/L), and six sorbitol-negative colonies were picked for O157 antigen latex agglutination test 
and colonies positive for agglutination were subjected to mPCR assay.  The O26 and O111 beads 
were streaked on MacConkey agar plates and ten colonies, randomly picked from each sample, 
were streaked individually on BAP and incubated overnight.  A single colony from each of the 
ten cultures was suspended individually in 1 ml of distilled water and 100 µl of suspensions from 
each of the ten colonies from each sample were pooled together and subjected to the mPCR 
assay.  For samples that were positive for any of the STEC based on the mPCR assay of the 
pooled cultures, the ten individual colonies were subjected to mPCR to identify the positive pure 
culture.  The isolates positive for STEC were stored at -80oC. 
 
Results 
 mPCR assay with pure cultures 
 The specificity of each primer pairs was tested individually using the mixture of the seven E. 
coli serogroups, O26, O45, O103, O111, O121, O145, and O157.  The primers only amplified 
the corresponding STEC serogroup (data not shown).  The serogroup-specific primers were then 
mixed with the primers for the four virulence genes, stx1, stx2, eae and hlyA.  After optimizing 
PCR conditions (stated in the materials and methods section), 11 distinct bands were obtained 
(Fig. 1).  The sizes of the amplicons were: 890 (wzxO45), 740 (wzxO103), 655 (stx1), 587 (wbqO121), 
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523 (wzxO145), 477 (stx2), 417 (wzxO26), 375 (eae), 296 (rfbO157), 230 (wzxO111), and 199 bp 
(hlyA).  
 A total of 185 strains belonging to the seven major serogroups (30 [O26], 4 [O45], 41 
[O103], 39 [O111], 12 [O121], 15 [O145], and 44 [O157]) were tested.  The 11-gene mPCR 
assay confirmed the serogroup of each of the 185 strains and their virulence gene profiles.  The 
prevalence of the four virulence genes varied between the serogroups.  In case of O157, all 
strains contained eae and hlyA, and 42 and 21 of 44 strains were positive for stx2 and stx1, 
respectively.  Of the 141 non-O157 STEC strains, 114 had stx1, 39 had stx2, 82 had eae, and 119 
strains had hlyA (Table 2).  Next to O157, O111 strains (n=39) possessed more virulence genes; 
38 stx1, 22 stx2, 38 eae, and 37 hlyA genes (Table 2).  None of the O-serogroup primer pairs 
amplified any of the 65 strains in the other STEC O-serogroups or from the five non-STEC 
ATCC strains; however, the primer pairs of the virulence genes amplified the virulence genes in 
other STEC O-serogroups.  The virulence gene profiles the other STEC-O groups matched the 
original descriptions (data not shown).  None of the 33 non-E. coli strains, representing both 
gram positive and gram negative bacterial species, showed any amplification (data not shown).   
 
 Assay sensitivity with pure cultures and spiked fecal samples 
 The initial concentration of pooled cultures of the seven O-serogroups was 6.5 x 107 CFU/ml 
(mean of two replications), which was subjected to four additional ten-fold dilutions to obtain 6.5 
x 106, 6.5 x 105, 6.5 x 104, and 6.5 x 103 CFU/ml.  The minimum concentration of the pooled 
culture that amplified all 11 genes was 6.5 x 104 CFU/ml (Fig. 2).  In fecal samples spiked with 
different concentrations of the pooled cultures of the seven O groups, the sensitivity of detection 
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was 6.5 x 105 CFU/g before enrichment (Fig. 3) and 6.5 x 102 CFU/g after enrichment for 6 h in 
EC broth (Fig. 4). 
 
 PCR assay vs. IMS-based detections of O26, O111 and O157 in cattle fecal samples 
The mPCR assay of the 50 fecal samples suspended in EC broth before enrichment showed 
seven samples (14%) positive for a total of nine O groups (O26=1, O45=4, O103=1, O121=2, 
and O157=1) compared to 23 samples (46%) positive for 34 O groups (O26=9, O45=6, O103=8, 
O121=3, and O157=8) after 6 h enrichment (Table 3).  Similarly, more samples were positive for 
the four virulence genes after enrichment compared to samples before enrichment.  None of the 
samples was positive for O111 and O145 serogroups.  Of the 50 fecal samples, 27 (54%) 
samples were negative for any of the seven major O-serogroups, and 14 (28%) were positive for 
one, 7 (14%) were positive for two, two (4%) were positive for three of the seven serogroups.  
We plated a subset of 20 of the 50 samples that were enriched in EC broth directly on 
MacConkey agar without the IMS procedure, and testing of the pooled colonies (10 randomly 
picked colonies per sample) yielded only three samples positive for O103.  After O157 IMS 
separation and agglutination confirmation of the sorbitol-negative colonies on CT-SMAC plates, 
17 of the 50 samples (34%) were positive for O157 serogroup.  All 17 O157 isolates possessed 
eae and hlyA, 15 had stx1 and stx2, and two isolates had stx2 only.  The use of O26 IMS beads 
and testing of the pooled 10 colonies from MacConkey agar plates yielded four samples positive 
for O26, two samples positive for O103, and one sample positive for O45 serogroups (Table 3).  
Samples after O111 IMS procedure had no positive O111, but 18 of 50 (36%) fecal samples 
were positive for O103 and two samples were positive for O45.  The 18 samples that were 
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positive for O103 included the three samples that were identified as positive by direct plating of 
the enriched samples (without IMS) on MacConkey agar.  Table 4 shows the comparison 
between mPCR (pre- or post-enriched samples) and culture-based method with IMS in detecting 
O26, O103 (with O111 IMS beads), and O157 serogroups in feces.  Fewer fecal samples were 
positive for any of the three serogroups by either mPCR or IMS than the number of samples 
positive regardless of the method used.  In contrast, only few samples were positive for any of 
the three serogroups by both mPCR and IMS.  For example, a total of 21 of 50 samples were 
positive for O157 based on either mPCR or IMS and only 4 of 21 samples were positive by both 
mPCR and IMS (Table 4). 
Overall, 50 fecal samples were positive for 27 non-O157 serogroups (4 for O26, 3 for O45 
and 20 for O103) based on testing of pooled colonies on MacConkey agar after the IMS 
procedure.  Because all samples were subjected to O26, O111 and O157 IMS procedures, 
multiple serogroups were identified from the same samples (nine samples had two, and four 
samples had three serogroups).  We tested the original single colonies that were stored in -80oC 
of each positive sample by mPCR for O-groups and virulence genes.  We identified the 27 non-
O157 serogroups in pure cultures, however, none of the 27 strains had stx genes.  One O103 
strain had eae and hlyA, five O103 and one O26 strains had only hlyA.  The serogrouping of the 
27 non-O157 E. coli positives were confirmed by the E. coli Reference Center at Pennsylvania 
State University.  When ten individual colonies from each positive samples were tested, 13 
isolates were identified that did not belong to the seven O-groups, but carried the virulence genes 
(4 had eae and hlyA, 2 had stx1 and hlyA, 4 had stx2 only, 2 had stx1 only, and 1 had hlyA only).  
All 13 isolates were confirmed as E. coli based on the API Rapid 20E kit (bioMérieux Inc., 
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Durham, NC).  The serogroups of the 13 strains were identified, by the Pennsylvania State 
University E. coli Reference Center, as O171 (n=4), O104 (n=2), O71 (n=2), and one each of 
O8, O108, O116, O153 and O109/O119 strain (Table 5).   
 
Discussion 
We developed the 11-gene mPCR to concurrently detect O157 and the ‘top six’ non-O157 
serogroups with the four major virulence genes.  According to the CDC, the ‘top six’ O-groups 
are responsible for 74% of non-O157 STEC infections in the US (Scallan et al., 2011).  The four 
virulence genes chosen, stx1, stx2, eae, and hlyA, code for key virulence factors in human 
infections with O157 and non-O157 STEC (Brooks et al., 2005; Karmali et al., 2010), and are 
routinely included in characterizations of STEC (Bai et al., 2010; Hu et al., 1999; Lefebvre et al., 
2005; Paton and Paton, 1998).  Few mPCR-based detections for identifications of O157 and the 
major non-O157 STEC have been published (DebRoy et al., 2011; Monday et al., 2007; Valadez 
et al., 2011).  Monday et al. (2007) developed a mPCR to detect O157 and 5 of the top six (O26, 
O103, O111, O121, and O145; no O45) STEC.  The assay also included primers for eae and 
Shiga toxins (a single primer pair to detect both stx1 and stx2).  The assay was validated with 
pure cultures of STEC only.  DebRoy et al. (2011) have reported on a mPCR to detect 8 STEC 
serogroups (the seven major STEC and O113) by targeting the wzx genes of the O-antigen gene 
clusters and specificity and sensitivity of the assay were evaluated with pure cultures and with 
artificially inoculated apple juice.  The assay did not target virulence genes and the applicability 
of the assay to detect STEC in cattle feces was not evaluated.   
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The primers in our study were designed to obtain 11 amplicons that formed distinct bands on 
agarose gels.  The designed primers were specific for the seven serogroups, based on specificity 
assays determined with pure cultures of a number of STEC, non-STEC, and other related or 
unrelated gram negative and gram positive bacteria.  The specificity, sensitivity and applicability 
of the assay to detect the seven serogroups were also evaluated with fecal samples inoculated 
with the pooled mixture of the seven STEC.  A minimum concentration of 6.5 x105 CFU/g (650 
CFU/µl of sample volume in PCR reaction) was needed to detect all 11 genes.  The sensitivity of 
the assay was improved to 6.5 x 102 CFU/g with the inclusion of a 6-h enrichment step in EC 
broth.  The sensitivity of the 11-gene assay was a half to one log lower than the sensitivity 
reported by DebRoy et al. (2011) for the mPCR of 8 O-groups with no virulence genes, and that 
of the six-genes mPCR (rfbO157, fliCH7, stx1, sxt2, eae and hlyA) without O-groups of non-O157 
reported by Bai et al. (2010).  We tested the 11-gene PCR primers on a single O157 strain that 
was positive to the four virulence genes (rfbO157, stx1, sxt2, eae and hlyA), and the sensitivity was 
similar (104 before enrichment and 101 after enrichment) to that of 8 O-groups (DebRoy et al., 
2011) and 6 virulence genes mPCR (Bai et al., 2010).  The difference in sensitivity may be 
reflective of the number of genes involved in the amplification (11 vs. 8 or 6). 
We evaluated the applicability of mPCR to detect the seven major serogroups of E. coli in 
cattle feces by comparing to that of culture-based detection methods (IMS followed by plating on 
CT-SMAC for O157 or MacConkey agar for the six non-O157) with a limited number of fecal 
samples (n=50).  The culture method was used only for three (O26, O111, and O157) of the 
seven STEC because of our inability to procure IMS beads for O103 and O145.  Beads for O45 
and O121 are not yet commercially available.  However, mPCR of the post-enrichment sample 
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identified 6 samples positive for O45 and 3 samples positive for O121.  The mPCR assay of the 
fecal samples suspended in EC broth before incubation for enrichment identified O-groups in 
seven of the 50 fecal samples (O26=1, O45=4, O103=1, O121=2, and O157=1), suggesting that 
the samples possibly contained high concentrations (> 104 per g) of the O-groups of E. coli.  
When we plated a subset of 20 samples after enrichment, without IMS, on to MacConkey agar, 
only three samples yielded O-groups and all three were O103.  The same 20 samples, after IMS 
with O26, O111, or O157 beads, yielded 12 O157 and 18 non-O157 strains (O26=4, O45=2, 
O103=12), which illustrates the advantage of using IMS beads.  The sensitivity of the mPCR and 
culture-based methods in detecting the major serogroups in feces differed between O-groups.  In 
case of O157, the IMS procedure with O157 beads identified 17 (34%) positive samples 
compared to eight (16%) of 50 samples by mPCR, which included nine of the 17 samples 
positive by IMS that were not detected by mPCR and four of the eight samples positive by 
mPCR that were not detected by IMS.  Interestingly, only four samples were positive by both 
methods.  In case of O111 beads, which identified O103, more samples were positive by IMS 
(18 of 50) compared to mPCR (8 of 50).  The difference in sensitivity is not surprising because 
for a PCR assay to be positive, the sample should contain at least 1,000 cells per g or ml of 
sample to assure that a sample volume of 1 µl in the PCR reaction contains DNA from at least 
one cell.  However, in case of O26, mPCR identified more positives (9 of 50) compared to IMS 
(4 of 50).  Additional samples need to be evaluated before suggesting that sensitivity of 
commercial O26 beads need improvement.  Interestingly, the commercially available O111 
beads did not yield any O111, but yielded several O103, suggesting that the beads were either 
nonspecific or perhaps mislabeled by the manufacturer.  Our data, although based on a limited 
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number of fecal samples, suggest that neither PCR nor culture based method was better in 
detecting the prevalence of the seven serogroups in cattle feces.  The PCR has the advantage in 
that it is amenable to rapid through-put and automation.  On the other hand, the culture-based 
method, which is labor-intensive and expensive, yields isolates that could then be tested for the 
presence of virulence genes.   
A total of 27 non-O157 strains (O26=4, O45=3, and O103=20) were isolated from 50 fecal 
samples.  Interestingly, none of the 27 strains carried stx genes, suggesting that cattle harbor 
Shiga toxin-negative E. coli belonging to the ‘top six’ non-O157 serogroups.  The other 
possibility is that the primers used in the PCR were not amplifying the stx from the non-O157 
serogroups.  The latter is unlikely because the primers amplified stx genes of all the known 
strains (n=250) that were tested in this and in a previous study (Bai et al., 2010).  An analysis of 
the stx2 gene in the current database indicated that the primers matched majority of non-O157 
STEC strains, except the stx2f subtype, which appear to be distantly related to all other stx 
subtypes (~40-60% identical to other subtypes; data not shown).  The stx2f subtype was mainly 
found in STEC isolated from pigeons (Schmidt et al., 2000; Unkmeir and Schmidt, 2000), and 
occasionally in isolates from humans with mild symptoms of enteritis (van Duynhoven et al., 
2008).  In addition to stx2f subtype, there is a single base mismatch in our stx2 reverse primer 
against the subtype stx2g.  However, the modified reverse primer (stx2R2: 
TGTCGCCASTTATCTGACATTC) did not detect stx2 from the 27 non-O157 strains (data not 
shown).  Studies on the prevalence of non-O157 STEC in cattle feces, generally from countries 
outside the US, have shown that many non-O157 strains do carry the stx genes (Jenkins et al., 
2003; Pearce et al., 2004; Pradel et al., 2000; Renter et al., 2005).  There are also reports of 
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prevalence of non-O157 STEC in cattle that lacked stx and other major virulence genes (Barlow 
and Mellor, 2010; Bosilevac and Koohmaraie, 2011; Bugarel et al., 2011).  A recent study of E. 
coli O26 strains in Germany indicated that 133 of 250 strains did not possess either stx genes, 
and the authors speculated that the virulent O26 strains were most likely the less virulent O26 
that acquired one or both stx genes (Bugarel et al., 2011).  In a study (Bosilevac and 
Koohmaraie, 2011) on the prevalence of non-O157 STEC in commercial ground beef in the US, 
only a small proportion of STEC isolates (10 of 338) recovered possessed major virulence genes 
to be considered of significant food safety threat. 
An obvious limitation of our mPCR is that the concurrent detection of virulence genes and 
the seven serogroups in a sample does not necessarily mean that the virulence genes are 
associated with the seven serogroups in the same sample.  Therefore, when more than one O-
serogroup is present in a sample, which is often the case (Barlow and Mellor, 2010; Renter et al., 
2007), the assay will not be able to associate the virulence gene(s) to any particular serogroup.  
Also, the virulence genes in the same sample could be from a serogroup other than the seven 
major STEC that have been shown to carry some of the virulence genes, including stx genes and 
more often the eae and the hlyA.  In our study, there were eight E. coli isolates from 50 fecal 
samples that did not belong to the top seven serogroups, but carried stx1 and/or stx2 genes.  
Blanco et al. (2005) also demonstrated that the eae gene is present in cattle E. coli serogroups 
O2, O8, O10, O15, O34, O64, O77, O113, O119, O128, O156, O177 and several ONT (O-
antigen nontypeable) strains.  The eae gene was also found in both stx-positive, and stx-negative 
E. coli serogroups (Ito et al., 2007).  Similarly, hlyA is found in E. coli O5, O69, O76, O84, O98, 
and O156 of both cattle and human origins (Boerlin et al., 1998).  Using our eae and hlyA 
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primers as queries to search the GenBank, we identified perfect match to our primers from 
multiple E. coli O-groups, including those that were not within the seven major STEC 
serogroups (data not shown).  The confirmation of the association of virulence gene(s) with a 
particular serogroup would require that the isolate be obtained in pure culture and then tested 
again by mPCR.  The major application of our11-gene mPCR assay may be in identifying 
serogroup and virulence genes of putative colonies of STEC that have been obtained by culture-
based method.   
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Figure 4.1. Gel image of amplicons of 11genes amplified by multiplex PCR of a pooled mixture 
of pure cultures of Escherichia coli O26, O45, O103, O111, O121, O145 and O157 strains.  Lane 
1: molecular size markers; Lane 2: Amplicons of 11 gene segments.   
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Figure 4.2. Sensitivity of the 11-gene multiplex PCR tested with ten-fold, serially diluted pooled 
cultures of Escherichia coli O26, O45, O103, O111, O121, O145 and O157 strains.  Lanes 1 and 
7: Molecular size markers; Lanes 2-6: Amplicons from pooled cultures with concentrations of 
107, 106, 105, 104, and 103 CFU/ml.   
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Figure 4.3. Sensitivity of the multiplex PCR assay determined with cattle fecal sample spiked 
with ten-fold, serially diluted pooled cultures of Escherichia coli O26, O45, O103, O111, O121, 
O145 and O157 strains.  Lanes 1 and 6: Molecular size maker; Lanes 2-4: Amplicons obtained 
from cattle fecal sample spiked with pooled cultures of 106, 105, and 104 CFU/g of feces; Lane 5 
(CK): Cattle feces before spiking with E. coli cultures.   
 
124 
 
124 
 
 
Figure 4.4. Sensitivity of the multiplex PCR assay determined with cattle fecal sample spiked 
with ten-fold, serially diluted pooled cultures of Escherichia coli O26, O45, O103, O111, O121, 
O145 and O157 strains after enrichment in Escherichia coli broth at 40 C for 6 h.  Lanes 1 and 
10: Molecular size makers; Lanes 2-8: Amplicons from enriched cattle fecal sample spiked with 
pooled cultures of 106, 105, 104, 103, 102, 101, and 100 CFU/g of feces; Lane 9 (CK): Enriched 
cattle feces without added E. coli cultures.   
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Table 4.1. Target genes, primer sequences and amplicon sizes  
Target 
genes 
Primer  Primer sequence (5’—3’) 
Amplicon 
size (bp) 
Reference 
wzxO45 O45-F GGGCTGTCCAGACAGTTCAT 
890 This study 
O45-R TGTACTGCACCAATGCACCT 
wzxO103 O103F2 GCAGAAAATCAAGGTGATTACG 
740 This study 
O103R2 GGTTAAAGCCATGCTCAACG 
stx1 stx1-F TGTCGCATAGTGGAACCTCA 
655 Bai et al., 2010 
stx1-R TGCGCACTGAGAAGAAGAGA 
wbqEO121 
wbqFO121 
O121-F2 TCAGCAGAGTGGAACTAATTTTGT 
587 This study 
O121-R2 TGAGCACTAGATGAAAAGTATGGCT 
wzxO145 O145F5 TCAAGTGTTGGATTAAGAGGGATT 
523 This study 
O145R5 CACTCGCGGACACAGTACC 
stx2 stx2-F CCATGACAACGGACAGCAGTT 
477 
Bai et al., 2010 
 stx2-R TGTCGCCAGTTATCTGACATTC 
wzxO26 O26F4 AGGGTGCGAATGCCATATT 
417 This study 
O26R4 GACATAATGACATACCACGAGCA 
eae eae-F CATTATGGAACGGCAGAGGT 
375 Bai et al., 2010 
eae-R ACGGATATCGAAGCCATTTG 
rfbO157 rfbE-F CAGGTGAAGGTGGAATGGTTGTC 
296 
Bertrand and Roig 
2007; Bai et al., 
2010 
rfbE-R TTAGAATTGAGACCATCCAATAAG 
wzxO111 O111F2 TGCATCTTCATTATCACACCAC 
230 This study 
O111R2 ACCGCAAATGCGATAATAACA 
hlyA hlyA-F GCGAGCTAAGCAGCTTGAAT 
199 Bai et al., 2010 
hlyA-R CTGGAGGCTGCACTAACTCC 
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Table 4.2.  Multiplex PCR confirmation of O-serogroups and virulence genes of 
seven major shiga toxin-producing E. coli strains  
 
 
 
 
 
 
 
 
 
 
 
 
Serogroups Number of strains Virulence genes 
stx1 stx2 eae hlyA 
O26 30 24 5 17 24 
O45 4 2 0 0 1 
O103 41 41 2 12 41 
O111 39 38 22 38 37 
O121 12 0 3 0 3 
O145 15 9 7 15 13 
O157 44 21 42 44 44 
TOTAL 185 135 81 126 163 
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Table 4.3.  Detection of the seven serogroups of Escherichia coli in cattle feces by multiplex PCR or culture-based methods 1 
Enrichment 
in Escherichia coli 
broth  
Immunomagnetic 
bead separation  
Number of fecal samples (n=50) positive for O-specific and virulence genes 
O26 O45 O103 O111 O121 O145 O157 stx1 stx2 eae hlyA 
Pre-enrichment None 1 4 1 0 2 0 1 3 8 22 31 
Post-enrichment None 9 6 8 0 3 0 8 17 22 35 44 
 O26  4 1 2 0 0 0 0 4 4 2 5 
 O111  0 2 18 0 0 0 0 1 0 4 10 
 O157  0 0 0 0 0 0 17 15 17 17 17 
 2 
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Table 4.4. Prevalence of Escherichia coli 
serogroups in fecal samples (n=50) by multiplex 
PCR (mPCR) or culture-based method with 
immunomagnetic separation (IMS): 
 
Method of 
detection 
Serogroups 
O26 O103 O157 
mPCR only 9 8 8 
IMS only 4 18 17 
mPCR and IMS 2 6 4 
mPCR or IMS 11 20 21 
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Table 4.5.  Prevalence of virulence genes in serogroups, 
other than the seven major serogroups, of Escherichia coli in 
Cattle Fecal Samples (n=50) 
 
 
 
 
 
 
 
 
 
 
 
 
Serogroups 
Number of 
strains 
Number of strains positive for 
virulence genes 
stx1 stx2 eae hlyA 
O171 4 0 4 0 0 
O104 2 2 0 0 2 
O71 2 0 0 2 2 
O8 1 1 0 0 0 
O108 1 0 0 1 1 
O116 1 0 0 0 1 
O153 1 0 0 1 1 
109/119 1 1 0 0 0 
Total 13 4 4 4 7 
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Chapter 5 - Escherichia coli O104 in the feces of feedlot cattle do not 
appear to carry traits of the virulent hybrid strain responsible for 
the 2011 German outbreak 
 
(Accepted in Applied and Environmental Microbiology) 
 
Abstract 
Shiga toxin-producing E. coli (STEC) O104:H4 was the cause of a large food-borne outbreak of 
hemorrhagic colitis and hemolytic uremic syndrome in Germany in 2011.  The serotype was a 
hybrid of STEC and enteroaggregative E. coli (EAEC) pathotypes that carried genes for Shiga 
toxin 2 (stx2), and enteroaggregative fimbrial adhesins, but lacked intimin (eae) and 
enterohemolysin (ehxA).  Because cattle are known reservoirs of STEC, we investigated fecal 
carriage of E. coli O104 in feedlot cattle.  A multiplex PCR (mPCR) was designed and validated 
to detect the following 8 genes: stx1, stx2, terD (tellurite resistance), eae, wzxO104 (O104 specific 
O-antigen flippase), fliCH4 (H4 flagella), ehxA and aggA (aggregative adherence fimbria 1).  A 
total of 248 fecal samples from 8 feedlots were collected, enriched in E. coli broth, extracted 
DNA and subjected to mPCR.  Overall, 20.6% (51/248) of fecal samples were positive for 
wzxO104.  None of the fecal samples was positive for aggA gene.  Enriched fecal samples positive 
for wzxO104 (n=51) were plated on several selective and differential media and presumptive E. 
coli colonies were tested by the mPCR.  Only 7 (13.7%) samples yielded pure cultures of 
serogroup O104 and all 7 isolates were negative for genes characteristics of STEC and EAEC.  
The lack of selectivity in culture methods may have limited our ability to identify more positive 
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samples.  Our results suggest that E. coli O104 is present in cattle feces, but the strains do not 
appear to carry genes characteristic of the virulent hybrid strain responsible for the 2011German 
outbreak.   
 
Introduction 
In the summer of 2011, a large outbreak of food-borne illness caused by an unusual serotype of 
Shiga toxin-producing Escherichia coli (STEC) was reported in Europe (Frank et al., 2011).  The 
striking feature of the illness was a surprisingly high incidence of hemolytic uremic syndrome 
(24%) in adults (Frank et al., 2011).  Epidemiological investigation implicated organic fenugreek 
sprouts as the point source of the outbreak (King et al., 2012).  The E. coli serotype was 
O104:H4, characterized as a hybrid strain of enteroaggregative E. coli (EAEC) and STEC 
(Bielaszewska et al., 2011).  The hybrid strain carried stx2 gene, lacked intimin (eae) and 
enterohemolysin (ehxA), and possessed an operon with genes (aggA, aafA, agg3A, and agg4A) 
coding for aggregative adherence fimbrial adhesins I, II, and III (AAF/I-III), typical of EAEC 
(Bielaszewska et al., 2011; Frank et al., 2011).  Such a hybrid pathotype with enteroaggregative 
and Shiga toxigenic features have been reported with two other serogroups, O111:H2 (Morabito 
et al., 1998) and O86:NM (Iyoda et al., 2000). 
 
 Cattle are a primary reservoir of STEC (Karmali et al., 2010) in which the organisms reside 
in the hindgut and are shed in the feces.  Cattle feces can be a source of direct or indirect 
contamination of food and water leading to human STEC illnesses (Ferens and Hovde, 2011; 
Rangel et al., 2005).  Therefore, it is of interest to determine whether cattle harbor serogroup 
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O104 and whether harbored strains of O104 carry virulence genes characteristic of STEC and or 
EAEC.  In Germany, no O104:H4 strain was detected in cattle feces in the outbreak area (Wieler 
et al., 2011).  In a report from France, based on a real-time PCR assays that targeted stx2, 
wzxO104, fliCH4, and aggA, none of the cattle fecal samples examined carried the four genes 
simultaneously, and the authors suggested that cattle are not likely a reservoir of E. coli O104:H4 
(Auvray et al., 2012).  However, similar studies to assess presence of O104 in feces of cattle in 
the US have not been conducted. 
 
 There are reports of prevalence of STEC O104 in cattle and sheep feces with flagellar types 
other than H4 (Blanco et al., 2003, 2004).  The O104 serogroup with H21 flagellar type, which 
was also negative for intimin (similar to O104:H4 outbreak strains), was implicated in a US 
outbreak of hemorrhagic colitis associated with consumption of raw milk in Montana in 1994 
(CDC, 1995; Feng et al., 2001).  In order to detect serogroup O104 with STEC and or EAEC 
traits, we designed and validated a multiplex PCR (mPCR) to detect the following 8 genes: stx1 
(Shiga toxin 1), stx2 (Shiga toxin 2), terD (tellurite-resistance), eae (intimin), wzxO104 (O104 
specific O-antigen flippase), fliCH4 (H4 specific flagella), ehxA (enterohemolysin) and aggA 
(pilin subunit of aggregative adherence fimbria 1[AAF/1]; Bielaszewska et al., 2011).  Our 
objectives were to screen feedlot cattle feces to detect the presence of the serogroup O104, and 
isolate and characterize E. coli O104 from PCR-positive fecal samples. 
 
133 
 
133 
 
 
Materials and Methods 
 Bacterial strains 
The following strains of E. coli were used in the development of the mPCR: a strain of O104:H4 
(ATCC BAA-2326; Rohde et al., 2011) involved in the 2011 German outbreak, a strain of 
O104:H21 (ATCC 172801; CDC, 1995) involved in the outbreak of hemorrhagic colitis in 
Montana in 1994 (CDC, 1995) and E. coli O157:H7 (ATCC 43894).  All strains were stored on 
CryoCare® beads (Key Scientific Products, Stamford, TX) at -80°C and to revive the frozen 
strains, a single bead was streaked on to blood agar (BAP; Remel, Lenexa, KS) and incubated 
overnight at 37°C. 
 
 Multiplex PCR assay 
A multiplex PCR was designed to target the following 8 genes: wzxO104, (O104 specific O-
antigen flippase), fliCH4 (H4 specific flagella), stx1 (Shiga toxin 1), stx2 (Shiga toxin 2), terD 
(tellurite resistance), eae (intimin), ehxA (enterohemolysin) and aggA (pilin subunit of 
aggregative adherence fimbria 1[AAF/1]).  Primers for wzxO104, fliCH4 and aggA genes were 
designed with Primer3 software (Version 0.4.0; Rozen and Skaletsky, 2000).  Target genes, 
primer sequences, and amplicons size are listed in Table 1.   Primers were individually 
reconstituted in 1 x TE buffer (pH 7.5) to concentrations of 100 pM/µl and equal amounts of 
each primer were mixed together.  Twenty microliter volume PCR reactions consisting of 10 µl 
iQ Multiplex Powermix (Bio-Rad, Hercules, CA), 8 µl of PCR grade H20, 1 µl of DNA template 
and 1 µl of the primer mixture (final individual primer concentration in PCR reaction of 0.31 
µM) were used.  The PCR program was: 94°C denaturation for 5 min, 25 cycles for pure culture 
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DNA or 35 cycles for fecal DNA, 94°C denaturation for 30 sec, and 65°C annealing for 30 sec 
and 68°C extension for 75 sec.  The final step was a 68°C extension for 7 min.  Amplified DNA 
was separated on 2.0 % agarose gel, stained with 0.5 µg/ml of ethidium bromide and visualized 
with a Bio-Rad GelDoc 2000 Fluorescent Imaging System.   
 
 PCR assay specificity validation 
The specificity of the mPCR assay was tested with 185 strains belonging to the seven STEC 
serogroups most common in the US (O26, O45, O103, O111, O121, O145 and O157), 81 strains 
belonging to other STEC serogroups (O6, O8, O15, O22, O38, O39, O49, O74, O84, O88, O91, 
O96, O109, O113, O116, O117, O118, O130, O136, O141, O146, O153, O159, O163, O171 and 
O172), five strains of non-Shiga toxin producing E. coli (ATCC 43886, 12014, 35401, 43896, 
and 25922) and three species of related Gram negative bacteria (Salmonella enterica, Klebsiella 
pneumonia and Proteus mirabilis).  Strains were revived from frozen beads by streaking onto 
BAP and incubating overnight at 37°C.  Template DNA for the mPCR reaction was obtained by 
mixing 1 or 2 colonies in a microcentrifuge tube in 1.0 ml of double deionized H2O, boiling for 
10 min and centrifuging at 9,300 x g for 5 min. 
 
 PCR assay sensitivity with pure culture and cattle fecal sample spiked with pure culture 
Escherichia coli O104:H4 (ATCC BAA-2326) was grown in Luria-Bertani (LB; Becton 
Dickinson Co., Sparks, MD) broth to an absorbance of 0.5 at 600 nm (approx. 108 CFU/mL) and 
serial 10-fold dilutions were made.  A 1.0 ml aliquot of each dilution was removed, boiled for 10 
min, centrifuged at 9,300 x g for 5 min and tested by the mPCR to determine the detection limit 
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in pure culture.  Another 1.0 ml of each dilution was mixed with aliquots of fresh fecal sample (1 
ml per 10 g of fecal sample) collected from a feedlot steer.  An aliquot (10 g) of feces mixed 
with 1 mL of sterile LB broth served as the uninoculated control.  One gram of spiked feces of 
each dilution was suspended in 9.0 ml of Escherichia coli broth (EC; Oxoid Ltd., Hampshire, 
UK), vortexed and incubated at 40°C for 6 h.  Aliquots (1.0 ml) of fecal suspensions before and 
after enrichment were placed in 1.5 ml microcentrifuge tube, boiled for 10 min and centrifuged 
at 9,300 x g for 5 min.  The dilutions of the O104:H4 culture used for inoculating feces were 
spread-plated on MacConkey agar (3 plates per dilution; Difco; Becton Dickinson, Sparks, MD) 
to determine colony counts.  DNA from both pre- and post-enrichment sub-samples were 
extracted and purified with a GeneClean DNA extraction kit (MP Biomedicals, Solon, OH), then 
subjected to the mPCR.  The detection limit of the mPCR was the lowest concentration of the 
serially diluted pure culture, pre- and post-enrichment spiked fecal samples in which all 5 bands 
were visualized.   
 
 PCR assay and culture detection of E. coli O104 in cattle fecal samples 
In the summer of 2012, a total of 248 fecal samples were collected based on a convenience 
sample of eight feedlots.  In 7 feedlots, 24 fresh pen floor fecal samples were collected from 10 
different pens (2-3 samples per pen).  From the eighth feedlot, a total of 80 fecal samples were 
collected from 18 different pens (4 or 5 samples per pen).  Fecal samples were placed in Whirl-
Pak bags, transported in coolers with ice packs to the laboratory, and processed within 24 h of 
sampling.  One gram of feces was placed in 9.0 ml of EC broth (Oxoid Ltd.), vortexed, and 
incubated at 40°C for 6 h.  Aliquots (1.0 ml) of fecal suspensions, before and after enrichment, 
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were placed in 1.5 ml microcentrifuge tube, boiled for 10 min and centrifuged at 9,300 x g for 5 
min.  DNA was extracted from the pre- and post-enrichment samples with a GeneClean DNA 
extraction kit and subjected to the mPCR.  The remaining post-enrichment fecal suspension was 
stored at 4°C and used for isolation.   
 
 Fecal samples (n=51) that were positive for E. coli O104 by mPCR were streaked on to 
MacConkey agar (BD), Rainbow agar (Biolog Inc., Hayward, CA), non-O157 STEC differential 
agar (Possé et al., 2008), CHROMagar™ STEC (CHROMagar Microbiology, Paris, France, 
distributed by DRG International, Mountainside, NJ) and CHROMagar™ STEC with O104 
supplement (CHROMagar Microbiology) plates.  All plates were incubated at 37°C for 24 h, and 
10 presumptive colonies per plate (based on colony appearance and color of pure culture 
O104:H4 on the same media; Table 3) were picked and streaked on to BAP.  A single colony 
from each of the ten isolates of each sample was suspended individually in 1 ml of distilled 
water and 100 µl of suspensions of each of the ten colonies were pooled together and subjected 
to the mPCR assay for the 8 genes.  If the DNA from the pooled colonies amplified the wzx104 
gene, then each of the ten colonies was tested individually by the mPCR to identify the pure 
culture of the serogroup O104.  Isolates that were positive for the wzx104 gene were submitted to 
the E. coli Reference Laboratory at Pennsylvania State University for serotype confirmation.  
 
 Statistical analysis 
Sample-level crude prevalence estimates were calculated based on the overall proportions of 
samples that tested positive for each gene.  Associations between presence of the serogroup 
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O104-specific gene (wzyO104) and stx1, stx2, eae or fliCH4 genes within enriched fecal samples 
were analyzed in generalized linear mixed models specified with a binomial distribution and 
logit link function.  Random effects were used to account for the hierarchical structure of to the 
data (samples within pens and pens within feedlots).  Odds ratios and confidence intervals (back 
transformed original scale) are reported.  Due to the small numbers of samples positive by 
culture-based methods, only descriptive statistics are provided for these data.   
 
Results 
 Multiplex PCR assay with pure cultures and spiked fecal samples 
The specificity of each primer pair was validated individually with the DNA of O104:H4 
ATCC strain, O104:H21 ATCC strain, O157:H7 ATCC strain or pooled DNA of O104:H4 and 
O157:H7 serotypes for amplifications of wzxO104, fliCH4, stx1, stx2, eae, terD, ehxA and aggA 
genes.  When tested individually, primers amplified only single bands corresponding to the 
expected sizes of each amplicon: 655 bp for stx1, 477 bp for stx2, 434 bp for terD, 375 bp for 
eae, 337 bp for wzxO104, 244 bp for fliCH4, 199 bp for ehxA and 151 bp for aggA.  When primers 
were combined into a single reaction and assay conditions were optimized, 8 distinct bands of 
the expected amplicons were detected with the pooled DNA of serotypes O104:H4 and O157:H7 
(Fig. 1).  The O104:H4 German strain was negative for all except stx1, eae, and ehxA, the 
Montana strain was positive for wzxO104, stx2, and ehxA and negative for stx1, fliCH4, eae, and 
aggA, and the O157:H7 strain was positive for stx1, stx2, eae, and ehxA, but negative for 
wzxO104, fliCH4 and aggA (Fig. 1).  The mPCR assay did not show amplifications of wzxO104, 
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fliCH4 or aggA genes in any of the 274 strains of STEC, non-STEC, and other related bacteria 
(data not shown).  All STEC strains were positive for at least one of the stx genes. 
The initial concentration of the O104:H4 ATCC strain, which was serially diluted to 
determine assay sensitivity, was 1.5 x 108 CFU/ml.  The minimum concentration of the pure 
culture that amplified the five expected genes (wzxO104, fliCH4, stx2, terD, and aggA) was 1.5 x 
104 CFU/ml.  In fecal samples spiked with serially diluted (10-fold) concentrations of O104:H4, 
the sensitivity of detection was 1.5 x 105 CFU/g before enrichment and 1.5 x 102 CFU/g after 
enrichment (Fig. 2).  Although lower concentrations showed amplifications of some genes (fliC4, 
terD, and ehxA), only 102 or higher concentrations of cells, after enrichment, showed all 5 bands 
of O104.  The fecal sample inoculated with sterile LB broth showed distinct bands of terD and 
ehxA, and a faint band of fliC4. 
 
 Multiplex PCR detection of O104 from cattle fecal samples 
Results from the mPCR assay of the 248 fecal samples from feedlots showed only 3 samples 
(1.1%) positive for the O104 serogroup before enrichment and 51 samples (20.6%) positive after 
enrichment in EC broth (Table 2).  The crude within-feedlot sample prevalence of wzxO104 gene 
in cattle feces ranged from none (0/24 fecal samples) to 11 of 24 fecal samples (45.8%).  
However, none of the 248 fecal samples was positive for the aggA gene.  More fecal samples 
were positive for the other six genes (fliCH4, stx1, stx2, eae, ehxA, and terD) after enrichment (58 
to 97.8%) compared to samples before enrichment (14.9 to 84.5%; Table 2).  Samples were more 
commonly positive for the stx2 gene (75.8%) the stx1 gene (58.1%).  A high percentage of fecal 
samples (82 to 98%) were positive for fliCH4, eae, ehxA, and terD genes.  Forty-one fecal 
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samples (16.5%) contained the three genes, wzxO104, fliCH4, and stx1 or stx2 (Table 2).  The 
presence of wzxO104 in enriched fecal samples was positively associated with the presence of 
fliCH4 (odds ratio [OR] of 11.8; confidence interval 1.89 to 71.43; P < 0.01) and eae (OR of 5.0; 
confidence interval 1.29 to 19.23; P = 0.02).  However, there was no significant association 
between the presence of wzxO104 and either of the Shiga toxin genes 
 
 Isolation of E. coli O104 from cattle fecal samples 
Fecal samples that were positive for wzxO104 gene (n=51) were plated on several media to 
isolate the serogroup O104 in pure culture.  Initially, MacConkey and Rainbow agar were used.  
Subsequently, three additional media, a selective and differential non-O157 STEC medium 
described by Posse et al (2008) and two commercial chromogenic media, CHROMagar STEC 
and CHROMagar STEC with O104 supplement were included.  The non-O157 STEC 
differential medium described by Posse et al (2008) consisted of lactose- free MacConkey agar 
base supplemented with sugars (sucrose and sorbose), additional bile salt, isopropyl β-D-1-
thiogalactopyranoside (IPTG), 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-gal), sodium 
tellurite, and novobiocin.  The plating of O104:H4 ATCC strain on all four media yielded 
lactose- fermenting pink colonies on MacConkey agar, and shades of light to dark blue to purple 
colored colonies on non-O157 STEC differential agar, Rainbow agar, CHROMagar STEC and 
CHROMagar STEC O104 (Table 3).  After plating enriched fecal samples that were positive for 
the serogroup O104 (n=51) by mPCR, 10 presumptive colonies (based on color) were randomly 
picked from each medium and streaked individually on BAP and incubated overnight.  If the 
DNA from the pooled colonies of 10 amplified the wzx104 gene, then each of the ten colonies was 
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tested by mPCR to identify the serogroup O104.  Of the 51 fecal samples, only 10 isolates (2 
from 51 samples plated on MacConkey, 3 from 51 samples plated on Rainbow agar, 0 from 42 
samples plated on non-O157 STEC differential agar, 1 from 42 samples plated on CHROMagar 
STEC and 4 from 16 samples plated on CHROMagar STEC O104) were positive for the O104 
serogroup-specific gene (wzx104).  None of the 10 isolates in pure culture was positive for Shiga 
toxin genes, eae, or aggA.  The four O104 isolates from CHROMagar STEC-O104 and 1 isolate 
from the Rainbow agar possessed terD and ehxA, while the other 6 isolates did not possess any 
of the other 4 genes (stx1, stx2, eae, and ehxA) tested by the mPCR.  Of the 10 isolates, 2 isolates 
on three occasions were from the same fecal sample on two different agars (MacConkey and 
Rainbow, MacConkey and CHROMagar STEC, Rainbow and CHROMagar STEC O104 agars), 
therefore, only seven samples were considered to have distinct isolates from different fecal 
samples (Table 4).  Of the seven isolates, five were confirmed as O104 with H7 flagellar type by 
the E. coli Reference Center at Pennsylvania State University.  Two of the seven isolates were 
identified as O8:H11 and O8:H21 by the E. coli Reference Center.  The H7 flagellar type of the 
five O104 isolates was confirmed with the primers designed to identify fliCH7 of E. coli O157 
(Bai et al., 2010).  A PCR described by Wang et al., (2001), designed for O8/O9 (F-
GGCATCGGTCGGTATTCC and R-TGCGCTAATCGCGTCTAC), was performed on the 
seven isolates.  The two isolates identified as O8 by the E. coli Reference Center yielded positive 
bands and the other 5 isolates were negative (Fig. 3).  We then retested E. coli O8 strains (n=19) 
that were in our culture collection with the primers designed for wzxO104 gene, and none of the 
strains yielded a positive band (Fig. 4).  The flagellar types (H11 and H21) of the two O104/O8 
isolates were confirmed by PCR assays (Durso et al., 2005; Sekse et al., 2011). 
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Discussion 
An 8-gene mPCR was designed to screen fecal samples of cattle for the presence of the 
serogroup O104 in association with the genes characteristic of the hybrid strain of STEC (stx2) 
and EAEC (aggA) with H4 flagellar antigen (fliCH4).  The aggA gene is one of four genes (aggA 
to aggD) in a cluster that encode for a type 1 aggregative adherence fimbrial (AAF) subunit 
required for the phenotypic expression of the aggregative adhesion pattern (Suzert et al., 2001).  
The aggA was chosen because it is more conserved than the other genes in the cluster, including 
the master regulator gene aggR of the AAF operon, typical of EAEC.  The AAF adhesins are 
responsible for the characteristic “stacked brick” aggregative adherence of EAEC demonstrated 
on Hep-II cells, a human cell line (Nataro et al., 1987).  Although 20.6% of the 248 fecal 
samples tested contained the serogroup O104, none of the fecal samples was positive for the 
aggA, which was not surprising because EAEC pathotype is generally considered as a human 
diarrheal pathogen, particularly of children in developing countries (Giammanco et al., 1996).  
However, E. coli strains displaying aggregative adherence pattern have been isolated from 
different animal species, including calves with diarrhea (Aidar et al., 2000; Uber et al., 2006).  
The EAEC strains of animal origin were classified as atypical EAEC because they lacked aggR 
and aggregative adherence fimbrial genes (Uber et al., 2006).  The pathotype with a combination 
of enteroaggregative and Shiga toxigenic traits is rare and prior to the German outbreak strain, it 
was only previously described in strains of O111:H2 and O86:NM involved in outbreaks of 
bloody diarrhea or hemolytic uremic syndrome in children in France and Japan, respectively 
(Morabito et al., 1998; Iyoda et al., 2001).  Similar to the German outbreak strain, the O111:H2 
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strain was negative for eae, but contained stx2 and genes that code for the aggregative fimbriae, 
but was positive, unlike the German strain, for the enteroaggregative heat stable enterotoxin.   
The specificity of the assay to detect the serogroup O104-specific gene was confirmed with a 
number of STEC (O157 and non-O157) strains and other related gram negative bacteria.  The 
sensitivity and applicability of the assay to detect the serogroup O104-specific gene were 
evaluated with a fecal sample inoculated with pure culture of O104:H4 strain.  A minimum 
concentration of 1.5 x 105 CFU/g (150 CFU per PCR reaction) was needed without an 
enrichment step to detect the five targeted genes of E. coli O104:H4 in cattle feces.  However, 
inclusion of an enrichment step in EC broth increased the sensitivity to 1.5 x 102 CFU/g of feces, 
which was similar to the sensitivity of detection by mPCR of other STEC (Paddock et al., 2012; 
Bai et al., 2012; DebRoy et al., 2011; Zhang et al., 2012).  The real-time PCR described by 
Zhang et al. (2012) targeting wzxO104, stx2, and fliCH4 was shown to have a detection limit of 7 x 
103 CFU/ml in human stool samples spiked with three different strains of E. coli O104:H4 and 
enriched for 4 h in Gram negative broth.   
Overall, the O104 serogroup-specific gene was present in 20.6% of fecal samples obtained 
from feedlot cattle.  The fliCH4 gene was detected more frequently (x%), suggesting that the 
flagellar type is present in other serotypes or species of bacteria.  The high overall prevalence of 
some of the virulence genes (stx1, stx2, eae, and ehxA) in fecal samples subjected selective 
enrichment has been previously reported (Bai et al., 2012; Paddock et al., 2012; Pradel et al., 
2000; Auvray et al., 2012).  A major limitation of a mPCR that detects serogroup, flagellar type 
and virulence genes in a fecal sample is that it does not indicate that the flagellar gene or 
virulence genes are associated with any particular serogroup.  Therefore, our estimation of the 
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crude prevalence of O104 in feces of cattle is based entirely on the detection of the gene that 
codes for the O antigen of O104.  Serogroup O104 with H4 flagellar type, which may be an 
STEC (positive for Shiga toxins and negative for enteroaggregative adhesins) or EAEC (positive 
for enteroaggregative adhesins, heat stable enterotoxin and negative for Shiga toxins) has been 
reported rarely to cause human infections (Bielazewaska et al., 2011; Germani et al., 1998; Kim 
et al. 2011; Mellman et al., 2008; Scavia et al., 2011).  Interestingly, the serotype of O104:H4, 
either Shiga toxigenic or enteroaggregative, has never been reported in animals or food (Mora et 
al., 2011).  However, strains of O104 with no H antigen (non motile) or different from H4 (e.g., 
H7, H11, H12, H21, etc.) have been reported in cattle feces (Blanco et al., 2003, 2004; Mora et 
al., 2011).  Wieler et al. (2011) tested 2,000 E. coli strains isolated from 100 fecal samples from 
cattle housed in farms located in the outbreak region of Germany with a multiplex PCR designed 
to detect rfb104, stx2, terD and fliCH4 (Bielaszewaska et al., 2011).  None of the strains showed 
the combination of four genes characteristic of the outbreak strain, which led the authors to 
conclude that cattle, in contrast to the other STEC, were not a reservoir for the O104:H4 
serotype.  A similar conclusion was reached by Auvray et al. (2012) after testing cattle feces in 
France.  A total of 1,468 French cattle were tested for fecal carriage of O104:H4 by PCR assay 
targeting wzx104, stx2, fliCH4, and aggR genetic markers and none of the fecal samples contained 
the four markers together.  Because the full combination of four genes typical of the German 
outbreak strain was not detected in any cattle feces, the authors concluded that French cattle are 
not a reservoir of the hybrid pathotype.  However, a small proportion (6.1%) of fecal samples 
contained the three genes, wzx104, stx2, and fliCH4.  In our study, we found 15.3% of fecal 
samples harbored the combination of wzx104, fliCH4 and stx2 genes, which does not necessarily 
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mean that stx2, and fliCH4 were carried by O104 as the genes could have been carried separately 
by distinct serotypes.   
Of the seven O104 strains recovered in this study, five had H7, and the other two had H11 
and H21.  None of the seven strains carried genes for Shiga toxin or enteroaggregative fimbrial 
subunit.  Two of the 7 strains carried the enterohemolysin gene.  Interestingly, 2 of the 7 strains 
were identified as O8 serogroup based on the serology performed by the E. coli Reference 
center.  The two strains were positive for the wzx104 gene by our mPCR and also gave positive 
bands with primers targeting O8 serogroup (Wang et al., 2001).  The oligosaccharide unit of the 
serogroup O104 has the identical structure as the E. coli K9 capsular antigen and the gene cluster 
that codes for O104 has the same genes in the same order as K9 gene cluster (Wang et al., 2001).  
The K9 antigen is generally present in strains of E. coli serogroups O8, O9, and O9a (Whitfield 
and Roberts, 1999).  Published PCR assays designed to detect O104 also were shown to detect 
the K9 positive O8/O9 E. coli (Wang et al., 2001; Delannoy et al., 2012; Zhang et al., 2012).  
Two of our isolated O104 strains were serotyped by the E. coli Reference lab as O8 and these 
isolates showed amplicons when tested with O8/O9-specific primers (Wang et al., 2001).  
However, the remaining five strains of O104 did not show amplification with the O8/O9 primers.  
In our validation assay, we tested 19 strains of O8 and none of them showed amplification with 
our designed O104 primers, which suggests the specificity of the O-gene region of O104 targeted 
for amplification. 
Because O104:H4 lacks unique biochemical characteristic no selective and differential 
medium has been developed for presumptive phenotypic identification.  Also, monoclonal 
antibodies have not been developed for use in immunomagnetic bead separation, a procedure 
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commonly used for selective isolation of O157 and some serogroups of non-O157 STEC.  In an 
attempt to isolate the serogroup O104 in pure culture from fecal samples that were PCR positive 
for O104 (n=51), we streaked enriched fecal suspension on to five different selective and 
differential media that allow color-based identification of non-O157 STEC.  The commercial 
chromogenic media (Rainbow agar and CHROMagar) have been used to isolate a variety of non-
O157 STEC serogroups (Hirvonen et al., 2012; Monaghan et al., 2012; Tillman et al., 2012; 
Tzschoppe et al., 2012).  Of the 5 media that we used, CHROMagar STEC with O104 
supplement, a proprietary preparation of undisclosed composition, identified O104 serogroup in 
4 of 16 PCR-positive (25%) fecal samples tested.  The commercial product was designed 
specifically to allow the growth of extended spectrum beta lactamase phenotype, a characteristic 
feature of the German outbreak strain.  Overall, culture-based methods identified the O104 
serogroup in only 7 of 51 (13.7%) PCR-positive fecal samples.  Obviously, lack of 
immunomagnetic separation step and suitable selective and differential medium  may have 
limited our ability to isolate O104 from fecal samples that were PCR positive for the serogroup-
specific gene.   
In conclusion, the 8-gene PCR assay will be useful to confirm putative isolates of serogroup 
O104 and determine the presence of major traits that are characteristics of STEC and EAEC 
pathotypes.  Additionally, the assay could be used to screen fecal samples for the prevalence of 
the serogroup O104 before subjecting the samples for culture-based detection and isolation.  
Although mPCR detected 21% of fecal samples as positive for serogroup O104, O104 isolates 
were only recovered by culture-based procedures from few (13.7%) of the PCR-positive 
samples.  Culture-based detection may have been limited by lack of selectivity in the isolation 
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procedure and further research to refine culture methods is needed.  Because none of the fecal 
samples contained the aggA, the enteroaggregative gene, and none of the isolated strains carried 
fliCH4, aggA, or stx genes, cattle do not appear to be a likely a reservoir for E. coli O104:H4 with 
characteristics of STEC and EAEC.  Further research is needed to determine the predominant 
pathotype (STEC, EAEC or non-pathogenic) of serogroup O104 that are shed in cattle feces.  
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Figure 5.1. Agarose gel images of amplicons obtained from multiplex PCR performed with two 
strains of Escherichia coli O104 (German [Lane 2] and Montana [Lane 3] strains), a strain of E. 
coli O157:H7 (ATCC strain 43894; Lane 4) and pooled DNA mixtures of O104 and O157 strains 
(Lane 5).  Lane 1 is the molecular size markers (100 bp). 
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Figure 5.2. Agarose gel images of amplicons obtained from multiplex PCR performed on fecal 
sample inoculated with ten-fold serial dilutions of Escherichia coli O104:H4 (1.5 x 107–1.5 x 101 
CFU/g) and enriched in Escherichia coli broth.  Lanes 1 and 10 are molecular size markers (100 
bp).  The positive control (POS CON; Lane 11) was pooled DNA of ATCC strains of O104:h4 
and O157:H7.  The negative control (NEG CON; Lane 9) was fecal sample mock-inoculated 
with sterile broth. 
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Figure 5.3. Agarose gel images of amplicons obtained from PCR with primers designed for 
Escherichia coli serogroups O104 (A) and O8  (B).  Lanes 1 and 12 are molecular size markers 
Lanes 3 to 9 are the seven E. coli O104 strains isolated in this study of cattle feces.  Lane 10 is E. 
coli O8 and lane 11 is negative control. 
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Figure 5.4. Agarose gel images of amplicons obtained from PCR with primers designed for 
Escherichia coli O104. Lane 2 is O104:H4 (German), lane 3 is O104:H21 (Montana), Lane 4 is 
serogroup O8, lanes 5 and 6 are strains of O104 and O8 isolated in this study, lane 7 is O157:H7, 
lane 8 is positive control (pooled DNA of O104 and O157 strains), lane 9 is negative control, and 
lanes 1 and 10 are molecular size markers (100 bp). 
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Table 5.1. Target genes, primers and amplicon sizes used for the multiplex PCR procedure 
Target 
genes 
Primer  Primer sequence (5’—3’) 
Amplicon 
size (bp) 
Reference 
wzxO104 
wzxO104-F GGTTTTATTGTCGCGCAAAG 
337 This study 
wzxO104-R TATGCTCTTTTTCCCCATCG 
     
fliCH4 
fliCH4-F ACGGCTGCTGATGGTACAG 
244 This study 
fliCH4-R CGGCATCCAGTGCTTTTAAC 
     
stx1 
stx1-F TGTCGCATAGTGGAACCTCA 
655 Bai et al., 2012 
stx1-R TGCGCACTGAGAAGAAGAGA 
     
stx2 
stx2-F CCATGACAACGGACAGCAGTT 
477 Bai et al., 2012 
stx2-R TGTCGCCAGTTATCTGACATTC 
     
eae 
eae-F CATTATGGAACGGCAGAGGT 
375 Bai et al., 2012 
eae-R ACGGATATCGAAGCCATTTG 
     
ehxA 
ehxA-F GCGAGCTAAGCAGCTTGAAT 
199 Bai et al., 2012 
ehxA-R CTGGAGGCTGCACTAACTCC 
     
terD 
terD-F AGTAAAGCAGCTCCGTCAAT 
434 
Bielaszewska et 
al., 2011 terD-R CCGAACAGCATGGCAGTCT 
     
aggA 
aggA-F CGTTACAAATGATTGTCCTGTTACTAT 
151 This study 
aggA-R ACCTGTTCCCCATAACCAGAC 
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Table 5.2. Number (and percentage) of cattle fecal samples positive for genes that 
encode for Escherichia coli O104 serogroup-specific traits before and after enrichment in 
Escherichia coli broth 
 
Genes (encoded protein or function) 
No. of samples (n=248) positive for (%): 
Before enrichment
1 
After enrichment 
wzxO104 (O104-antigen flippase) 3 (1.2) 51 (20.6) 
fliCH4 (H4 flagellar antigen) 103 (41.5) 214 (86.3) 
stx1 (Shiga toxin 1) 37 (14.) 144 (58.1) 
stx2 (Shiga toxin 2) 100 (40.3) 188 (75.8) 
eae (Intimin) 92 (37.1) 204 (82.3) 
ehxA (enterohemolysin) 210 (84.5) 243 (97.8) 
terD (tellurite resistance) 119 (48.0) 233 (94.0) 
aggA (aggregative adherence fimbriae 
1) 
0 0 
   
wzxO104 + fliCH 2 (0.8) 47 (20.0) 
wzxO104 + fliCH + stx1 2 (0.8) 30 (12.1) 
wzxO104 + fliCH + stx2 2 (0.8) 38 (15.3) 
wzxO104 + fliCH + stx1 or stx2 2 (0.8) 41 (16.5) 
1Fecal samples were enriched by incubating 1 g of feces in 9 ml of Escherichia coli broth at 
40°C for 6 h 
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Table 5.3. Occurrence of serogroup 104 (wzx104), H4 flagellar antigen (fliCH4), Shiga toxins (stx1 and stx2), intimin (eae), 
enterohemolysin (ehxA), tellurite resistance (terD), and enteroaggregative (aggA) genes in pooled colonies from cattle fecal samples 
that were positive for wzx104. 
 
 
1
 Number of fecal samples that contained the wzx104 when extracted DNA was screened by the multiplex PCR 
2
 Ten colonies from each plate exhibiting the indicated morphology were pooled together and tested by multiplex PCR for the 
indicated genes 
 
Culture medium  
for isolation 
No. of fecal 
samples1 
Colony 
morphology2 
Number of pooled colonies positive for: 
wzxO104 fliCH4 stx1 stx2 eae ehxA terD aggA 
MacConkey agar 51 Pink colored 2 13 1 2 2 7 15 0 
           
Rainbow agar 51 Blue-purple centered 
colonies with purple 
edges 
 
3 8 2 2 4 10 12 0 
Non-O157 STEC  
Differential agar 
(Possé agar) 
42 Dark purple colonies 0 10 1 5 7 8 29 0 
           
CHROMagarTM STEC 42 Light purple 
colonies 
1 19 2 13 11 16 31 0 
           
CHROMagarTM 
STEC-O104 
16 Light purple 
colonies 
4 1 3 4 10 11 15 0 
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Table 5.4. Virulence genes profiles of Escherichia coli O104 strains isolated from cattle feces.   
 
 
Strain origin 
 
Strain 
No. of 
strains O type H type 
Virulence genes 
stx1 stx2 eae ehxA terD aggA 
German Outbreak ATCC # BAA-2326 1 O104 H4 - + - - + + 
Montana Outbreak ATCC # BAA-178 1 O104 H21 - + - + - - 
Cattle feces This study 5 O104 H7 - - - + + - 
Cattle feces This study 1 O104/O8 H11 - - - - - - 
Cattle feces This study 1 O104/O8 H21 - - - - - - 
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Chapter 6 - Chapter 6 Escherichia coli O26 in feedlot cattle: 
Fecal prevalence, isolation, characteristics and effects of an E. 
coli O157 vaccine and a direct-fed microbial intended  
 
Abstract 
Escherichia coli serogroup O26 is second only to O157 as a cause of food borne, Shiga toxin-
producing E. coli infections.  Our objectives were to determine fecal prevalence E. coli O26 and 
isolate and characterize virulence genes of E. coli O26 in cattle in a commercial feedlot that were 
enrolled in a study to evaluate an E. coli O157:H7 siderophore receptor and porin (SRP®) 
proteins-based vaccine (VAC) and direct-fed microbial (DFM; Bovamine®).  Cattle were 
randomly allocated to 40 pens within 10 complete blocks; pens were randomly assigned to 
control, VAC, DFM, or VAC+DFM treatments.  Vaccine was administered on days 0 and 21, 
and DFM was fed (106 CFU/animal/day) throughout the study period.  Pen floor fecal samples 
(30/pen) were collected weekly for four consecutive weeks at the end of the study period.  
Samples were enriched in E. coli broth and subjected to a multiplex PCR designed to detect O26-
specific wzx gene and four major virulence genes (stx1, stx2, eae, and ehxA) and to a culture-
based procedure that involved immunomagnetic separation and plating on MacConkey agar.  
Ten presumptive E. coli colonies were randomly picked from the plate, pooled and tested by the 
multiplex PCR for O26 and four virulence genes.  Pooled colonies that were positive for O26 
serogroup were streaked on sorbose MacConkey agar and 10 colonies, randomly picked per 
sample, were tested individually again by the multiplex PCR.  The overall prevalence was higher 
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by the culture-based detection method (1,089/4,800; 22.7%) compared to the detection by mPCR 
assay (502/4,800; 10.5%).  No significant effects of treatment, or treatment by sampling week 
interaction, on O26 prevalence were detected by either PCR- or culture-based method.  
Escherichia coli O26 was recovered in pure culture from 23.9% (260 out of 1,089) of O26 PCR-
positive pooled colonies.  Only seven of the 260 strains of O26 were STEC and 90.1% of the 
strains possessed eaeβ gene that codes for intimin subtype β, but not the bfpA gene that codes for 
bundle-forming pilus, indicating that majority of the O26 strains in cattle feces belonged to 
atypical enteropathogenic E. coli. 
 
Introduction 
Shiga toxin-producing E. coli (STEC) are major food borne pathogens that cause illnesses in 
humans with symptoms ranging from diarrhea, with or without blood, to hemolytic uremic 
syndrome, and even death (Tarr et al., 2005).  Among STEC, the serotype O157:H7 has caused a 
greater number of food borne outbreaks than any other serotypes (Rangel et al., 2005).  Recent 
epidemiological data have shown that non-O157 STEC represent a larger portion of foodborne 
STEC infections compared to O157 (Scallan et al., 2011).  Of the non-O157 STEC, the 
serogroup O26 accounts for the largest proportion of infections (Brooks et al., 2005; Stigi et al., 
2012).   
Ruminants, particularly cattle, are considered to be major reservoirs of non-O157 STEC 
(Karmali et al., 2010).  However, not much is known about the fecal prevalence and ecology of 
serogroup O26 because isolation and detection methods have not been optimized (Jenkins et al., 
2008; Ferens and Hovde, 2011).   A fecal prevalence of 6.5 % (Lynch et al., 2011), 23.0% (Hofer 
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et al., 2012), 80.0 % (Renter et al., 2004) and 82.5 % (Paddock et al., 2012), based on PCR assay 
targeting the O26 serogroup-specific gene (wzxO26), have been reported.  However, because of 
lack of selective isolation procedures, the subsequent recovery rate of E. coli O26 isolates from 
positive samples has been low (4.3 to 35.7% of PCR-positive fecal samples [Hofer et al., 2012; 
Lynch et al., 2011; Paddock et al., 2012]). 
Preharvest intervention strategies that include the use of direct-fed microbials and vaccines 
have been shown to reduce the fecal shedding of E. coli O157:H7 in cattle.  An E. coli O157:H7 
siderophore receptor and porin protein- based (SRP®) vaccine was shown to reduce the overall 
fecal shedding of E. coli O157:H7 (Fox et al., 2009; Thomson et al., 2009; Thornton et al., 2009; 
Cull et al., 2012).  Direct-fed microbials (DFM), particularly Lactobacillus acidophilus-based 
products, have been shown to reduce fecal shedding of E. coli O157:H7 (Loneragan and 
Brashears, 2005).  The effects of SRP vaccine or DFM on fecal shedding of non-O157 STEC in 
feedlot cattle have not been evaluated; but it is conceivable that the mechanisms responsible for 
the possible E. coli O157:H7 reduction may also reduce other serogroups.  Our objective was to 
determine fecal prevalence of serogroup O26 in cattle feces, evaluate selective isolation 
procedures, characterize virulence genes of the isolates, and determine if vaccine (SRP) and 
direct-fed microbial (Bovamine®) intended to reduce the prevalence of E. coli O157:H7 in 
feedlot cattle have effects.   
 
Materials and Methods 
All procedures in the care and management of cattle were approved by the Kansas State 
University Institutional Care and Use Committee. 
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 Animals and study design 
The animals, study location and study design have been previously described by Cull et al. 
(2012).  The study was a randomized complete block design with a 2 x 2 factorial treatment 
structure of control, vaccine (VAC), DFM, and VAC plus DFM.  The DFM The control group 
(CON) received neither DFM nor VAC.  The DFM was Bovamine® (Nutrition Physiology Corp., 
Guymon, OK), which was mixed into the cattle’s diet to provide 106 CFU/animal/day of 
Lactobacillus acidophilus and 109 CFU/animal/day of Propionibacterium freudenreichii 
throughout the study for DFM and VAC + DFM groups.  Cattle in the VAC and VAC + DFM 
groups received a 2 ml subcutaneous dose of the vaccine (E. coli SRP® vaccine, Pfizer Animal 
Health, New York, NY) on the day of study allocation and 21 days later.  Cattle in all treatment 
groups were fed a high moisture corn (46.4%)-based finishing diet with wet distiller’s grains 
(25%), silage (7.1%), corn steep (2.5%) and a mineral supplement mix (2.0%) with 280 mg of 
monensin and 90 mg of tylosin per animal per day (Elanco Animal Health, Greenfield, IN) on a 
dry-matter basis.  Cattle were randomly assigned to 1 of 4 treatment groups within blocks (10 
time-based blocks) based on the the time of allocation during an 7 week enrollment period.  
Treatment groups within a block were subsequently randomized to a pen within a pre-determined 
set of 4 consecutive pens (40 pens).  During the 4 weeks prior to the end of study date for each 
respective block, fresh pen floor fecal samples (n = 30/pen/week) were collected.  Samples were 
transported on ice to the Kansas State Universities pre-harvest food safety laboratory.  Samples 
were assigned sequential numbers, thus blinding laboratory personal to treatment assignments.   
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 PCR detection of E. coli O26 
 Fecal samples were processed within 24 h after collection.  Samples were enriched by 
preparing a suspension of 1.0 g of feces in 9.0 ml of E. coli broth (EC; Oxoid Ltd., Hampshire, 
England) and incubating at 40° C for 6 h (Paddock et al., 2012).  A 1.0 ml sample of the enriched 
fecal suspension was placed in 1.5 ml microcentrifuge tube, boiled for 10 min and centrifuged at 
10,000 x g for 5 min.  DNA was extracted and purified with a GeneClean DNA extraction kit 
(MP Biomedicals, Solon, OH) and subjected to an 11-plex PCR (mPCR; Bai et al., 2012) 
designed to detect the seven STEC serogroups (O26, O45, O103, O111, O121, O145, O157) and 
four major STEC virulence genes (stx1, stx2, eae and ehxA). 
 
 Culture-based detection of E. coli O26 
 Another 1.0 ml sample of the enriched fecal suspension was subjected to immunomagnetic 
separation (IMS) with Dynabeads® VTEC/STEC O26 (Invitrogen, Carlsbad, CA).  Twenty 
microliters of the bead suspension were pipetted onto MacConkey agar (BD Biosciences, 
Franklin Lakes, NJ) and streaked with an inoculating loop to obtain isolated colonies.  Plates 
were incubated at 37 C for 24 h and up to ten lactose-fermenting colonies were randomly picked 
and suspended in 1 ml of peptone broth.  A 100 µl aliquot of the pooled colony mixture was 
boiled for 10 min and subjected to the11-plex PCR.  The remaining colony mixture was 
preserved with glycerol (15% final concentration) and stored at -80°C.  Pooled colony mixtures 
that were positive for serogroup O26 by the mPCR were then used to isolate E. coli O26 in pure 
culture.   
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 Evaluation of culture media for isolation of E. coli O26 
A lactose-free MacConkey agar base (BD Biosciences, Sparks, MD) with sorbose (10 g/l; 
SorboseMAC) or rhamonse (10 g/l; RMAC) as the sole sugar source (Posse et al., 2008; 
Hiramatsu et al., 2002) was evaluated.  The sorboseMAC medium was evaluated with 
supplementation of no additives, novobiocin (8.0 mg/l; Sigma-Aldrich, St. Louis, MO; 
Hiramatsu et al., 2002), potassium tellurite (2.5 mg/l; Sigma-Aldrich), or novobiocin and 
potassium tellurite.  The evaluation of the selectivity and ability to differentiate O26 serogroup 
from others were done with pure cultures of O26 (n = 36) and non-O26 (n = 116) STEC.  The 
strains were streaked onto each medium to determine growth and fermentability of the sugar 
after a 24 h incubation at 37°C.  Media on which all E. coli O26 strains grew and fermented the 
sugar to form colored colony were further evaluated for their selectivity in isolating and 
differentiating E. coli O26 from a subset (n = 34) of the O26 positive pooled colony mixtures.   
 
 Isolation of E. coli O26 from PCR-positive pooled colony mixtures 
The colony mixtures were thawed and 10 µl was streaked onto each medium.  Following 24 
h incubation at 37°C, colonies (up to 10) with presumptive E. coli O26 fermenting characteristics 
were selected and individually tested by the mPCR.  The medium with the highest recovery rate 
was then used to isolate E. coli O26 from the remaining O26 positive pooled colony mixtures. 
Isolates that were confirmed as O26 were stored on CryoCare beads at -80°C.   
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 Characterization of E. coli O26 isolates 
Isolated E. coli O26 were further characterized with individual PCR assays for additional 
genes; bfpA (bundle forming pilus; Gunzburg et al., 1995), eaeβ1 (intimin; Blanco et al., 2003), 
espP (secreted effector protein; Cookson et al., 2002), fliCH11 (flagellar gene for H11; Durso et 
al., 2005), and tir (translocated intimin receptor; Bardiau et al., 2011).  Two strains, TW01597, a 
STEC O26 (Thomas Whittam E. coli Reference Laboratory at Michigan State University) and 
EDL933 (ATCC 700927; American Tissue and Culture Collection, Manassas, VA), a STEC 
O157:H7 were used as positive controls.  Strains and isolates were grown on blood agar, DNA 
was extracted from 1 or 2 colonies by mixing with 1.0 ml of ddH20, boiling for 10 min and 
centrifugation at 10,000 x g for 5 min 
 
 Statistical analysis 
 Dichotomous outcome variables, whether an animal’s sample was positive or negative for 
each serogroup or virulence gene, were analyzed as pen-level proportions for treatment effects in 
generalized linear mixed models (GLMM; Proc Glimmix; SAS Version 9.2, SAS Institute Inc., 
Cary, NC) assuming a binomial distribution and utilizing a logit link function as described by 
Cull et al. (2012).  Treatment, sampling week and treatment × sampling week interaction were 
included in the model as linear predictors.  Block was included as a random effect.  In addition, 
pen over time was included as a repeated effect in all models accounting the lack of 
independence between the four samples from each pen.  Model-adjust means (LSmeans; back 
transformed to the original scale) and standard error of the means are reported.  For all models, P 
values < 0.05 were considered statistically significant and P values ranging from 0.05 to 0.10 
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were considered statistical trends.  To determine if an individual fecal sample was more likely to 
be O26 positive by PCR on DNA extracted from enriched feces compared to culture method 
(IMS separation, plating on MacConkey and testing of pooled colonies),   data were analyzed by 
GLMM was used where the outcome was considered binary for each sample for each detection 
method.  Block was included as a random effect.  As before pen over time was included as a 
repeated effect in all models accounting the lack of independence between the four samples from 
each pen.  The odds ratio and 95% confidence intervals were reported.   
Results 
 Overall, 10.5% (502/4,800) of the fecal samples were positive for the O26 serogroup, based 
on the mPCR assay, and the prevalence of the four virulence genes, stx1, stx2, eae, and ehxA, 
were 12.4% (597/4,800), 24.0% (1,151/4,800), 45.4% (2,179/4,800), and 84.7% (4,066/4,800), 
respectively (Table 1).  The prevalence of serogroup O26 in feces collected weekly, based on the 
mPCR assay, ranged from 0.4 to 41.5% (Fig 1A).  Based on culture method (IMS followed by 
plating on MacConkey agar), the O26-positive samples ranged from 2.5 to 36.7% of the samples 
tested (Fig 1B).  Neither vaccine or DFM, nor both had significant effects on the fecal prevalence 
of the serogroup O26 or the four virulence genes in cattle feces (Table 1).  When a mixture of 10 
randomly picked colonies, obtained from plating O26 IMS beads on MacConkey agar, were 
tested by the mPCR, the O26 serogroup was detected in 22.7 % (1,089 out of 4,800) of the fecal 
samples (Table 2).  Although O26 IMS beads were intended to retrieve O26 from the enriched 
sample, the pooled colonies also contained six other STEC serogroups that were part of the 
mPCR assay.  The other serogroups, in the order of prevalence, were 9.8 % O103 (470/4,800), 
5.7 % O111 (273/4,800), 0.8 % O145 (37/4,800), 0.6% O157 (38/4,800), 0.4 % O121 (21/4,800) 
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and 0.4 % O45 (18/4,800).  The prevalence of virulence genes in the pooled colonies were 2.4% 
of stx1 (117/4,800), 10.8% of stx2 (519/4,800), 7.9% of eae (378/4,800) and 16.6% of ehxA 
(776/4,800).  The prevalence estimates of O26 based on IMS, plating on MacConkey agar and 
testing 10 pooled colonies picked randomly were not affected by the vaccine, DFM or both.  
There was no treatment group by sampling week interaction.  However, more pooled colonies (P 
< 0.01) were O26 positive in weeks 3 and 4 compared to weeks 1 and 2 (data not shown).  Of the 
1,089 samples that were O26 positive based on testing of the pooled colonies, 561 (51.5%) were 
negative for all four virulence genes and the remaining (528/1,089; 48.5%) contained at least one 
of the four virulence genes.  Among the O26-postive pooled colonies, 45 (8.5%), 216 (40.9%), 
179 (33.9%) and 311 (58.9%) were positive for stx1, stx2, eae and ehxA, respectively (Table 3).  
Only a small proportion of O26 positive pooled colonies contained a combination of stx1 or stx2 
and eae (10.4%).  Among the other six serogroups detected in the pooled colonies, only O103 
and O111 were in high numbers (168/1,089 [15.4%] and 259/1,089 [23.8%] for O103 and O111, 
respectively; Table 3).  The proportions of pooled colonies positive for O103 and O111 that 
contained stx1 or stx2 and eae were 6.6 and 10.0%, respectively.  The number of O26-positive 
pooled colonies that contained O45, O121, O145 or O157 ranged from 4 to 13 (Table 3).  
 In order to obtain pure culture of O26 from pooled colonies from samples that were PCR 
positive for O26 (n=1,089), use of lactose-free MacConkey agar containing sorbose as the sole 
sugar and without or with potassium tellurite (2.5 µg/ml) and or novobiocin (8 µg/ml) was 
evaluated.  Initially, growth and fermentation of sorbose by pure cultures of O26 strains (n=36) 
and non-O26 STEC strains (O45, O103, O111, O121, O145, and O157; n=116) on media 
without or with potassium tellurite and or novobiocin were tested (Table 5).  All O26 strains 
tested fermented sorbose sugar (pink-colored colonies), while sorbose fermentation was highly 
172 
172 
 
 
variable among the other six serogroups.  Only few strains of O45, O103, O111, O121, and 
O145 fermented sorbose, however, none of the O157 strains (n=20) fermented sorbose.  
Inclusion of potassium tellurite (2.5 µg/ml) inhibited the growth of 4 of 36 strains of O26, 2 of 2 
O45, 9 of 40 O103, 0 of 29 O111, 6 of 9 O121, 2 of 16 O145, and none of the 20 O157 strains.  
Novobiocin (8 µg/ml) inclusion in the medium had no effect on the growth of O26 or other 
STEC strains (Table 5).  A subset (n=34) of O26 PCR-positive pooled colonies were plated on 
sorbose-MacConkey agar without or with potassium tellurite and or novobiocin to evaluate the 
selectivity of the media to detect O26 serogroup (Table 5).  Of the 34 samples of pooled 
colonies, O26 was recovered from 14 (41.2%) samples on the medium with sorbose alone or 
sorbose with potassium tellurite and novobiocin.  Twelve of the 14 isolates from the two media 
were from the same samples and two isolates were from different samples.  Fewer than 14 were 
detected on media containing sorbose with potassium tellurite or novobiocin (Table 5).  Based on 
this data, we used sorbose MacConkey agar without potassium tellurite or novobiocin to isolate 
O26 from all the PCR positive O26 pooled colonies.  Of the1,089 samples of pooled colonies, 
O26 was obtained in pure cultures from 260 samples, representing a recovery rate of 23.9%.  
Because we used mPCR to test individual colonies, we also obtained 1 each of O121 and O145, 
2 of O45 and 26 of O103 serogroups.  However, no O157 strain was obtained.  In order to 
enhance recovery rate of O26 from PCR-positive samples, we tested 3 additional media, sorbose 
MacConkey agar with novobiocin, rhamnose MacConkey agar with novobiocin and a selective 
and differential medium described by Posse et al., (2007; without potassium tellurite), with a 
subset (n=47) of O26 positive poled colonies that did not yield O26 in pure culture on sorbose 
MacConkey agar (Table 6).  Rhamnose sugar is not fermented by O26 (Posse et al., 2007), 
therefore, gray-colored colonies (nonfermenters) were picked from the Rhamnose MacConkey 
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agar plates.  The three different media yielded O26 in pure culture from six of 47 pooled colonies 
that were tested. 
 Of the 260 isolates of O26 obtained, only seven isolates carried Shiga toxin genes, with six 
carrying stx1 and one carrying stx2 (Table 7).  From the other serogroups detected among the 
individual isolates, only one O145 isolate carried a Shiga toxin gene (stx1).  Interestingly, 59 
additional isolates were recovered that contained one or both Shiga toxin genes but did not 
belong to the seven serogroups detectable by the mPCR assay.  In order to further characterize 
the O26 isolates, PCR assay was conducted for five additional genes, eaeβ1, bfpA, tir, fliCH11 
and espP that code for intimin subtype β1, bundle forming pilus, translocated intimin receptor, 
flagellar H11 protein and secreted effector protein, respectively (Table 8).  Seventeen of the 260 
O26 isolates carried none of the virulence genes tested.  One of the 17 isolates was positive for 
the H11 gene.  None of the isolates was positive for the bfpA, a gene characteristic of the typical 
enteropathogenic E. coli (EPEC).  Majority of the O26 isolates (236/260) carried the eaeβ1 gene 
with no stx.  These O26 atypical EPEC (aEPEC) possessed a variety of virulence gene profiles.  
The majority of O26 aEPEC (234 out of 236) was positive for tir, which is commonly found on 
the LEE with eaeβ1, and the presence of fliCH11 identifies that these isolates were O26:H11 
aEPEC.  Fewer of the aEPEC isolates (37 out of 236) carried the tir and eaeβ1 but not the 
fliCH11.  A small number of isolates of aEPEC O26 (7 out of 236) was positive for tir, fliCH11 and 
ehxA.  Only three O26 aEPEC isolates were positive for tir and fliCH11, as well as espP which are 
commonly observed in STEC.  Of the seven O26 STEC, six different virulence gene profiles 
were observed.  All seven O26 STEC were positive for the eaeβ1 and tir.  Six of the 7 O26 
STEC were O26:H11.  Only two isolates were ehxA positive and three isolates were espP 
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positive.  Samples were 2.64 times (CI: 2.35 to 2.98) more likely to be found O26 positive by 
mPCR from DNA extracted from colony pools compared to DNA extracted from enriched feces.   
 
Discussion 
 The study focused on the serogroup O26 because, according to the CDC, it is the most 
frequent serogroup involved in human non-O157 STEC infections in the US (Brooks et al., 
2005).  The O26 serogroup accounted for 22% of non-O157 STEC infections reported between 
1983 and 2002.  The fecal samples used in the study to test for O26 was part of a study that was 
designed to study the effects of a E. coli O157 vaccine and a Lactobacillus acidophilus-based 
DFM on fecal shedding of E. coli O157:H7 (Cull et al., 2012).  The study showed that that a 
two-dose vaccination significantly reduced fecal shedding of E. coli O157:H7.  However, the 
DFM had no effect on fecal shedding of E. coli O157:H7 and the lack of effect may be because 
of the low dose used in the study compared to studies that have shown reduction in shedding 
(Cull et al., 2012; Loneragan and Brashears, 2005).  The vaccine is based on siderophore 
receptor and porin proteins of E. coli O157:H7 and the efficacy in reducing fecal shedding is 
attributed to induced immunity that blocks bacterial uptake of iron (Thomson et al., 2009).  
Because O26 may have surface proteins similar to that of E. coli O157:H7, it is logical to expect 
for the vaccine to have an effect on fecal shedding of E. coli O26.  Direct fed microbials, 
particularly products containing L. acidophilus, have been shown to reduce fecal shedding of E. 
coli O157:H7 (Jacob and Nagaraja, 2012).  Although the mode of action is not well accepted, it 
is generally believed that the reduction of E. coli O157:H7 is because of alteration in the hindgut 
ecosystem resulting in inhospitable environment for E. coli O157:H7.  The effects of E. coli 
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O157:H7 vaccine and the DFM on fecal shedding of O26 or any other non-O157 STEC have not 
been investigated.  Neither vaccine nor DFM had any effect on fecal O26 estimated by either 
mPCR assay or culture-based method.  The lack of DFM effect on O26 was not unexpected 
because the product also had no effect on fecal shedding of E. coli O157:H7 (Cull et al., 2012).  
The lack of vaccine effect indicates that the surface proteins of O26 involved in iron uptake are 
antigenically different from those of E. coli O157:H7. 
 Cattle are considered to be a major reservoir of STEC (Karmali et al., 2010) and serogroup 
O26 was isolated from cattle feces almost 50 years ago (Bokhari and Orskov, 1952). However, 
not much is known about fecal prevalence and factors affecting fecal shedding of O26 in cattle, 
mainly because a selective medium that can phenotypically distinguish O26 from other 
serogroups has not been developed.  In this study, two methods were used to obtain fecal 
prevalence estimates and weekly estimates of fecal prevalence of the serogroup O26, regardless 
of the treatment group, differed between the two methods of detection.  The overall prevalence 
was higher by the culture-based detection method compared to the detection by mPCR assay 
(22.7 vs. 10.5%), in spite of plating the O26 specific-IMS beads on MacConkey agar, a relatively 
nondifferential medium, for detection and isolation.  A similar difference in sensitivity of 
detection between culture- and PCR-based methods has been shown with O157 in fecal samples 
(Bai et al., 2012).  Jenkins et al. (2003) have reported that IMS beads were 2.5 times more 
sensitive than the procedure that used PCR to detect Shiga toxins and then plating the positive 
samples on MacConkey to detect by colony hybridization with Shiga toxin probes.  The 
difference in sensitivity may be because of the volume of sample used in the detection procedure.  
In the PCR assay, the volume of sample was 1 µl, which requires the sample to contain a 
minimum of 1,000 cells per g or ml to assure that the sample volume in the PCR reaction 
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contains DNA from at least one cell.  However, in the same study (Bai et al., 2012) with a 
limited number of fecal samples (n=50), the mPCR identified more O26 (9 of 50) compared to 
IMS (4 of 50) method.  The detection limits for enrichment, IMS, and plating for O157 or non-
O157 serotypes have been reported to be 20-90 CFU/25 g of feces (Verstraete et al., 2010).  Hall 
et al. (2006) have reported that the recovery of inoculated O26 from bovine fecal pats by IMS 
and plating on a chromogenic agar differed between different strains and bovine feces.  The 
suggested reasons for the difference included variation in test sensitivity and interactions 
between inoculated strains and growth inhibitors in feces (Hall et al., 2006).  In a survey 
conducted to determine the prevalence of O26 and other non-O157 STEC in feces of cattle in 
Scotland by culture-based method, O26 was detected in 4.6% of fecal pats (Pearce et al., 2006). 
 Although commercial IMS beads were coated with O26-specific antibodies, and therefore, 
intended to selectively retrieve O26 from cattle feces, the use of relatively non-differential 
MacConkey agar and mPCR assay allowed us to identify the other six serogroups contained in 
the pooled colonies.  Of the six serogroups, O103 and O111 were identified more frequently 
(9.8% of O103 and 5.7% of O111) than the other four serogroups (0.4 to 0.8% of O45, O121, 
O145, and O157).  The higher frequency of detection of O103 and O111 suggests some cross 
reactivity of the O26 antibodies with O-antigens of O103 and O111.  
 Relative to serogroup O157, only a few studies have been reported on the detection and or 
prevalence of O26 serogroup in cattle or sheep feces (Brandal et al., 2012; Cobbold et al., 2004; 
Renter et al., 2005, 2007; Barlow and Mellor, 2010; Hall et al., 2006; Pradel et al., 2000; Jenkins 
et al., 2003; Pearce et al., 2004; Sasaki et al., 2011; Wells et al., 1991).  The majority of cattle or 
sheep shedding O26 are healthy, although the serogroup has been isolated from calves and lambs 
with diarrhea (Blanko et al., 1994; Caprioli et al., 1993, Cid et al., 2001; De et al., 2002).  
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Although O26-specific IMS beads are available, the limitation of culture-based methodology to 
detect or isolate O26 serogroup is lack of a selective medium, similar to sorbitol MacCOnkey 
agar for O157, for presumptive identification based on phenotypic characteristic (colony color),.  
Possé et al. (2008a) have described a selective (enteric Gram negative bacteria) and differential 
MacConkey agar base medium supplemented with a mixture of sugars (sucrose, sorbose, 
rhamnose) with inhibitory components (potassium tellurite and novobiocin) and a chromogenic 
compound to signal β-galactosidase activity that allowed color-based identification of O26 and 
other non-O157 E. coli (O103, O111, and O145).  Based on sugar fermentation characteristics of 
non-O157 STEC described by Possé et al. (2008a), sorbose fermentation was used for 
phenotypic identification of O26 cultured on a lactose-free MacConkey agar.  All strains of O26 
serogroup of STEC in our culture collection (n=36) fermented sorbose, however it was not a 
unique characteristic of O26 because some of the strains of other STEC also fermented, although 
none of the O157 strains fermented sorbose.  Inclusion of potassium tellurite or novobiocin in the 
sorbose MacConkey agar was inhibitory to certain strains of O26 and othernon-O157 STEC.  
The use of sorbose MacConkey agar allowed isolation of O26 in pure culture from 23.9% 
(260/1,089) samples of pooled colonies that were PCR positive for the serogroup O26.  The poor 
recovery is reflective of lack of selectivity of the medium and the logistical limitation of finding 
a positive O26 from a mixture of 10 colonies that were pooled together.  Fukushima and Seki, 
(2004) enriched and performed IMS on 605 fecal samples and streaked the resulting beads to 
Chromocult agar, a commercial chromogenic medium.  A colony sweep from each plate was 
screened with a PCR to detect stx genes and subsequently recovered stx-positive pure cultures 
from 50% of the stx positive colony sweeps.  While the most prevalent STEC was the O26 
serogroup (20 out of 114 STEC isolates), 68 different STEC serogroups were isolated.  Barlow 
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and Mellor, (2010) found that 78 of 300 enriched fecal samples were positive for stx and eae, 
and only three of the 78 were positive for the O26 serogroup.  Attempt to isolate O26 from three 
enriched fecal samples that were positive for O26, stx and eae yielded only one O26 isolate.   
 Escherichia coli O26 serogroup is broadly classified into Shiga toxigenic and 
enteropathogenic (EPEC) based on virulence factors, although both are capable of causing 
attaching and effacing lesions (Kaper et al., 2004).  The genetic determinants for the production 
of A/E lesions are located on the locus of enterocyte effacement (LEE), a pathogenicity island 
that contains the genes (eae) encoding the intimin, a type III secretion system, a number of 
secreted (Esp) proteins and the translocated intimin receptor (Tir) (McDaniel et al., 1995).  
Intimin is the outer membrane protein responsible for the intimate attachment between E. coli 
and enterocytes and the 280-amino acid residues at the C-terminus has antigenic variation that 
allows classification of distinct subtypes among STEC and EPEC strains (Adu-Bobie et al., 
1998).  The Esp proteins (EspA, EspB, and EspD) are involved in the formation of a translocon 
to deliver effector proteins to the host cell to induce cytoskeleton rearrangement and subversion 
of the host cell function (Frankel et al., 1998).  The translocated intimin receptor (Tir) is one of 
the proteins inserted in the host cell membrane to serve as a receptor for intimin (Kenney etal., 
1997).  Strains of EPEC produce a characteristic adherence, called local adherence, in which 
bacterial cells form microcolonies or clusters.  This type of adherence is associated with the 
presence of a plasmid, called EAF (EPEC adherence factor) plasmid, which also has a cluster of 
genes that encode bundle-forming pili (BFP; Nataro and Kaper, 1998).  Strains of EPEC carrying 
bfpA gene are called typical EPEC.  In contrast to typical EPEC, certain strains that carry eae 
gene of the β subtype, but do not have the EAF plasmid encoding bfpA, are called atypical EPEC 
(aEPEC; Chen and Frankel, 2005).  A total of 260 strains of O26 were obtained in the study and 
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seven were STEC, with 6 possessing stx1and one strain had stx2.  Generally, STEC strains of 
bovine origin, including O26, are more likely to carry stx1 than stx2 (Pearce et al., 2004, 2006; 
Aktan et al., 2007).  The majority of the O26 isolates (236/260; 90.1%) obtained in the study 
contained eaeβ1, but none was positive for bfpA, suggesting they belonged to atypical EPEC.   
Sekse et al., (2011) and Kobayashi et al., (2001) screened O26 isolated from ruminant feces (n = 
142 and 9, respectively) and also reported that none of them carried the bfpA.   
 In conclusion, serogroup 026 was detected in in 10.5% (502/4,800) and 22.7 (1,089/4,800) of 
fecal samples collected from feedlot cattle based on PCR- and culture-based methods, 
respectively.  The interventions (vaccine and or DFM) had no impact on fecal shedding of O26. 
Only 260 of the 1,089 culture positive samples yielded pure cultures of O26.  Only seven of the 
260 strains of O26 were STEC and majority of the strains was aEPEC 
180 
180 
 
 
 
Literature Cited 
Adu-Bobie, J., G. Frankel, C. Bain, A. Guedes Goncalves, L. R. Trabulsi, G. Douce, S. Knutton, 
and G. Dougan. 1998. Detection of intimins α, β, γ, and δ, four intimin derivatives 
expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol., 36:662-668. 
Aktan, I., B. carter, H. Wilking, R. M. La Ragione, L. Weiler, M. J. Woodward, and M. F. 
Anjum. 2007. Influence of geographical origin, host animal and stx gene on the virulence 
characteristics of Escherichia coli O26 strains. J. Med. Microbiol., 56:1431-1439. 
Bai, J., Z. D. Paddock, X. Shi, S. Li, B. An, and T. G. Nagaraja. 2012. Applicability of a 
multiplex PCR to detect the seven major Shiga toxin-producing Escherichia coli based on 
genes that code for serogroup-specific O-antigens and major virulence factors in cattle 
feces. Foodborne Pathog Dis 9:541-548. 
Barlow, R. S., and G. E. Mellor. 2010. Prevalence of enterohemorrhagic Escherichia coli 
serotypes in Australian beef cattle. Foodborne Path. Dis. 7:1239-1245. 
Blanco M, et al. 1994. Genes coding for Shiga-like toxins in bovine verotoxin-producing 
Escherichia coli (VTEC) strains belonging to different O:K:H serotypes. Vet. Microbiol. 
42:105–110 
Brandal, L. T., C. Sekse, B. A. Lindstedt, M. Sunde, I. Løbersli, A. M. Urdahl, and G. Kapperud. 
2012. Norwegian Sheep Are an Important Reservoir for Human-Pathogenic Escherichia 
coli O26:H11 Appl. Environ. Microbiol. 78:4083-4091. 
 
181 
181 
 
 
Brooks, J. T., E. G. Sowers, J. G. Wells, K. D. Greene, P. M. Griffin, R. M. Hoekstra, and N. A. 
Strockbine. 2005. Non-O157 Shiga toxin–producing Escherichia coli infections in the 
United States, 1983–2002. J. Infect. Dis. 192:1422-1429. 
Cid D, et al. 2001. Association between intimin (eae) and EspB gene subtypes in attaching and 
effacing Escherichia coli strains isolated from diarrhoeic lambs and goat kids. 
Microbiology 147:2341–2353. 
Cobbold R.N., Rice D.H., Szymanski M., Call D.R., Hancock D.D., 2004. Comparison of Shiga-
toxigenic Escherichia coli prevalences among dairy, feedlot, and cow-calf herds in 
Washington State. Appl. Environ. Microbiol. 70, 4375-4378. 
Caprioli A, Morabito S, Brugere H, Oswald E. 2005. Enterohaemorrhagic Escherichia coli: 
emerging issues on virulence and modes of transmission.Vet. Res. 36:289-311. 
Chen, H. D. and G. Frankel. 2005. Enteropathogenic Escherichia coli: unraveling pathogenesis. 
FEMS Microbiol. Rev. 29:83-98. 
Cull, C. A., Z. D. Paddock, T. Nagaraja, N. M. Bello, A. H. Babcock, and D. G. Renter. 2012. 
Efficacy of a vaccine and a direct-fed microbial against fecal shedding of Escherichia 
coli O157: H7 in a randomized pen-level field trial of commercial feedlot cattle. Vaccine 
30:6210-6215.  
De L, et al. 2002. Prevalence and characteristics of attaching and effacing strains of Escherichia 
coli isolated from diarrheic and healthy sheep and goats. Am. J. Vet. Res. 63:262–266. 
Ferens, W. A., and C. J. Hovde. 2011. Escherichia coli O157: H7: animal reservoir and sources 
of human infection. Foodborne Pathog. Dis. 8:465-487. 
Fox, J. T., D. U. Thomson, J. S. Drouillard, A. B. Thornton, D. T. Burkhardt, D. A. Emery, and 
T. Nagaraja. 2009. Efficacy of Escherichia coli O157: H7 siderophore receptor/porin 
182 
182 
 
 
proteins–based vaccine in feedlot cattle naturally shedding E. coli O157. Foodborne 
Pathogens and Disease 6:893-899. 
Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. 
Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. 
Mol. Microbiol., 30:911-921. 
Fukushima, H., and R. Seki. 2004. High numbers of Shiga toxin-producing Escherichia coli 
found in bovine faeces collected at slaughter in Japan. FEMS Microbiol Lett 238:189-
197. 
Hall, L. M., J. Evans, A. W. Smith, M. C. Pearce, H. I. Knight, G. Foster, J. C. Low, and G. J. 
Gunn. 2006. Sensitivity of an immunomagnetic-separation-based test for detecting 
Escherichia coli O26 in bovine feces.  Appl. Environ. Microbiol. 72:7260-7263. 
 
Hiramatsu, R., M. Matsumoto, Y. Miwa, Y. Suzuki, M. Saito, and Y. Miyazaki. 2002. 
Characterization of Shiga toxin-producing Escherichia coli O26 strains and establishment 
of selective isolation media for these strains. J. Clin. Microbiol. 40:922-925. 
Hofer, E., R. Stephan, M. Reist, and C. Zweifel. 2012. Application of a real time PCR based 
system for monitoring of O26, O103, O111, O145 and O157 Shiga toxin producing 
Escherichia coli in cattle at slaughter. Zoonoses and Public Health 59:408-415.  
Jacob, M. E. and T. G. Nagaraja. 2012. Use of direct-fed microbials as a preharvest food safety 
intervention in cattle. p 189-202. In: Direct-Fed Microbials and Probiotics for Animals: 
Science and Mechanisms of Action. T. R. Callaway and S. C. Ricke (eds.) Springer Publ., 
NY. 
183 
183 
 
 
Jenkins, C., J. Evans, H. Chart, G. Willshaw, and G. Frankel. 2008. Escherichia coli serogroup 
O26–a new look at an old adversary. J. Appl. Microbiol. 104:14-25. 
Jenkins, C., M. C. Pearce, A. W. Smith, H. I. Knight, D. J. Shaw, T. Cheasty, G. Foster, G. J. 
Gunn, G. Dougan, H. R. Smith, and G. Frankel. 2003. Detection of Escherichia coli 
serogroups, O26, O103, O111, and O145 from bovine feces using immunomagnetic 
separation and PCR/DNA probe techniques. Lett.. Appl. Microbiol. 37:207-212. 
Karmali, M. A., V. Gannon, and J. M. Sargeant. 2010. Verocytotoxin-producing Escherichia coli 
(VTEC). Vet. Microbiol. 140:360-370. 
Kenny, B., R. Devinney, M. Stein, D. J. ReinschiedE. A. Frey, and B. B. Finlay. 11997. 
Enteropathogenic E. coli transfers its receptor for intimate adherence into mammalian 
cells. Cell, 91:511-520. 
Kobayashi, H., J. Shimada, M. Nakazawa, T. Morozumi, T. Pohjanvirta, S. Pelkonen, and K. 
Yamamoto. 2001. Prevalence and characteristics of Shiga toxin-producing Escherichia 
coli from healthy cattle in Japan. Appl. Environ. Microbiol. 67:484-489. 
Loneragan, G., and M. Brashears. 2005. Pre-harvest interventions to reduce carriage of E. coli 
O157 by harvest-ready feedlot cattle. Meat Sci. 71:72-78. 
Lynch, M., E. Fox, L. O’Connor, K. Jordan, and M. Murphy. 2012. Surveillance of 
verocytotoxigenic Escherichia coli in Irish bovine dairy herds. Zoonoses and Public 
Health. 59: 264-271. 
McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of 
enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. 
Acad. Sci. U. S. A., 92:1664-1668. 
184 
184 
 
 
Monaghan, Á., B. Byrne, S. Fanning, T. Sweeney, D. McDowell, and D. J. Bolton. 2011. 
Serotypes and virulence profiles of non-O157 shiga toxin-producing Escherichia coli 
isolates from bovine farms. Appl. Environ. Microbiol. 77:8662-8668. 
Paddock, Z., X. Shi, J. Bai, and T. G. Nagaraja. 2012. Applicability of a multiplex PCR to detect 
O26, O45, O103, O111, O121, O145, and O157 serogroups of Escherichia coli in cattle 
feces. Vet. Microbiol. 156:381-388. 
Pearce M.C., Jenkins C., Vali L., Smith A.W., Knight H.I., Cheasty T., Smith H.R., Gunn G.J., 
Woolhouse M.E.J., Amyes S.G.B., Frankel G., 2004. Temporal shedding patterns and 
virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a 
cohort of beef calves and their dams. Appl. Environ. Microbiol. 70, 1708-1716. 
Pearce M.C., J. Evans, I. J. McKendrick, A. W. Smith, H. I. Knight, D. J. Mellor, M. E. J. 
Woolhouse, G. J. Gunn, and J. C. Low. 2006. Prevalence and Virulence Factors of 
Escherichia coli Serogroups O26, O103, O111, and O145 Shed by Cattle in Scotland. 
Appl. Environ. Microbiol. 72, 653-659. 
Possé, B., L. De Zutter, M. Heyndrickx, and L. Herman. 2007. Metabolic and genetic profiling 
of clinical O157 and non-O157 Shiga-toxin-producing Escherichia coli. Res. Microbiol. 
158:591-599. 
Possé, B., L. De Zutter, M. Heyndrickx, and L. Herman. 2008. Novel differential and 
confirmation plating media for Shiga toxin producing Escherichia coli serotypes O26, 
O103, O111, O145 and sorbitol positive and negative O157. FEMS Microbiol. Lett. 
282:124-131. 
Pradel N., Livrelli V., De Champs C., Palcoux J.B., Reynaud A., Scheutz F., Sirot J., Joly B., 
Forestier C., 2000. Prevalence and characterization of Shiga toxin-producing Escherichia 
185 
185 
 
 
coli isolated from cattle, food, and children during a one-year prospective study in 
France. J. Clin. Microbiol. 38, 1023-1031. 
Rangel, J. M., P. H. Sparling, C. Crowe, P. M. Griffin, and D. L. Swerdlow. 2005. Epidemiology 
of Escherichia coli O157: H7 outbreaks, United States, 1982–2002. Emerg. Infect. Dis. 
11:603. 
Renter, D. G., S. L. Checkley, J. Campbell, and R. King. 2004. Shiga toxin-producing 
Escherichia coli in the feces of Alberta feedlot cattle. Can. J. Vet. Res. 68:150. 
Renter D.G., Bohaychuk V., Van Donkersgoed J., King R., 2007. Presence of non-O157 Shiga 
toxin-producing Escherichia coli in feces from feedlot cattle in Alberta and absence on 
corresponding beef carcasses. Can. J. Vet. Res. 71, 230. 
Renter D.G., Morris J.G., Sargeant J.M., Hungerford L.L., Berezowski J., Ngo T., Williams K., 
Acheson D.W.K., 2005. Prevalence, risk factors, O serogroups, and virulence profiles of 
Shiga toxin-producing bacteria from cattle production environments. J. Food Prot. 68, 
1556-1565. 
 
Sasaki, Y., Y. Tsujiyama, M. Kusukawa, M. Murakami, S. Katayama, and Y. Yamada. 2011. 
Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 
in beef farms. Vet. Microbiol. 150:140-145. 
Scallan, E., R. M. Hoekstra, F. J. Angulo, R. V. Tauxe, M. A. Widdowson, S. L. Roy, J. L. 
Jones, and P. M. Griffin. 2011. Foodborne illness acquired in the United States—major 
pathogens. Emerg. Infect. Dis. 17. 
186 
186 
 
 
Sekse, C., M. Sunde, B.-A. Lindstedt, P. Hopp, T. Bruheim, K. S. Cudjoe, B. Kvitle, and A. M. 
Urdahl. 2011. Potentially human-pathogenic Escherichia coli O26 in Norwegian Sheep 
flocks. Appl. Environ. Microbiol. 77:4949-4958. 
Stigi, K. A., J. K. MacDonald, A. A. Tellez-Marfin, and K. H. Lofy. 2012. Laboratory practices 
and incidence of non-O157 Shiga toxin–producing Escherichia coli infections. Emerg. 
Infect. Dis. 18:477. 
Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and 
haemolytic uraemic syndrome. Lancet 365:1073-1086. 
Thomson, D. U., G. H. Loneragan, A. B. Thornton, K. F. Lechtenberg, D. A. Emery, D. T. 
Burkhardt, and T. G. Nagaraja. 2009. Use of a siderophore receptor and porin proteins-
based vaccine to control the burden of Escherichia coli O157: H7 in feedlot cattle. 
Foodborne Pathog. Dis. 6:871-877. 
Thornton, A., D. Thomson, G. Loneragan, J. Fox, D. Burkhardt, D. Emery, and T. Nagaraja. 
2009. Effects of a siderophore receptor and porin proteins based vaccination on fecal 
shedding of Escherichia coli O157: H7 in experimentally inoculated cattle. J. Food Prot. 
72:866-869. 
Verstraete, K., L. De Zutter, W. Messens, L. Herman, M. Heyndrickx, and K. De Reu. 2010. 
Effect of the enrichment time and immunomagnetic separartion on the detection of Shiga 
toxin-producing Escherichia coli O26, O103,O111, O145 and sorbitol-negative O157 
from artificially-inoculated cattle feces. Vet. Microbiol. 145:106-112. 
187 
187 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.   Prevalence of serogroup O26, based on multiplex PCR assay (A) and culture 
method (Immunomagnetic separation and plating on MacConkey agar; B), in feces of feedlot 
cattle (n=4,800). 
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Table 6.1.  Prevalence of the O26 serogroup and virulence genes, based on multiplex PCR, in 
Escherichia coli broth-enriched fecal samples (n=4,800) of feedlot cattle that received no 
treatment (control), vaccine (siderophore receptor and proteins-based), direct-fed microbials 
(Lactobacillus acidophilus and Propionibacterium freudenreichii) or both. 
Serogroup and 
virulence genes 
Total 
Number of samples (n=1,200) positive for O26 (%) 
Control Vaccine 
Direct-fed 
microbials 
Vaccine + 
Direct-fed 
microbials 
O26 502 (10.5) 110 (2.3) 87 (1.8) 179 (3.7) 126 (2.6) 
stx1 597 (12.4) 118 (2.5) 130 (2.7) 226 (4.7) 123 (2.6) 
stx2 1,151 (24.0) 263 (5.5) 251 (5.2) 341 (7.1) 296 (6.2) 
eae 2,179 (45.4) 537 (11.2) 546 (11.4) 629 (13.1) 467 (9.7) 
ehxA 4,066 (84.7) 1,047 (21.8) 967 (20.2) 1,068 (22.3) 984 (20.5) 
 
.
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Table 6.2. Prevalence of the seven serogroups of Shiga toxin-producing Escherichia coli and 
major virulence genes in pooled, randomly selected (n=10) colonies from MacConkey agar 
plated with fecal samples (n=4,800) that were enriched in Escherichia coli broth and subjected to 
O26 immunomagnetic beads separation. 
 
Serogroup 
and 
virulence 
genes 
 No. of samples positive for serogroup and virulence genes (%) 
 
Total 
(n=4,800) 
 
Control 
(n=1,200) 
Vaccine 
(n=1,200) 
Direct-fed 
microbial 
(n=1,200) 
Vaccine  + 
Direct-fed 
microbial 
(n=1,200) 
O26  1,089 (22.7)  263 (24.2) 275 (25.3) 270 (24.8) 281 (25.8) 
O45  18 (0.4)  6 (33.3) 7 (38.9) 3 (16.7) 2 (11.1) 
O103  470 (9.8)  140 (29.8) 99 (21.1) 95 (20.2) 136 (28.9) 
O111  273 (5.7)  68 (24.9) 91 (33.3) 57 (20.9) 57 (20.9) 
O121  21 (0.4)  10 (47.6) 5 (23.8) 4 (19.1) 2 (9.5) 
O145  37 (0.8)  5 (13.5) 11 (29.7) 10 (27.0) 11 (29.7) 
O157  28 (0.6)  6 (21.4) 8 (28.6) 5 (17.9) 9 (32.1) 
stx1  117 (2.4)  37 (31.6) 25 (21.4) 30 (25.6) 25 (21.4) 
stx2  519 (10.8)  137 (26.4) 125 (24.1) 102 (19.7) 155 (29.8) 
eae  378 (7.9)  105 (27.8) 112 (29.6) 76 (20.1) 85 (22.5) 
ehxA  776 (16.2)  186 (24.0) 184 (23.7) 197 (25.4) 209 (26.9) 
1
 Ten colonies were randomly picked and pooled together for the DNA extraction and 11-plex 
PCR assay. 
2  Samples were collected from feedlot pen floor fecal pats weekly for four consecutive weeks 
before the end of the study 
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Table 6.3. Prevalence of the six serogroups and four major virulence genes in pooled colonies 
(n=10) from MacConkey agar plated with fecal samples (n=4,800) that were enriched in 
Escherichia coli broth and subjected to O26 immunomagnetic beads separation and were PCR-
positive (n=1,089) for the serogroup O26 
 
Serogroups 
Number 
detected 
Virulence genes (%) 
None stx1 stx2 eae ehxA stx1 
+ eae 
stx2 
+ eae 
stx1 or 
stx2 + 
eae 
O26 1089 
561 
(51.5) 
45 
(8.5) 
216 
(40.9) 
179 
(33.9) 
311 
(58.9) 
7 
(1.3) 
52 
(9.9) 
55 
(10.4) 
O45 4 2 1 2 0 1    
O103 
168 75 
(44.6) 
12 
(7.1) 
44 
(26.2) 
29 
(17.3) 
54 
(32.1) 
1 
(0.6) 
8 
(4.8) 
11 
(6.6) 
O111 
259 112 
(43.2) 
6 
(2.32) 
50 
(19.3) 
104 
(40.2) 
57 
(22.7) 
1 
(0.4) 
23 
(8.9) 
26 
(10.0) 
O121 13 4 0 4 6 3    
O145 12 2 1 2 6 7    
O157 10 10 2 5 7 7    
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Table 6.4.  Growth and fermentation of sorbose in lactose-free MacConkey agar with or without potassium tellurite and or novobiocin 
of pure cultures of the seven Shiga toxin-producing Escherichia coli 
 Number of strains fermenting sorbose/Number of strains that grew on the medium 
Culture medium 
O26 
(n=36) 
O45 
(n=2) 
O103 
(n=40) 
O111 
(n=29) 
O121 
(n=9) 
O145 
(n=16) 
O157 
(n=20) 
Lactose-free MacConkey agar base 
with: 
       
Sorbose (10 g/l) 36/36 1/2 14/40 2/29 3/9 4/16 0/20 
 
Sorbose (10 g/l) and potassium 
tellurite (2.5 mg/l) 
32/32 0/0 13/31 2/29 3/3 3/14 0/20 
 
Sorbose (10 g/l) and novobiocin 
(8 mg/l) 
36/36 0/0 14/40 2/28 3/9 3/16 0/20 
 
Sorbose (10 g/l) + potassium 
tellurite (2.5 mg/l) + novobiocin (8 
mg/l) 
32/32 0/0 13/31 2/28 3/3 3/14 0/20 
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Table 6.5.  Isolation of Escherichia coli O26 in pure culture from pooled colonies that were PCR-positive for serogroup O26. 
Item1 
Samples 
tested 
(n = 34) 
PCR positive for 
O26 
Virulence genes5 
stx1 stx2 eae ehxA 
Pooled colonies (n=10) 34 34 3 3 3 4 
Sorbose MacConkey 34 14 1 0 0 1 
Sorbose MacConkey + Novobiocin (8 mg/l) 34 10 0 0 0 1 
Sorbose MacConkey +Potassium tellurite (2.5 mg/l)  34 8 0 0 0 2 
Sorbose MacConkey + Novobiocin (8 mg/l) and 
Potassium tellurite (2.5 mg/l) 
34 14 2 0 0 2 
193 
193 
 
 
Table 6.6. Isolation of Escherichia coli O26 from pooled colonies that were PCR-positive for 
serogroup O26 but did not yield O26 when plated on sorbose MacConkey agar (n = 47) 
Item 
PCR positive 
for O26 
Virulence genes 
stx1 stx2 eae ehxA 
Pooled colonies1 47 1 9 9 12 
Isolates from each agar2: 
     
Sorbose MacConkey agar3 0 0 7 0 1 
Sorbose MacConkey agar + Novobiocin 
(8 mg/l) 3 1 6 2 2 
Rhamnose MacConkey agar4 + 
Novobiocin (8 mg/l) 2 0 11 6 3 
Non-O157 Shiga toxin-producing E. coli 
differential agar5 + Novobiocin (8 mg/l) 1 0 1 3 1 
1Pooled colonies isolated from MacConkey agar, previously indicated to be positive for E. coli 
O26 by mPCR, but did yield E. coli O26 when an initial attempt was made by streaking onto 
sorbose MacConkey agar.   
3Sorbose agar was a lactose-free MacConkey agar base with sorbose added (10.0 g/l). 
4Rhamnose agar is lactose-free MacConkey agar base with rhamnose (10.0 g/l). 
5Composition according to Posse et al., 2008.  
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Table 6.7.  Pathotypes and virulence gene profiles of isolated Escherichia coli O26 (n=260). 
Pathogroup 
No. of 
isolates 
Virulence genes 
stx1 stx2 eaeβ1 ehxA bfpA tir fliCH11 espP 
Shiga toxin- 
Producing E. coli O26 
7 6 1 7 3 0 7 6 3 
Profile 1 2 + - + + - + + + 
Profile 2 1 + - + - - + + + 
Profile 3 1 + - + - - + + - 
Profile 4 1 + - + + - + + - 
Profile 5 1 + - + - - + - - 
Profile 6 1 - + + - - + + - 
          
Atypical enteropatho-
genic1 E. coli O26 
236 0 0 236 7 0 234 197 3 
Profile 1 187 - - + - - + + - 
Profile 2 37 - - + - - + - - 
Profile 3 7 - - + + - + + - 
Profile 4 3 - - + - - + + + 
Profile 5 2 - - + - - - - - 
 
Avirulent\ E. coli O26 17 0 0 0 0 0 0 1 0 
Profile 1 16 - - - - - - - - 
Profile 2 1 - - - - - - + - 
1Atypical enteropathogenic classification is based on the presence of eae and absence of bfpA 
and stx genes. 
 
 
